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Abstract 
In New Zealand, there has been limited enquiry into the experiences of dialysis 
patients and the health professionals who work with these patients.  The number 
of people requiring dialysis is increasing every year and the support they require 
to manage end stage kidney disease is complex.  It involves the invasive physical 
intervention of dialysis, as well as psychological support to cope with the 
significant life changes and social support to help patients to manage this disease.  
The purpose of this research is to explore the nature of psychological well-being 
of patients under the care of the Waikato Regional Renal Unit.  The level of 
psychological support that the patients have access to is investigated and 
suggested improvements rationalised against prior research findings are 
presented.   The intent of this research is to create an awareness of the 
psychological needs of dialysis patients.   It aims to give insight into the 
participants’ lived experience as they openly describe their lives as dialysis 
patients, and endeavours to open up discussion for change. 
Two data gathering approaches were used to engage with patients and health 
professional.  I completed interviews with 11 renal patients and 14 health 
professionals, and administered a mail out questionnaire to 197 patient 
respondents.   Thematic analysis of the interview data identified the following 
themes; the impacts of end stage kidney disease on the psychological well-being 
of renal patients, the need for psychological support for patients with end stage 
kidney disease, and the need for improved communication between and across all 
parties; the support people, the health professionals and the renal patient. 
 
 
  
iii 
 
Acknowledgements 
First and foremost, I would like to express my gratitude to the patient and staff 
interview participants who took the time to share their stories, wisdom and 
knowledge with me and a big thank you to the respondents who completed the 
questionnaire for this research.  This study would not have been possible without 
your contribution for which I am sincerely grateful.  
A special dedication to my oldest and dearest friend Cherie Tuaupiki who is 
unfortunately suffering from end stage kidney disease.  Before you started 
dialysis, I can honestly say that I knew very little about this disease and the 
catastrophic effects it has on the lives of those with end stage kidney disease.  I 
continue to witness your struggle and I am constantly amazed by your resilience 
and determination to map out a better life.  You are an inspiration to me.  
To my main supervisor Professor Linda Waimarie Nikora, thank you for your 
ongoing support, guidance and friendship.  You provided a safe space for me to 
learn and it is warmly appreciated.  Dr Carrie Barber, thank you for your advice 
and assistance whilst I was doing the research for this thesis.  It has been a 
privilege to be helped by such strong women.   
Special mention needs to go to Rae Braithwaite who kept me sane in times of 
turmoil, and helped me throughout my university journey.  Your friendship is 
highly valued and appreciated, I thank you.  Thank-you also to Jane Currie and 
Julie Batley for kindly offering to proofread for me and for all your positive 
affirmations, and Vonnie Fly who encouraged me to study and has always 
supported me.  
I would also like to thank Mr P Sizeland the clinical director of the renal unit, Mrs 
Helen O’Connell and the Waikato District Health Board for facilitating the 
conducting of this research.  Also, the Māori & Psychology Research Unit for the 
scholarship they awarded me to complete this thesis, it was appreciated. 
Finally, my children Sean, Aaron and Amy, you are always there to support me, 
thank you for believing in me, I am so grateful to be your mum.  
  
iv 
 
Table of Contents 
 
Abstract ................................................................................................................... ii 
Acknowledgements ................................................................................................ iii 
Table of Contents ................................................................................................... iv 
List of Figures ........................................................................................................ ix 
List of Tables........................................................................................................... x 
Introduction ............................................................................................................. 1 
Chapter One: Literature Review ............................................................................. 2 
Treatment Options ............................................................................................... 4 
Haemodialysis ................................................................................................. 4 
Peritoneal Dialysis .......................................................................................... 6 
Kidney Transplant ........................................................................................... 8 
Conservative Treatment ................................................................................ 10 
Causes of Kidney Failure .................................................................................. 11 
Diabetes ......................................................................................................... 11 
Glomerulonephritis ....................................................................................... 12 
Hypertension ................................................................................................. 13 
Analgesic Nephropathy ................................................................................. 13 
Vascular Risks ............................................................................................... 14 
Screening ........................................................................................................... 14 
The impacts of kidney failure ........................................................................... 15 
Nutrition ........................................................................................................ 15 
Medication..................................................................................................... 16 
Pain ................................................................................................................ 16 
The financial cost of kidney failure .............................................................. 17 
Psychological effects of kidney failure ......................................................... 18 
v 
 
Depression ..................................................................................................... 20 
Health related quality of life ......................................................................... 23 
Treatment ...................................................................................................... 23 
Non-compliance ............................................................................................ 24 
Self-efficacy .................................................................................................. 26 
Locus of control ............................................................................................ 29 
Social support ................................................................................................ 30 
Anxiety .......................................................................................................... 30 
Summary ........................................................................................................... 32 
Chapter Two: Method ........................................................................................... 33 
Recruitment of participants ............................................................................... 33 
Recruitment procedures ................................................................................ 33 
Recruitment of questionnaire participants .................................................... 33 
Recruitment of Peritoneal dialysis and haemodialysis patients for interview
 ....................................................................................................................... 34 
Recruitment of health professionals for interview ........................................ 34 
Participants .................................................................................................... 34 
Development of research tools .......................................................................... 35 
Research flyer................................................................................................ 35 
Participant information sheet ........................................................................ 35 
Participant consent form ............................................................................... 35 
Interview questions for dialysis patients ....................................................... 36 
Interview question for health professionals .................................................. 36 
Mail-out Questionnaire ................................................................................. 36 
The Social Provisions Scale – Short Version .................................................... 37 
The Beck Depression Inventory ........................................................................ 38 
The Beck Anxiety Inventory ............................................................................. 39 
vi 
 
Ethical Approval ............................................................................................... 39 
Research procedures.......................................................................................... 40 
Semi structured interviews ............................................................................ 40 
Thematic analysis .......................................................................................... 42 
Chapter three: Questionnaire Findings.................................................................. 44 
Transplant list .................................................................................................... 45 
Coping mechanisms .......................................................................................... 45 
Requests during treatment ................................................................................. 46 
Feeling secure.................................................................................................... 46 
Nurses responses ............................................................................................... 46 
Level of care ...................................................................................................... 47 
Health Rating .................................................................................................... 47 
Activities ........................................................................................................... 48 
Section Three: Social Provisions Scale-Short Version ..................................... 49 
Section Four: Beck Depression Inventory (BDI) – Second Edition ................. 52 
Section Five: Beck Anxiety Inventory (BAI) ................................................... 54 
Summary ........................................................................................................... 58 
Chapter Four: Qualitative Findings ....................................................................... 61 
Section one: Impacts on psychological well-being ............................................... 61 
Screening for renal disease................................................................................ 61 
Reactions to diagnosis and treatment ................................................................ 62 
Depression ......................................................................................................... 64 
Anxiety .............................................................................................................. 65 
Compliance ....................................................................................................... 66 
Implications ....................................................................................................... 68 
Section two: Need for psychological support for patients .................................... 71 
Psychological training ....................................................................................... 71 
vii 
 
Psychological Screening ................................................................................... 73 
Family support .................................................................................................. 73 
Psychological support ....................................................................................... 78 
Spiritual support ................................................................................................ 80 
Implications from this research ......................................................................... 81 
Section Three: Need for improved communication .............................................. 85 
Negative experiences with the healthcare system ............................................. 85 
Resources .......................................................................................................... 87 
Pain .................................................................................................................... 91 
Challenges to renal health professionals ........................................................... 91 
Coping mechanisms .......................................................................................... 92 
Implications for improved communication from this research ......................... 93 
Chapter Five: Discussion and Conclusion ............................................................ 97 
Impacts on psychological well-being ................................................................ 97 
Need for psychological support for patients ................................................... 100 
Patients need for improved communication .................................................... 104 
Future research ................................................................................................ 107 
Why this research? .......................................................................................... 108 
References ........................................................................................................... 110 
Appendices .......................................................................................................... 123 
Appendix A: Questionnaire confirmation sheet .............................................. 124 
Appendix B: Dialysis patient questionnaire .................................................... 125 
Appendix C: Flyer - Patient ............................................................................ 138 
Appendix D: Flyer – Health Professional ....................................................... 139 
Appendix E: Information sheet - Patients ....................................................... 140 
Appendix F: Information sheet – Health professional .................................... 142 
Appendix G: Consent form - Patients ............................................................. 144 
viii 
 
Appendix H: Consent form – Health professional .......................................... 145 
Appendix I: Interview questions - Patients ..................................................... 146 
Appendix J: Interview question – Health professional ................................... 147 
 
 
 
  
ix 
 
List of Figures 
 
Figure 1: The WHO analgesic ladder.................................................................... 17 
 
 
  
x 
 
List of Tables 
 
Table 1: Advantages and disadvantages of PD & HD ............................................ 7 
Table 2: Iranian Model.......................................................................................... 10 
Table 3: Factors contributing to depression in patients with CKD ....................... 20 
Table 4: Symptoms of depressive disorders (DSM 5) .......................................... 21 
Table 5: Nonmedical factors for chronic diseases ................................................ 25 
Table 6: Chronic disease tasks .............................................................................. 26 
Table 7: Self-efficacy enhancing strategies .......................................................... 27 
Table 8: Self-efficacy enhancing interventions..................................................... 28 
Table 9: Symptoms of Generalized Anxiety Disorder .......................................... 31 
Table 10: Phases of thematic analysis ................................................................... 43 
Table 11: Types of dialysis treatment ................................................................... 44 
Table 12: Patient requests ..................................................................................... 46 
Table 13: Health rating.......................................................................................... 47 
Table 14: Treatment activities ............................................................................... 48 
Table 15: SPS subscales and family care .............................................................. 49 
Table 16: SPS subscales and family understanding of ESKD .............................. 51 
Table 17: BDI test items ....................................................................................... 53 
Table 18: BAI test items ....................................................................................... 55 
Table 19: BAI and income test.............................................................................. 56 
Table 20: BAI and dialysis treatment option ........................................................ 57 
 
 
1 
 
Introduction 
I came to this research topic as a support person for approximately four years to 
my friend, a patient with end stage kidney disease. This has allowed me the 
opportunity to walk alongside a dialysis patient and witness her journey.  This 
experience has given me valuable insight into the complexities of this disease, its 
management and the very real needs of renal patients.  Inspired and encouraged 
by my friend, other renal patients and staff of the WDHB, I embarked on this 
thesis research endeavour to better understand the psychological needs of renal 
patients and of developing services and solutions responsive to them. 
This thesis is comprised of five chapters. Chapter one of this thesis reviews the 
relevant literature regarding end stage kidney disease and the treatment options 
available.  The causes of kidney failure and the impacts of this are then examined.  
Chapter Two describes the method used for the recruitment of participants, the 
research tools I developed to complete this research, and the research procedures I 
used to collect and analyse the data.  Chapter Three presents the quantitative 
results of the findings from my questionnaire.  Chapter Four presents an analysis 
of the transcribed interviews, discusses these findings and the implications of 
these for patients and the health professionals working with them.  Chapter five 
includes a discussion of the findings and considerations for future research are 
also included in this chapter.  
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Chapter One: Literature Review 
This chapter begins with a description of kidney failure, and then the treatment 
options that are available for dialysis patients are explored.  The causes of kidney 
failure are critiqued and finally the impacts of kidney failure are discussed.  
Christensen and Ehlers (2002) suggest that “end stage kidney disease is a disorder 
marked by an extreme loss of personal control, an array of acute and chronic 
stressors, a high degree of emotional distress and psychiatric co-morbidity” (p. 
720). 
Description of kidney failure 
To comprehend what is meant by end stage kidney disease (ESKD) or end stage 
renal failure (ESRF) an understanding of the illness and a grasp of the 
terminology is required.  The word ‘kidney’ derives from the medieval English 
word ‘kidenei’ for kidney. The term ‘renal’ comes from the Latin word ‘ren’ 
meaning kidney or relating to the kidneys.  “Nephrology’ is the science of kidney 
medicine and is derived from the Greek word ‘nephros’ which also means kidney 
(New Zealand Kidney Foundation, 2007).  The kidneys serve important functions 
including filtration and excretion of waste products, the regulation of necessary 
electrolytes and fluid, as well as acid-base (pH) balance. They also stimulate the 
production of red blood cells. The kidneys regulate blood pressure and control 
reabsorption of water and maintain intravascular volume.  The kidneys activate 
Vitamin D, reabsorb glucose and amino acids and have hormonal functions 
(Medscape, 2015a).  
Chronic kidney disease (CKD) is a general term referring to various disorders that 
affect the structure and function of the kidney.  CKD is a gradual and progressive 
loss of kidney function.  This loss varies dependent upon the cause and pathology, 
the severity and rate of progression (Levey & Coresh, 2012).  A diagnosis of CKD 
is confirmed by routine laboratory tests to detect the levels of the glomerular 
filtration rate (GFR) and the levels of albuminuria in the urine (Levey & Coresh, 
2012).  Albuminuria is a protein that is measured through the urine and high 
levels of albuminuria are the first signs of kidney disease (National Kidney 
Foundation Inc, 2015a).  GFR is the measurement of the amount of creatinine in 
3 
 
the blood which is a normal waste product removed from the body by the kidneys 
(Kidney Health New Zealand, 2015; Zhao, 2013).  The GFR is the best indicator 
of kidney function and takes into account the person’s age, sex and body size to 
produce an accurate measure (National Kidney Foundation Inc, 2015b).  Once 
kidney disease has been confirmed further tests are then required.  These include 
imaging tests which could consist of ultrasounds, computerised tomography (CT) 
scans and X-rays.  Often a kidney biopsy is performed to determine what type of 
kidney disease is present and the extent of the damage (New Zealand Kidney 
Foundation, 2007). 
There are three types of kidney failure.  These consist of acute kidney failure 
(AKF) or acute kidney injury (AKI), chronic kidney failure (CKF) or chronic 
renal failure (CRF), and ESKD or ESRF (Casey, 2012).  AKF is a sudden loss of 
kidney function, which can be the result of ischemia, which is the reduced blood 
supply to a bodily organ (Campbell, 2003).  This could be the result of a serious 
accident, a compromised immune system or an infection to the kidney (New 
Zealand Kidney Foundation, 2007).  In New Zealand (NZ) about four percent of 
patients in intensive care develop AKF, which has a greater than 60% mortality 
rate.  Of the general hospital population in NZ the incidence of AKF is 
approximately 18% with a mortality rate of 30% to 60 %. When recovering from 
AKF approximately 12% of patients will require ongoing dialysis.  Up to 30% 
will develop CKD (Casey, 2012).  In NZ, there has been a rise of CKD patients 
mainly because of the diabetes epidemic.  Most of these patients will eventually 
require dialysis to survive (Nikolajenko, 2013).  There are five stages of CKD; 
stage one CKD is when there is normal kidney function with normal or increased 
GFR, stage two CKD is when there is kidney damage with mild decrease in GFR, 
stage three CKD is when there is a moderately decreased GFR, stage four has a 
severely decreased GFR, and stage five is termed as ESKD.  This latter diagnosis 
is given when a person’s kidney function has stopped.  ESKD is fatal because a 
human body cannot survive more than a few days without kidney function.  
Therefore, some form of renal replacement therapy (RRT) is necessary for 
survival. I consider these options in the next section. 
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Treatment Options  
In NZ there were 4368 people receiving RRT as at 31 December 2015 (Kidney 
Health New Zealand, 2017).  Of these 1694 have a functioning kidney transplant 
and 2674 were receiving dialysis treatment.  The mean age of NZ patients 
requiring RRT is 56 years and the median is 59 years (Kidney Health New 
Zealand, 2017).  The number of patients commencing RRT each year in Australia 
and NZ increased by 321% between 1990 and 2009.  This rise was largely driven 
by increases in patients with diabetic nephropathy, which is damage to the 
kidneys caused by diabetes.  In 2009 diabetic nephropathy accounted for 35% of 
patients newly diagnosed with ESKD, 92% of these had type 2 diabetes.  By 2015 
this number had increased to 47% of all newly diagnosed patients.  Furthermore, 
an increased acceptance for dialysis of older and sicker patients is also 
contributing to increased numbers receiving RRT (Grace, Clayton, & McDonald, 
2012; Kidney Health New Zealand, 2017).  There are two types of dialysis 
treatments available for a person with ESKD. These are haemodialysis (HD) and 
peritoneal dialysis (PD).  Kidney transplants are an option if the patient meets the 
criteria and a donor kidney is available.  However, the only option for some 
patients is conservative treatment, which is a form of palliative care. 
Haemodialysis 
Dialysis treatment for renal patients will be a lifetime requirement for survival, or 
a long-term necessity until a kidney transplant is available.  ESKD patients use 
haemodialysis (HD) to remove the build-up of excess fluid and clean the blood.  
HD requires the patient to have an intravenous catheter or an arteriovenous fistula 
(AVF) or an arteriovenous graft (AVG) inserted to create an access site.  
Intravenous catheters are a soft tube placed in a large vein, usually at the neck, 
chest or groin area for short to medium term use of between weeks to months 
(Moss, McLaughlin, Lempert, & Holley, 1988).  AVFs join the patient’s own 
artery and vein to create a vascular access or fistula, whereas AVG’s use a 
synthetic material to join an artery and vein.  The AVFs have a mean problem free 
patency period of about three years, and the AVGs last one to two years before 
indications of failure or thrombosis are noted (Sofocleous & Cho, 2015).  AVFs 
and AVGs can often cause ongoing problems for patients. 
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The catheters facilitate the connection of the patient to a specialised dialysis 
machine.  The 5008/5008S Therapy System is currently used in the Waikato 
Regional Renal Centre.  This dialysis machine monitors the patient’s blood 
pressure, blood temperature and blood volume.  It provides patient safety by using 
ultrapure dialysis fluid and filters to filter the blood (Fresenius Medical Care 
Australia Pty Ltd, 2015).  Two needles are inserted into the patient’s fistula or 
graft.  One draws the blood out of the body and the other returns the cleansed 
blood to the body.  The blood is filtered through a dialyzer or artificial kidney 
which removes waste products such as urea, creatinine, potassium and excess 
fluid, and these are washed away.  The average person has about five litres of 
blood which is cleaned through the dialysis machine approximately six to ten 
times in a dialysis session.  Only about 300ml or two cups of blood are out of the 
body at any time.  Dialysis sessions are required on average three times a week 
with each session lasting four to eight hours (National Kidney Foundation Inc, 
2015c).  According to Marshall, Byrne, Kerr, and McDonald (2006) the optimal 
session length is greater than four and a half hours three times a week to ensure 
the maximum waste products and fluid are removed.  
HD is carried out at renal units which are usually attached to a hospital.  These 
units have full-care and self-care facilities depending on the patient’s needs.  Full-
care HD patients are under the care of a renal nurse for the duration of their 
treatment.  Self-care HD patients carry out some of the procedures themselves, but 
nursing staff are available to assist them.  This allows patients to take a more 
active part in their dialysis treatment and sometimes take full control.  HD 
equipment can also be installed in private homes under the guidance of the renal 
team and after patient training has been completed.  Recently the Kidney Society 
established four HD community houses in Auckland where up to sixty people can 
dialyse, and this new initiative is proving very popular for local patients (Kidney 
Society, 2017).  In New Zealand, there were 1752 patients receiving HD treatment 
as at 31 December 2015 and this has remained static for the past three years. 
These numbers were made up of 959 patients using hospital based HD, 442 using 
satellite HD units and 482 using home HD (Kidney Health New Zealand, 2017).  
Sinclair (2009) states that often patients struggle with home HD because of the 
lack of explanation regarding techniques, fear of failure and social isolation.  
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Further issues affecting home HD patients include needle phobias, fear of change, 
aging and lack of space in the home environment.  However, McGregor et al. 
(2000) report that home HD offers good rehabilitation with good blood pressure 
control and longer sessions which are on average seven hours of treatment three 
times a week.  Also, home HD has advantages over hospital dialysis due to the 
lower costs, higher quality of life and longer survival rates.  
Peritoneal Dialysis 
Peritoneal dialysis (PD) replaces lost kidney function by using the peritoneal 
membrane in the abdominal cavity as a filter.  The peritoneal membrane covers 
abdominal organs including the stomach, liver, spleen and intestines.  These 
organs are rich in blood vessels which are ideal for the exchange of waste and 
excess fluid.  To access the peritoneal cavity a catheter needs to be surgically 
inserted.  A peritoneal dialysis catheter is composed of a flexible silicone tube 
with an open-ended port and several side holes to provide optimal drainage and 
absorption of the dialysate (Ellsworth & Kim, 2015).  Dialysate is the fluid used 
in PD which enters and leaves the peritoneal cavity from bags via the catheter.  
During PD, the peritoneal cavity is filled with dialysate which draws fluids and 
toxins out of the blood vessels, and supplies electrolytes and other chemicals to 
the blood vessels.  After a predetermined time, the dialysis fluid is drained into a 
bag and then discarded along with the removed toxic substances and then replaced 
with a fresh solution.  An adult will hold two to three litres of fluid per exchange 
depending on their body size and individual conditions (New Zealand Kidney 
Foundation, 2007). 
There are two types of PD, continuous ambulatory peritoneal dialysis (CAPD) and 
automated peritoneal dialysis (APD).  CAPD is continuous and machine free and 
consists of a daily routine that requires the patient to exchange dialysis fluids 
every four to six hours.  Each exchange takes about forty-five minutes and can be 
carried out in any clean environment.  APD is done overnight with a cycler 
machine that performs exchanges automatically while patients sleep.  The 
machine controls the movement of fluid in and out of the peritoneal cavity with 
usually six to eight exchanges every night.  The final exchange leaves fluid in the 
peritoneal cavity so that dialysis can still occur slowly during the day.  The APD 
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machine is portable allowing the user to move freely if required (New Zealand 
Kidney Foundation, 2007).  
PD is the most common form of home dialysis. “The overall proportion of 
prevalent patients on PD in NZ is 35%, home HD 98%, with the remainder 
receiving hospital dialysis” (Walker & Marshall, 2014, p. 41).  PD is less 
expensive to set up and maintain than HD (Remuzzi et al., 2013).  PD is also 
associated with reduced mortality when used at dialysis commencement.  In 
Australasia patients starting on PD have approximately 20% reduced adjusted risk 
of death in the first years of dialysis compared with patients who dialyse in 
hospital (McDonald, Marshall, Johnson, & Polkinghorne, 2009; Walker & 
Marshall, 2014).  Furthermore, compared with hospital based HD, patients using 
PD at home report a better quality of life and a more flexible lifestyle, greater 
independence and more opportunities for employment and social involvement 
(Kutner, Zhang, Barnhart, & Collins, 2005; Mowatt, Vale, & MacLeod, 2004). 
There are advantages and disadvantages with both forms of dialysis.  The New 
Zealand Kidney Foundation created this comparison list (Table 1). 
Table 1: Advantages and disadvantages of PD & HD   
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Peritoneal Dialysis Haemodialysis 
Performed every day – continuous control 
of blood chemistry. 
Usually performed three times a week – 
blood chemistries vary from day to day. 
Performed every day of the week.  Usually four days off per week. 
CAPD is relatively portable – easy to take 
with you for holidays or travel for work.  
APD is also portable, as modern machines 
will fit in the boot of a car. 
Haemodialysis has to be done where there 
is proper plumbing, so if you need to 
travel you will have to book into a 
haemodialysis facility close to where you 
will be. 
Peritoneal dialysis is usually done by the 
patient themselves, and is easy for one 
person to manage.  If required a partner 
can be trained to assist or perform the 
treatment. 
Some form of assistance is usually 
required to set up haemodialysis.  It can be 
performed by the patient themselves, or by 
another person such as a nurse if the 
patient is unable to do it themselves. 
Peritoneal dialysis is always done at home. Haemodialysis can be done at home, or in 
a self-care centre near your home, or at a 
hospital renal unit. 
The main complication of peritoneal 
dialysis is infection – peritonitis.  Other 
risks include blocking or leakage of the 
peritoneal catheter. 
The main complication of haemodialysis is 
partial or complete blockage of the fistula 
or graft providing vascular access. 
Residual renal function is better preserved 
in peritoneal dialysis than in 
haemodialysis. 
Residual renal function is lost more 
rapidly in haemodialysis than in peritoneal 
dialysis. 
 
Source: (New Zealand Kidney Foundation, 2007, p. 29) 
Kidney Transplant 
A kidney transplant can be another treatment option for people with ESKD.  
Kidney transplants are one of the most common and the most successful organ 
transplantation operations with over an 80% success rate (Youngson, 2000).  
Donated kidneys can come from two sources, living donors and cadaveric or 
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recently deceased donors.  In NZ, the number of kidney transplants in 2016 was 
172.  These consisted of 72 live donor transplants and 77 kidneys from 53 
cadaveric donors.  The median age for NZ transplant recipients in 2015 was fifty 
and the mean donor age was thirty-six (Kidney Health New Zealand, 2017).  
Unfortunately, there are more people on the waiting list than there are donors.  
The average waiting time for a cadaveric kidney in NZ is two to three years (New 
Zealand Kidney Foundation, 2007). 
Another alternative recently carried out in NZ was the establishment of a kidney 
transplant chain.  In 2011 the first two-pair kidney transplant chain operation was 
performed.  This can be utilised when a donor is incompatible with a particular 
recipient but can be matched with another recipient.  This occurred when an 
‘emotional donor’, the wife of an ESKD patient, wanted to donate to her husband 
but was not compatible.  Another ‘altruistic donor’ was compatible with her 
husband so he received this kidney and his wife then donated her kidney to 
another patient.  This transplant chain created the opportunity for two recipients to 
receive kidneys instead of just using the altruistic donor’s kidney for the husband.  
This relatively new concept has the potential to increase the amount of living 
donor transplantations (Voitov, Dittmer, Burton, & Muthu, 2012).  As the number 
of patients requiring kidney transplants is predicted to continue to rise by 4 to 6%  
annually until at least 2020, the transplant chain model is of significance for NZ 
patients (Nikolajenko, 2013).  It is important to understand that kidney transplants 
are only available to medically suitable patients.  The evaluations of both the 
recipient and donor involve a rigorous procedure.  Regrettably as time passes the 
health of a recipient will often deteriorate and they may then no longer meet the 
criteria for a kidney transplant. 
The problem of organ shortage has been addressed in Iran by introducing the 
Iranian model.  This model coordinates potential recipients and donors and 
organises tests to ensure compatibility.  A charity known as the Society for 
Supporting Dialysis and Transplantation Patients was founded in 1978 and by 
1990 it had the backing of the Iranian government.  The government covers the 
donor’s full medical care and medical insurance for one year after surgery but 
only conditions related to the surgery.  Donors also receive a gift of about 
US$1200 to compensate for lost earnings and absence from work.  These 
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incentives have increased the number of renal donations available to ESKD 
patients, and in 1999 the waiting list for kidney transplantations fell to almost zero 
(Einollahi, 2010).  The Iranian Model consists of the following characteristics 
listed in Table 2 below. 
Table 2: Iranian Model 
Characteristics of ‘Iranian Model’ for living unrelated donor renal 
transplantation 
No coercion 
Donors to be true volunteers (altruistic or emotionally related donors) 
Donors age > 18 years 
Donors given gifts supported by the government 
Donors given one year of free health insurance 
No commercialism 
No matchmaker or broker 
No financial benefit for transplant team 
No foreign recipients for Iranian donors 
No foreign donors for Iranian recipients 
Foreigner recipients and donors must be of the same nationality 
No waiting list 
Rich and poor patients are equally transplanted 
Written consent will be obtained from the donor 
Written consent will be obtained from the donor’s parents and/or spouse 
 
Source: (Einollahi, 2010, p. 3) 
Conservative Treatment 
Dialysis or kidney transplantation is not always a suitable option for a patient with 
renal failure, because it may not be considered in the best interests of the patient’s 
wellbeing.  Brown and Crail (2013) report that in most cases patients for whom 
treatment is not a viable option are “elderly and have significant co-morbidity, 
poor functional status, malnutrition or who reside in a nursing home” (p. 401).  A 
conservative treatment pathway is based on realistic discussions about the likely 
survival of the patient and their quality of life.  All decisions regarding these 
choices involve the patient and family who weigh up the advantages of dialysis 
versus non-dialysis.  With the increased expertise that palliative care specialists 
can offer, the option of a more holistic approach might be suitable for some 
patients (Crail, Walker, & Brown, 2013).  Treatment options can be reconsidered 
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at any stage as the patient continues to be under the care of the renal team until 
death.  If a patient is experiencing severe symptoms whilst on dialysis they may 
change their mind and request conservative treatment and this can then be 
implemented. For these patients, support can include psychiatric services, 
counsellors, cultural liaison staff, spiritual care advisers, palliative care and 
hospice (Egan et al., 2014).  The decision to decline treatment will ultimately lead 
to death within a very short period of time (New Zealand Kidney Foundation, 
2007). 
In the following section, I turn my attention to the causes of kidney failure. 
Causes of Kidney Failure 
Diabetes 
Diabetic nephropathy or diabetic kidney disease is reported to be the leading 
cause of renal failure in persons requiring RRT (Ravenscroft, 2005).  Diabetic 
nephropathy affects the ability of your kidneys to do their usual work of removing 
waste products and extra fluid from your body.  The glomeruli are a cluster of 
capillaries located in the nephron which is the filtering and excretory unit of the 
kidneys (Gattone, 2009).  Diabetic nephropathy causes damage to the capillaries 
in the kidneys glomeruli, and is characterized by nephrotic syndrome and diffuse 
scarring of the glomeruli (Mayo Foundation for Medical Education and Research, 
2017). 
In NZ 49 % of all new patients have diabetic nephropathy as the cause of their 
ESKD (Kidney Health New Zealand, 2015).  In Australia and NZ males are more 
likely to commence RRT due to diabetes than females, except among Australian 
Aborigines where females are more at risk (Grace et al., 2012).  Māori and Pacific 
Islanders are three times more likely to get diabetes.  Joshy, Dunn, Fisher, and 
Lawrenson (2009) report that Māori with diabetes are up to forty-six times more 
likely to have renal failure, much higher than the current official estimate which is 
three times more likelihood of renal failure for Māori.  Also, Māori with type 2 
diabetes are fifteen times more likely to die from diabetic nephropathy than NZ 
Europeans with type 2 diabetes.  Māori diabetes patients have significantly higher 
incidence of dialysis or transplantation (46-fold), rates of renal admission (7-fold) 
and renal death (4-fold).  Māori patients progressed to ESKD at a faster rate from 
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initial hospital admission for CKD.  This huge ethnic disparity highlights the need 
for Māori diabetes patients to be screened regularly for kidney disease, and the 
monitoring and management of risk factors (Collins, 2010; Joshy et al., 2009).  
Patients with diabetes are susceptible to the thickening of the walls of the small 
arterioles and capillaries which can affect the kidneys, retina, brain and peripheral 
nerves.  This arteriole damage can cause diabetic nephropathy which leads to 
ESKD (Medscape, 2015b).  The number of people with type 1 and type 2 diabetes 
is rising, however due to obesity rates increasing type 2 diabetes is now an 
epidemic (Ministry of Health New Zealand, 2013).  According to Ravenscroft 
(2005) the “incidence and onset of diabetic nephropathy for type 1 diabetes is 33-
45%, type 2 diabetes 15-25%.  The incidence of kidney failure after 15-20 years 
of diabetes for type 1 diabetes is 30-50% and for type 2 diabetes it is 5-10%” (p. 
503). 
Type 1 diabetes is a chronic illness where the pancreas can no longer produce 
insulin.  Onset is often in childhood but it can also develop as an adult.  
Approximately 5% of diabetics are type 1 and they will need to inject insulin to 
stay alive.  Type 2 diabetes is when there is a resistance to insulin, or the 
production of insulin is not enough to keep a person healthy (Ravenscroft, 2005).  
The treatment for type 2 diabetes consists of diet, exercise, medication and 
education pertaining to blood glucose control.  ESKD patients who have type 1 
diabetes and meet the requirements for a kidney transplant may also be suitable 
for a pancreas transplant.  This can be done simultaneously or separately 
depending on the availability of the organs.  The benefit of this is that the 
transplanted pancreas can produce insulin which cures diabetes, improving the 
overall health of the patient.  The prevalence of co-morbid conditions is markedly 
higher for patients with diabetes and survival rates significantly poorer (National 
Kidney Foundation Inc, 2015d).   
Glomerulonephritis 
The second most common cause of ESKD is Glomerulonephritis (GN).  GN is a 
kidney disease affecting the capillaries of the glomeruli.  GN is characterised by 
the presence of albuminuria and edema which is a build-up of fluid in the cells of 
tissue or in body cavities.  Hypertension, the elevation of blood pressure, is also 
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present (Medscape, 2015a).  Very little is known about the cause of GN however 
it is understood that the patient’s own immune system attacks the nephron and 
causes inflammation, damage and scarring.  The onset of GN can be slow or 
rapid.  While some people recover without treatment and some respond to 
immunosuppressive medication, others progress to ESKD  (New Zealand Kidney 
Foundation, 2007).  In NZ 20% of new patients present with this condition 
(Kidney Health New Zealand, 2015). 
Hypertension   
In NZ the cause of ESKD in 11% of all new patients is attributed to Hypertension 
(HTN) or high blood pressure (Kidney Health New Zealand, 2015).  HTN can 
contribute to or cause CKD and vice-versa in a cyclic relationship.  HTN damages 
the blood vessels within the kidney and throughout the body.  When this damage 
occurs in the kidney the function is impaired and the kidney cannot efficiently 
filter fluid and waste from the blood. This leads to an increase of fluid volume in 
the blood which causes an increase in HTN (Buffet & Riccheitti, 2015).  The 
importance of lowering blood pressure through effective treatment can reduce the 
risk of kidney damage by half and the risk of kidney failure by a third  (New 
Zealand Kidney Foundation, 2007). 
Analgesic Nephropathy 
Analgesic Nephropathy is a term used by nephrologists to describe how some 
drugs cause kidney damage.  The most prevalent of these to cause kidney damage 
was the drug phenacetin, which was used for pain relief (van der Woude et al., 
2007).  Phenacetin was mixed with aspirin and codeine and sold as a head-ache 
powder, but in the early 1980s phenacetin was banned because it was found to be 
causing kidney damage (New Zealand Kidney Foundation, 2007).  Phenacetin has 
also been listed as a risk factor in kidney cancer if a person has a past history of 
long term use (National kidney Foundation Inc, 2015e).  Other non-phenacetin 
combinations are also under constant review especially those containing 
paracetamol, aspirin and caffeine, to ensure they are safe from causing kidney 
damage (van der Woude et al., 2007). 
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Vascular Risks  
Vascular risks occur when there is a compromised blood flow to the kidney.  This 
can involve the large blood vessels leading to the kidney or the smaller blood 
vessels within the kidney.  When these vessels become blocked it can result in 
kidney damage and renal failure.  The vascular system is put at risk if a person is a 
smoker, if they have a diet high in fatty foods, high cholesterol, do not regularly 
exercise or are obese.  The consequences of these lifestyle choices can cause heart 
attacks, strokes and kidney failure (New Zealand Kidney Foundation, 2007). 
Obesity is a strong risk factor for developing CKD and ESKD.  The kidneys must 
work harder in obese people to meet the demands of the increased body weight 
more blood must be filtered which can damage the kidneys.  The World Health 
Organisation (2017b) estimates that by 2025 “obesity will affect 18% of men and 
over 21% of women worldwide, and that severe obesity will affect 6% of all men 
and 9% of all women, people who are overweight or obese have 2 to 7 times more 
chance of developing ESKD compared to those of normal weight” (p. 1).  
Furthermore, acute kidney injury (AKI) occurs more frequently in obese people.  
By reducing obesity CKD can be reversed or the progression slowed down (World 
Health Organisation, 2017a). 
Screening  
In NZ regular screening for CKD in the Primary Health Organisations has been 
recommended by the Ministry of Health, however there is currently no systematic 
process for screening apart from those who have diabetes (Nikolajenko, 2013).  
According to Walker, Abel, and Meyer (2010) early detection of renal failure is 
important so that the patient can receive pre-dialysis care, which is effective in 
extending the time before going on dialysis is necessary.  Pre-dialysis education 
also improves patient acceptance of their diagnosis and the treatment choices 
available.  One research project in NZ analysed the historical abnormal 
glomerular filtration rates (GFR) of a community over five years to gain a 
baseline of how prevalent CKD was in this community.  The results showed that 
2130 people had results consistent with stage 1 CKD (normal kidney 
function with normal or increased Glomerular Filtration Rate (GFR); 5390 
were consistent with stage 2 CKD (kidney damage with mild decrease in 
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GFR); 1201 were consistent with stage 3 CKD (moderately decreased 
GFR); 69 were consistent with stage 4 CKD (severely decreased GFR); 
and eight with stage 5 CKD (end stage kidney failure).  While the eight 
people with stage 5 CKD knew their diagnosis, a significant number of 
those at stage 3 and 4 did not” (Nikolajenko, 2013, p. 16). 
In total 8798 people had results consistent with different stages of CKD.  Of these 
1270 were diagnosed as stages 3 and 4 CKD, when pre-dialysis care should be in 
place.  Pre-dialysis education is effective in reducing the requirement to start 
dialysis urgently, and for improving patient and clinical outcomes. 
In the next section, I move on to explore the impacts of kidney failure for end 
stage kidney patients, which are many and complex. 
The impacts of kidney failure 
Nutrition 
Nutrition management is complex for renal patients because everything that is 
ingested produces waste which builds up in the bloodstream.  In particular the 
levels of sodium, potassium, phosphate and fluids need to be closely monitored.  
Elevated levels of any of these will cause the renal patient to experience negative 
side effects and even death (Beto & Bansal, 2004).  The recommendation is that 
HD patients gain no more than 500 grams per day measuring from their dry 
weight which is “the weight when all extra fluid is removed, ideally post-dialysis 
weight as a goal” (Beto & Bansal, 2004, p. 407).  The recommended fluid intake 
is no more than 1.0 – 1.5L of fluid including fluid in food over 24 hours, because 
prolonged fluid overload is related to “congestive heart failure, hypertension, 
pulmonary edema and shortened patient survival” (Christensen & Ehlers, 2002, p. 
713).  PD patients have fewer problems regarding fluid retention than HD 
patients.  A further problem for renal patients can be malnutrition and between 
thirty and fifty percent suffer from this (Fouque, Pelletier, Mafra, & Chauveau, 
2011).  However, it is common for renal patients to have a high body mass index 
(BMI).  A BMI of between twenty-five and twenty-eight has been correlated with 
higher survival rates.  Renal patients who are under the care of a dietician have a 
19% lower mortality rate which confirms that nutrition care is vital (Steiber, 
2014).   
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Medication 
People with chronic kidney failure (CKD) have complex medical needs likely to 
involve the need to take medication.  Medication for patients with CKD and 
ESKD requires special consideration because the kidneys metabolize or filter a 
large proportion of all medications.  Due to the reduced glomerular filtration rate 
(GFR) the clearance of these medicines needs to be strictly monitored (Weir & 
Fink, 2014).  Caution is required with over the counter medications as there is a 
significant risk associated with certain medications such as non-steroidal anti-
inflammatory drugs which need to be avoided (University of Maryland, 2011).  
As CKD patients have high co-morbidities such as diabetes and hypertension 
requiring medication there is a risk of polypharmacy, creating an opportunity for 
negative drug interactions.  Commonly prescribed medications for a person with 
renal failure are erythropoietin which is used to treat anaemia; blood pressure 
medication to lower the patient’s blood pressure; phosphate binders to help 
control the level of phosphate and calcium in the body; vitamins and minerals in 
particular vitamin D which is normally activated by the kidneys; lipid lowering 
agents to help lower cholesterol; diuretics which increase the flow of urine and 
antibiotics to treat infections (New Zealand Kidney Foundation, 2007). 
Pain 
Pain is particularly common in patients with renal failure, with a reported 80% of 
those on haemodialysis experiencing pain.  Although pain is a frequent symptom 
for most patients with ESKD, it remains ineffectively managed (White & 
McDonnell, 2014).  Salisbury et al. (2009) discuss key reasons for this including 
the lack of recognition that there is a problem because of poor communication 
with patients, the pathology of the pain is poorly understood and it is often 
chronic and complex.  The pain could be a result of ESKD or from a co-morbid 
condition such as vascular disease or diabetic neuropathy. In patients with ESKD 
the pharmacokinetics or the movement of drugs within the body, and the 
pharmacodynamics or the biochemical and physiologic effects of drugs and how 
these are altered is a concern.  This can lead to reluctance to prescribe effective 
doses of analgesic drugs that offer relief from pain (Salisbury et al., 2009).  The 
World Health Organization developed a pain management approach known as the 
analgesic ladder.  However, this ladder was inappropriate for ESKD patients 
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because it contains non-steroidal anti-inflammatory drugs, in particular morphine 
which is not recommended for renal patients as it is not removed by dialysis and 
accumulates in the body.  The analgesic ladder has been modified for renal 
patients and includes three steps which are designed to provide increased pain 
relief (Figure 1). 
 
Figure 1: The WHO analgesic ladder 
Source: (Brown, 2015, p. 494)  
 
The undertreatment of pain has a significant impact on the quality of life of renal 
patients and “may induce depression, anxiety, insomnia, and decreased functional 
capacity and interfere with ability to interact socially” (Barakzoy & Moss, 2006, 
p. 3202).    
The financial cost of kidney failure 
The cost for a person requiring renal replacement therapy ranges from $65,000 per 
patient annually for hospital-based dialysis, or home-based dialysis costs around 
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$35,000 annually.  “Expenditure on RRT accounts for between 1 to 2% of the 
total public health expenditure.  Dialysis currently costs NZ over $150 million 
each year” (Henderson, 2014, p. 4).  If the patient is a NZ resident the public 
health system covers these costs.  Renal patients in NZ consist of 68% using HD 
and 31% using PD (Kidney Health New Zealand, 2015).  Karopadi, Mason, 
Rettore, and Ronco (2013) reported that in 2008 the prevalence of ESKD 
worldwide meant that 1.75 million patients were receiving dialysis treatments.  
89% or 1.55 million were using HD and 11% or 197,000 were using PD.  They 
further established that HD was used more in developed countries and PD in 
developing countries.  The cost of a kidney transplant in NZ is estimated at 
$90,000 in its first year (Henderson, 2014).  The survival rate for the first year 
after a kidney transplant now exceeds 90%, however at ten years it is less than 
40% (Levey & Coresh, 2012).   
There are financial factors for a renal patient that must also be taken into 
consideration which include the loss of regular income.  This can be due to 
treatment times clashing with work commitments and hospitalisations due to 
illness.  The renal patient has high travelling expenses because they have regular 
hospital and clinic visits as well as hospital based treatments for some HD 
patients.  Most renal patients take a cocktail of medications which have an 
associated cost, however this is minimal for the individual patient in NZ because 
of government subsidies.  A mobile phone is also essential for a patient who is on 
the transplant list so they can be contacted if a kidney becomes available. 
Psychological effects of kidney failure 
People with renal disease will usually experience grief and loss associated with 
their diagnosis and illness.  Grief is “prolonged or abnormal levels of bereavement 
or sense of abandonment following a loss” (Brown & Barlow, 2011, p. 128).  The 
psychological effects for people diagnosed with kidney failure usually include the 
grief cycle.  This consists of the emotional stages of denial, anger, bargaining, 
depression and finally acceptance.  These stages have no particular order or any 
specific time frame that these emotions will affect individual patients (New 
Zealand Kidney Foundation, 2007). 
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The psychological challenges for people with CKD may include the change in 
their identity from being healthy to being sick and the fear of dialysis treatment.  
Some patients may feel acceptance about dialysis treatment as it keeps them alive, 
but many resent and dislike this invasive treatment.  They may worry about the 
uncertainty of the disease outcome and the risk of death.  They may experience 
disruptions to daily life and financial struggles because of the rigid treatment 
programme.  Patients’ self-concept and self-esteem will often be altered due to 
changes in their physical ability, lifestyle and social roles and they may feel like a 
burden to family and friends  (Schick Makaroff, 2012).   
Schick Makaroff (2012) raises issues regarding the impact of a lack of freedom 
for a CKD patient.  This is due to the time spent in treatment, restricted diet and 
fluids, limited options for travel especially for HD patients, work constraints, 
medical costs, reduced income and increased dependence on others.  De Sousa 
(2008) concurs that these restrictions impede on the person who is living with 
kidney failure so they struggle to pursue a normal life.  CKD patients can rarely 
return to full time work and as a result their income and the associated sense of 
accomplishment, self-esteem and identity are affected.  They may encounter 
negative experiences with the healthcare service and feel a lack of autonomy 
when decisions are made about care. This is common among people suffering 
with chronic illness (Schick Makaroff, 2012).     
Living with a kidney transplant also requires psychological adjustment.  These 
patients worry about their future health and finances, and they must also cope with 
the side effects of immunosuppressive medications. Transplant patients must 
follow a strict medication regimen and continue to go to clinic and laboratory 
appointments.  Non-adherence to these factors is believed to be an important 
contributor to renal graft rejection and failure (Christensen & Ehlers, 2002).  
Furthermore, if the kidney came from a cadaveric donor, the recipient may need to 
mourn the death of the unknown person and also feel guilt about receiving the 
organ.  Live donor recipients may fear organ failure, and struggle with how to 
show their gratitude to the donor.  If the organ does fail and dialysis is re-initiated 
this can be a major crisis point for the patient, with an estimated 60% 
experiencing symptoms of depression (Zalai, Szeifert, & Novak, 2012).   
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Depression 
The psychological distress imposed on patients with CKD contributes to at least 
one in four suffering from depression (Zalai et al., 2012).  It is estimated that the 
prevalence of depressive disorders in patients with chronic medical illnesses is 
one and a half to four times higher than the general population.  ESKD patients 
are reported to have the highest incidence with four times higher rates of 
depressive disorders.  This is associated with adverse dialysis outcomes.  
Contributing to this are biological, psychological, spiritual and socio-economic 
factors as presented in Table 3 below.  
Table 3: Factors contributing to depression in patients with CKD  
 
Psychological Distress and Depression in Patients with Chronic Kidney 
Disease 
Biological factors:  Uremic toxins; chronic inflammation; disturbance of 
glucose-insulin homeostasis; deregulation of hypothalamic–pituitary–
adrenal axis; other biological mechanism → Changes in neuro-hormonal activity 
→ Somatic symptoms, sickness behaviour; sleep disturbance; pain; fatigue; 
reduced appetite; decreased sexual drive. 
Psychological, spiritual factors:  Changes in social roles and self-image; 
decreased autonomy and control; loss of freedom; hopelessness; limited capacity 
for self-expression, productivity and social involvement; negative body image; 
low self-esteem; fear of uncertain future, ill health, death and dying, existential 
questions, meaning of life. 
Socio-economic factors:  Younger age; female gender; low perceived social 
support; unemployment; low income. 
=Depression 
 
Source: (American Psychiatric Association, 2013, p. 160) 
Depressive disorders are diagnosed by severity, duration and the number of 
symptoms.  Table 4 provides a description of Major Depressive Disorder, 
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Persistent Depressive Disorder (Dysthymia) and examples of Other Specified 
Depressive Disorder.        Table 4: Symptoms of depressive disorders (DSM 5) 
Major Depressive Disorder 
Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood 
or (2) loss of interest or pleasure. 
1. Depressed mood 
2. Markedly diminished interest or pleasure in all, or almost all activities 
3. Significant weight loss or gain or decrease or increase in appetite 
4. Insomnia or hypersomnia 
5. Psychomotor agitation or retardation 
6. Fatigue or loss of energy 
7. Feelings of worthlessness or excessive or inappropriate guilt 
8. Diminished ability to think or concentrate, or indecisiveness 
9. Recurrent thoughts of death, recurrent suicidal ideation, or a suicide attempt  
The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning 
Persistent Depressive Disorder (Dysthymia) 
Depressed mood for at least 2 years 
Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating 
2. Insomnia or hypersomnia 
3. Low energy or fatigue 
4. Low self-esteem 
5. Poor concentration or difficulty making decisions 
6. Feelings of hopelessness 
Examples of Other Specified Depressive Disorder 
Recurrent brief depression: depressive episodes lasting from 2 – 13 days at least once per month 
Short-duration depressive episode (4-13 days): Depressed affect and at least four of the eight symptoms 
of a major depressive episode 
Depressive episode with insufficient symptoms: Depressed affect and at least one of the eight symptoms 
of a major depressive episode 
Source: (Zalai et al., 2012, p. 430) 
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It should be noted that diagnosis of depression in ESKD patients is problematic 
due to similarities between the somatic symptoms of depression and the physical 
symptoms associated with the side effects of ESKD treatment.  Neurovegetative 
signs of depression comprising of “fatigability, cognitive deficits, decreased 
appetite, insomnia and loss of libido can occur secondary to chronic renal failure 
and in the absence of a depressive syndrome” (Christensen & Ehlers, 2002, p. 
717).  ESKD is associated with conditions such as “anaemia, electrolyte 
disturbances, and underlying systemic disease (e.g., diabetes) which may mimic 
depressive symptoms. In addition, ESKD patients may take medications such as 
antihypertensive and corticosteroids which can produce mood-altering effects” 
(Christensen & Ehlers, 2002, p. 717).  Antihypertensive drugs are a class of drug 
used to treat hypertension and prevent the complications of high blood pressure 
such as stroke or myocardial infarction.  Myocardial infarction or heart attack is 
the irreversible death of heart muscle secondary to prolonged lack of oxygen 
supply (Medscape, 2017).  Corticosteroids, often referred to as steroids, are man-
made drugs that closely resemble cortisol, a hormone that your adrenal glands 
produce naturally (Cleveland Clinic, 2017).   
De Sousa (2008) states that depression, anxiety, suicide and delirium are common 
complications for ESKD patients.  Repeated observational studies about 
depression have reported that ESKD patients have higher suicide rates than the 
normal healthy population. To cause death these patients simply miss dialysis 
treatment or consume high potassium foods, or voluntarily withdraw from dialysis 
altogether (De Sousa, 2008).  ESKD patients are also more likely to be 
noncompliant regarding diabetes treatment and hypertension and have alcoholic 
tendencies. ESKD patients are noted as the biggest deniers of psychiatric illness 
because they already feel over-medicalised.  According to Gurkan, Pakyuz, and 
Demir (2015) they may “practise dysfunctional coping strategies including 
behavioural disengagement, mental disengagement, focusing on and venting of 
emotions, denial and substance abuse” (p. 1394).  Increased mortality and 
hospitalisation rates and less treatment compliance are associated with depression 
in CKD leading to poorer quality of life for these patients (Bautovich, Katz, 
Smith, Loo, & Harvey, 2014). 
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Health related quality of life 
White and McDonnell (2014) refer to the growing body of literature reporting that 
impaired health relates to quality of life.  Health related quality of life (HRQOL) 
is defined as “the state of one’s well-being in the areas of physical health, mental 
health, social health and a global sense of one’s health.  It is the subjective impact 
that a disease process has in a patient” (White & McDonnell, 2014, p. 76).  The 
health-related quality of life (HRQOL) for patients with ESKD is identified as 
poorer when compared to patients with other chronic illnesses and has been 
likened to cancer patients receiving palliative care.  Patients can become resentful 
of the enduring nature of the disease and the high symptom burden of ESKD 
impacts on HRQOL.  As routine psychosocial screening is not included in 
treatment patients with ESKD, depression is often unrecognised and undertreated 
by healthcare professionals.  A more vigorous management of depression has the 
potential to dramatically improve HRQOL (White & McDonnell, 2014).  
Bhowmik and Kumar (2014) also note that because of the multiple co-morbidities 
that occur in ESKD patients, they need a more specialised treatment programme.  
They suggest that to improve the quality of life for these patients the nephrology 
teams work in tandem with palliative care practitioners and with patients and their 
families. 
Treatment 
Bautovich et al. (2014) stress that there is an urgent need for well-conducted 
randomised trials of intervention for depression in CKD, to provide more 
knowledge around the safety and efficacy of treatments.  Schick Makaroff (2012)  
note that research is required to explore the role of lay caregivers and children of 
parents living with CKD in the treatment of depression.  Avşar et al. (2015); Zalai 
et al. (2012) highlight the importance of intervening early when treating major 
depression to obtain the best results.  Routine screening is suggested for 
depression at either clinic appointments or dialysis treatment to identify people in 
psychological distress using a screening tool such as the Beck Depression 
Inventory (BDI) which takes approximately five minutes to complete (Zalai et al., 
2012).  The BDI is used to detect the presence of depression and to determine a 
baseline level of severity.  This baseline can then be used to determine the 
effectiveness of interventions (Groth-Marnat, 2009).    
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According to De Sousa (2008) antidepressant therapy combined with 
psychotherapy is the recommended treatment for depression.  Zalai et al. (2012) 
also recommend psychotherapy and pharmacotherapy, but suggest that these can 
be complemented with other therapies including “light therapy; different stress 
reduction methods; music, or art therapy, and physical activity” (p. 434).  
Cognitive behavioural therapy (CBT) is a goal oriented, time limited, and 
evidence based therapy which treats depression.  Significant reductions in 
depressive symptoms have been recorded when CBT was used with CKD patients 
and they also maintained better emotional, behavioural, interpersonal and 
cognitive adjustment.  Group and individual sessions were both successful in 
reducing the symptoms of depression.  An advantage of CBT is that it does not 
involve medication.  If antidepressant medication is required for CKD patient’s 
careful attention must be paid to the possibility of drug interactions and side 
effects (Zalai et al., 2012). 
Gabbard (2001) states that the therapeutic alliance is especially important in 
depressed patients.  Also, that the patient therapist match is just as important 
between patients and their pharmacotherapy healthcare providers and their 
psychotherapy providers. Positive psychology which focuses on resilience and 
protective psychosocial factors can also help patients and their families cope with 
CKD.  Furthermore, Zalai et al. (2012) suggest that “narrative medicine, whole 
person care, integrative and holistic medicine” (p. 435) could be helpful for staff 
caring for these patients. For CKD patients who have home based treatments the 
option for telephone or computer-based telecommunication has been 
recommended.  It is suggested that future studies should focus on the promotion 
of self-management through telemedicine and the internet (Taal, 2013; Zalai et al., 
2012).    
Non-compliance 
According to Christensen and Ehlers (2002) ESKD is unique among medical 
conditions because of the extreme dependence on artificial means for survival, as 
well as the considerable behavioural demands on the patient.  The psychological 
factors for ESKD patients include “patient non-adherence with the medical 
treatment regimen, patient emotional distress, and psychosocial influences on 
morbidity and mortality” (p. 713).  I present these factors in Table 5 below. 
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Table 5: Nonmedical factors for chronic diseases     
 Nonmedical factors influencing morbidity for people with chronic diseases 
Cognitive, emotional and behavioural factors 
 Depression due to loss of role function 
 Persistent or chronic intermittent pain resulting in avoidance behaviours 
 Poor psychological adjustment due to fear, anxiety, low self-esteem 
 Lack of confidence in prevailing abilities 
 Poor pain coping skills 
 Mood fluctuations 
 Stress and fatigue 
 Helplessness 
 Affective distress 
 Health distress 
Physical factors 
 Muscle weakness 
 Poor or reduced aerobic capacity 
 Poor flexibility 
 Obesity or malnourishment 
 Sleep disturbances 
Other factors 
 Marital status and stability 
 Poor patient-health provider communication skills 
 Problem of poor adherence to long-term maintenance of treatment regimes 
 Extent and quality of social support 
 Access to quality health care 
 Age, race, gender, education level, culture, socioeconomic status 
__________________________________________________________________ 
Source: (Marks, Allegrante, & Lorig, 2005, p. 39) 
The most significant behavioural impediment for ESKD patients is non-adherence 
to the medical treatment regimen.  Non-adherence among renal patients has been 
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estimated at between 30% and 60%.  This includes not adhering to diet, fluid 
intake and medication recommendations.  The restrictions regarding the 
recommended amount of fluid intake is the most common non-adherence 
(Christensen & Ehlers, 2002).  Non-adherence by missing dialysis treatment 
sessions is relatively rare and is estimated to occur in approximately 2% of 
patients. However, this does not include the shortening of treatment sessions 
because of problems or negative symptoms.  
Self-efficacy 
Favourable outcomes for ESKD patients have been attributed to the concept of 
self-efficacy.  Bandura (1995) defined self-efficacy as ones’ belief in ones’ ability 
to succeed in specific situations or in accomplishing a task. One's sense of self-
efficacy can play a major role in how one approaches goals, tasks, and challenges.  
High self-efficacy is related to positive behaviours patients can sustain for longer, 
whereas low self-efficacy has the opposite effect (Wierdsma, Van Zuilen, & Van 
Der Bijl, 2011).  The tasks associated with chronic disease are displayed in Table 
6. 
Table 6: Chronic disease tasks 
 Tasks a patient with chronic disease may have to be able to perform  
Correct medication usage 
Exercise 
Weight loss 
Appropriate food selection 
Stress management strategies 
Pain and other management strategies 
Behaviours that improve or slow down disease progression, for example, testing for blood 
glucose 
Accurate self-diagnoses, data analysis, and decisions such as adjusting insulin levels  
Modified personal care, household and community mobility activities 
Adjustments to new social and economic circumstances 
Pertinent communications with physicians, family members, and other caregivers 
Modification of his or her living and work environment as well as valued activities 
__________________________________________________________________ 
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Source: (Marks et al., 2005, p. 151) 
There are many factors that are potentially modifiable when self-efficacy 
improves and focusing on self-efficacy perceptions can influence morbidity in 
chronic illness (Marks et al., 2005).  Hence a focus on self-efficacy can improve 
the long-term maintenance which is required for ESKD patients to successfully 
manage this chronic disease, therefore improving quality of life significantly.  
Conversely, having low self-efficacy may create changes in health-related self-
management behaviours which worsens health outcomes especially pain levels 
and mental health status (Marks et al., 2005, p. 40).  Self-efficacy in patients with 
chronic illness such as ESKD is facilitated when awareness and training about 
self-efficacy are implemented (Fu et al., 2003; Lorig et al., 2001; Tsay, 2003; Wu, 
Hsieh, Lin, & Tsai, 2016).   
One of these programmes is the Chronic Disease Self-Management Program 
which consists of a 17-hour course delivered over seven weeks to patients with a 
variety of chronic illnesses.  It focuses on the day-to-day self-management of 
symptoms common in patients with a chronic illness.  Other self-efficacy 
programs implemented with ESKD patients involve topics such as 
“pathophysiology of renal failure and haemodialysis, medications, complications, 
nutrition, fluid restrictions, control of thirst and urge to drink, and stress 
management” (Tsay, 2003, p. 372).  Participants in these reported improved 
health behaviour, self-efficacy, and health status.  A list of self-efficacies 
enhancing strategies pertinent to managing chronic disease such as ESKD is 
displayed in Table 7. 
Table 7: Self-efficacy enhancing strategies 
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Summary of primary characteristics of successful self-efficacy enhancing strategies 
for people with chronic disease 
1. Use a variety of learning strategies including lectures, discussions, brainstorming, 
demonstrations, goal setting, contracting, modelling, mental practice, homework, 
recall-enhancing methods, workbooks, texts, and videotapes, and provide mutual 
aid and support. 
2. Involve significant others, such as spouse or family members, and encourage 
collaboration with other health care providers and self-efficacy of caregivers. 
3. Foster self-management of exercise, food selection, weight control, fear, pain, 
depression and anxiety, and related self-monitoring strategies in small steps. 
4. Apply encouragement, persuasion, and direct or indirect support for the desired 
changes. 
5. Foster self-appraisal of emotional and physiological responses, decision making, 
and the necessary knowledge, skills, and problem-solving ability to deal with 
disease-related issues across different domains. 
6. Use trained educators, a detailed manual, and multicomponent teaching strategies 
with content drawn from both patients and practitioners. 
7. Use both individual and small-group intervention approaches especially 
collaborative and active participation strategies. 
__________________________________________________________________ 
Source: (Marks et al., 2005, p. 152) 
 
There is growing evidence that suggests self-management programs that include 
self-efficacy can be valuable regarding the management of chronic disease.  These 
outcomes are hypothesized in Table 8. 
Table 8: Self-efficacy enhancing interventions 
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 Well-designed and implemented self-efficacy enhancing interventions for people with 
chronic health conditions 
↓ 
Increased self-efficacy of the individual for managing disability producing health 
behaviour(s) 
↓ 
Improved affect 
Heightened motivation 
Better function 
Treatment adherence 
Better clinical outcomes 
Better social outcomes 
↓ 
Decreased health care costs and utilization 
Source: (Marks et al., 2005, p. 153) 
Locus of control 
The construct of locus of control (LOC) is related to self-efficacy.  LOC is a 
“cognitive style or personality trait characterized by a generalized 
expectancy about the relationship between behaviour and the subsequent 
occurrence of reinforcement in the form of reward and punishment. People 
with internal locus of control tend to expect reinforcements to be the 
consequences of their own efforts or behaviour, whereas people with 
external locus of control expect them to be the consequences of chance, 
luck, fate, or the actions of powerful others” (Colman, 2017, p. 1). 
Christensen and Ehlers (2002) posit that HD patients with internal locus of control 
exhibit more favourable treatment adherence.  However other research suggests 
that internal LOC expectancies is not related to HD regimen adherence (Brown & 
Fitzpatrick, 1988; Schneider, Friend, Whitaker, & Wadhwa, 1991).  This 
controversy according to Christensen, Turner, Smith, Holman, and Gregory 
(1991)  is because most of the previous research does not differentiate between 
internal LOC, powerful others, and external LOC beliefs which may factor into 
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the apparent inconsistency of these findings. Furthermore, LOC can change as the 
illness progresses and becomes life threatening, especially among patients who 
experience rapid illness progression. One technique is to suggest patients’ focus 
move from the uncontrollable factors such as the necessity to dialyse, to the more 
controllable factors such as self-care activities.  Self-care activities are 
controllable and improve internal LOC.  Whilst coping with a largely 
uncontrollable illness such as ESKD this change can impact positively on 
patients’ health status (Cvengros, Christensen, & Lawton, 2005).   
Social support 
Isolation for the renal patient can include the feelings of disconnection within 
established relationships, and a view that they are being left behind and that no 
one cares. They often feel as though they are a burden on family members who 
may have to help support them financially and emotionally (Schick Makaroff, 
2012).  Social support is very important for renal patients and this can be received 
from family members, friends and medical personnel.  According to Hoth, 
Christensen, Ehlers, Raichle, and Lawton (2007) social support is associated with 
reduced depressive symptoms.  Patients who are severely ill and have a less 
supportive family environment reportedly had higher levels of depression and 
anxiety than patients with a more supportive family environment.  However, in 
patients with low illness impairment it was reported that the effect of family 
support was not significant (Christensen & Ehlers, 2002).  Kimmel (2001)  
recognise social support as an important factor for patients adjusting to chronic 
and acute illness and its link to improved health outcomes.  It has been associated 
with better compliance in ESKD patients, lower levels of interdialytic weight gain 
and better biochemical compliance measures.  Quality social support also 
correlates positively with adherence in ESKD patients to their fluid and treatment 
regimens.  If a patient has a supportive family environment and little intra-familial 
conflict they are more likely to cope better with all the restrictions.  Interestingly, 
Christensen and Ehlers (2002) suggest that the perceived level of social support is 
more important for males than females.  
Anxiety 
Research pertaining to anxiety in patients with ESKD has not received as much 
attention as depression.  “Anxiety is a physiological and psychological state 
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characterised by cognitive, somatic, emotional, and behavioural components” 
(Kohli, Batra, & Aggarwal, 2011, p. 177).  Anxiety is typically recognised as 
uneasiness, apprehension or worry.  Anxiety is a normal response to stress but 
extreme or prolonged anxiety can lead to mental health problems and reduced 
quality of life. The symptoms of Generalized Anxiety Disorder are presented in 
Table 9 as follows.  
Table 9: Symptoms of Generalized Anxiety Disorder 
Generalized Anxiety Disorder 
Excessive anxiety and worry occurring more days than not for at least six months 
The individual finds it difficult to control worry 
The anxiety and worry are associated with three (or more) of the follow 
1. Restlessness or feeling keyed up for on edge 
2. Being easily fatigued 
3. Difficulty concentrating or mind going blank 
4. Irritability 
5. Muscle tension 
6. Sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying 
sleep) 
 
Source: (American Psychiatric Association, 2013, p. 222) 
HD patients with cardiac disease are more likely to have higher anxiety and 
reduced general health, and generally females on HD have higher anxiety with 
lower quality of life (Alavi, Aliakbarzadeh, & Sharifi, 2009).  House (1987) 
conducted a study with HD patients and reported that 17.1% suffered from 
depression and 8.7% from anxiety which were the most common diagnoses.  
However, Öyekçin, Gülpek, Sahin, and Mete (2012) report depression at 11.1% 
and anxiety at 2.8%.  Numerous other studies have reported a significant 
correlation between depression and anxiety in ESKD patients (Alavi et al., 2009; 
Hmwe, Subramanian, Tan, & Chong, 2015; Kohli et al., 2011) 
ESKD patients with internal LOC generally show less anxiety and cope better 
with solution management (Kohli et al., 2011).  Coping strategies for ESKD 
32 
 
patients experiencing anxiety or depression include problem focused coping 
strategies such as “active coping, planning, restraint coping, seeking of 
instrumental social support, suppression of competing activities” (Gurkan et al., 
2015, p. 1394).   Emotion focused coping strategies include “positive 
reinterpretation, humour, seeking emotional social support and turning to 
religion” (Gurkan et al., 2015, p. 1394).  Religion is used as a coping strategy 
because praying can evoke the feelings of serenity, rest and acceptance.  Gurkan 
et al. (2015) found that non-Western patients who practice traditional philosophies 
such as Chinese-Confucianism, Buddhism and Taoism manage life stressors 
differently from patients with Western philosophies who turn to religion for 
comfort. 
Summary 
It cannot be denied that the psychological effects for patients with ESKD are 
many.  They must manage the enduring treatments of HD or PD as well as 
changes regarding occupational, marital, familial, societal and personal aspects of 
their lives.  Furthermore, normal life is impeded by dietary constraints, time 
restrictions, feelings of handicap, financial burdens and an awareness of 
impending death (Kohli et al., 2011).  It is essential that these patients be 
equipped to formulate a ‘new normal’ whilst surviving amid uncertainty (Schick 
Makaroff, 2012). 
This chapter provides a guide into understanding the complexities of ESKD.  It 
highlighted what the issues are for renal patients and the resources required to 
support these patients.  The physical, emotional, social and financial factors were 
considered in this review.  The research reviewed in this chapter provides a 
starting point to explore the nature of psychological wellness of renal patients on 
dialysis under the care of the Waikato Regional Renal Centre, which is the focus 
of this study. 
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Chapter Two: Method 
The primary focus of this research was to explore the nature of psychological 
wellness of renal patients on dialysis.  This research used both qualitative and 
quantitative methods to obtain data.  The qualitative data was made up of semi-
structured interviews with dialysis patients and renal health professionals.  The 
quantitative data was derived from a questionnaire designed for PD and HD 
patients.  The questionnaire also gathered short qualitative responses. 
Recruitment of participants 
Recruitment procedures 
A meeting was held at the Waikato Renal Unit attended by Mr P. Sizeland the 
clinical director, Mrs H. O’Connell the associate charge nurse of the unit and 
myself.  It was decided that I would not be allowed access to the names and 
addresses of patients because I was not employed by the District Health Board 
(DHB).  However, Mr Sizeland advised me that the staff were prepared to label 
the envelopes and post out the questionnaires on my behalf.  I agreed to supply 
them with the sealed envelopes and they facilitated their distribution.  I provided 
the Regional Renal Centre in Hamilton, and the satellite units in Gisborne, 
Rotorua, Tauranga and Whakatane with a total of five hundred and thirty-one 
envelopes.  The envelopes contained the questionnaire, interview recruitment 
poster, and a letter from the Renal Centre supporting my research.  Also included 
was a self-addressed envelope and a complementary ballpoint pen.  A total of four 
hundred and seventy-five questionnaires were either handed out or posted to renal 
patients, and the fifty-six that were not required were destroyed.  Three hundred 
and fifty-five envelopes required outgoing and return postage, and 176 required 
only return postage because they were handed out at the renal centres to the in-
care haemodialysis patients.  Staff confirmed these numbers by completing and 
returning to me a confirmation sheet (Appendix A). 
Recruitment of questionnaire participants 
An envelope containing the questionnaire was either posted or handed out as 
arranged by the renal staff.  The questionnaire included a brief synopsis about the 
research and about myself, and informed participants about their rights if they 
decided to participate.  The questionnaire included background questions and 
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asked about social support using the Social Provisions Scale–Short Version (SPS).  
Also included was the Beck Depression Inventory-Second Edition (BDI) and the 
Beck Anxiety Inventory (BAI), as well as questions pertaining to psychological 
well-being (Appendix B). 
Recruitment of Peritoneal dialysis and haemodialysis patients for interview 
Patients on dialysis were recruited for an interview using a flyer.  This flyer was 
included with the questionnaire.  The flyer included the title of the research, 
researchers name and a brief description of what the research entailed.   
Recruitment of health professionals for interview 
Health professionals were recruited for interviews using a flyer distributed at the 
renal unit.  However, some health professionals were contacted directly for an 
interview including the clinical director of the renal unit and staff who work at the 
Kidney Society.  Unfortunately, the clinical director did not respond to my 
requests and no interview was obtained.   
Participants 
The following demographic information was collected from section one in the 
questionnaire.  The patient sample who responded to my questionnaire was 
comprised of 114 males and 82 females, one participant withheld this information.  
They were aged between 29 to 91 years old (Mean = 60.73 years, Median = 62 
years).  Four participants did not verify their age.  Twenty-seven participants were 
never married, 115 were married or de facto, 25 widowed and 29 separated / 
divorced.  One participant did not answer this question.   
The self-identified ethnicity of the participants included 99 Māori (50.5%), 77 NZ 
European (39.3%), 8 Other European (4.1%), 7 Pacific Islander (3.6%), and 5 of 
some ‘other’ ethnicity (2.6%).  The high representation of Māori participants was 
expected due to the considerably higher rates of ESKD among indigenous people 
(McDonald & Russ, 2003).  One participant did not answer this question.  
However, 14 participants listed more than one ethnicity or ticked the box labelled 
‘Other’, highlighting the diversity of the sample which included Dutch, New 
Zealander, Middle Eastern, Indian Nepalese, South African, Malay, Scottish, 
Irish, Chinese, African, Pakeha, Kiwi and English. 
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Just over a third of participants indicated a household income of less than $20,000 
(N=71, 38.6%), there were 45 in the 20,001-30,000 range (24.5%), 28 in the 
30,001-50,000 range (15.2%), 19 in the 50,001-70,000 range (10.3%), 12 in the 
70,001-100,000 range (6.5%), and 9 whose house-hold income was 100,001 or 
more (4.9%).  A low income of less than $30,000 was reported by 63.1% of the 
participants, with only 36.9% above this figure. 
Development of research tools 
Research flyer 
Two separate research flyers were developed, one for dialysis patients and one for 
health professionals. They included the title of the study and a brief description 
about what the research entailed (Appendices C & D).  I provided my contact 
details (phone and email) so that they could arrange a time to meet with me and 
share their personal stories.  Ethical approval details were also provided to 
reassure potential participants that the study had been ethically approved.   
Participant information sheet 
Two information sheets were developed to inform participants about the research, 
one for renal patients and another for health professionals.  The information sheets 
explained the objective of the research, and the rights of the participants 
(Appendices E & F).  The information sheets listed the contact details for myself, 
my supervisor and the Chair of the Ethics Committee.  This was to ensure that 
interested people or participants could contact the appropriate person if they 
needed to. 
Participant consent form 
Two consent forms were developed for either patients or health professionals to 
ensure the participants understood their rights and what was required of them.  I 
asked each participant to read and complete the form.  Each participant received a 
copy of this form which included the contact details for the Ethics Committee 
(Appendices G & H). They were given adequate time to ask questions of me as 
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the researcher and to have their questions answered to their satisfaction, or to 
discuss their participation with others if they wanted to. 
Interview questions for dialysis patients   
The interview questions for the renal patients consisted of nineteen different 
questions (Appendix I).  An interview checklist and reflexive notes were taken at 
every interview.  The interview schedule included items to gather patient 
background information and treatment modalities which were followed by items 
to invoke conversation about psychological help, well-being, social support and 
the roles whanau/family/significant others play in their lives.  The items in the 
dialysis patients’ interview schedule were aligned with items in the survey 
questionnaire and interview schedule for health professionals to allow for the 
emergence and examination of parallel and related perspectives. 
Interview question for health professionals   
The health professional schedule included 18 items (Appendix J) and included 
items that enquired of their training in mental health and their strategies for 
determining depression and anxiety amongst renal patients.  Items about the lack 
of psychological services and the impact access to these services could have for 
these patients were also included.  Further items related to their perspective on 
how whanau / family / significant others impact on their care of the patient.  
Mail-out Questionnaire  
The questionnaire included a cover letter introducing myself and why the research 
was being conducted.  It also included confirmation of ethics approvals and 
contact details.  The questions were arranged in sections and the first section 
consisted of background questions such as age, gender, ethnicity and income.  The 
next section asked about the type of dialysis treatment the patient was using and 
the length of time they had been in treatment.  It also asked whether or not they 
were on the transplant list.  Then three self-report measures were used: a) the SPS, 
b) the BDI and the c) BAI.  Participants were then asked questions pertaining to 
aspects of renal services being provided and their individual coping mechanisms 
used during treatment, followed by social support questions.  Finally, different 
therapies and holistic techniques were presented to gauge the patient's amount of 
interest in these.  
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The Social Provisions Scale – Short Version 
The SPS was completed by the questionnaire participants.  This scale was used to 
assess the way in which participants perceived their social relationships, and rated 
various dimensions of social support and interactions available to them.  There 
were ten questions in total.  Each question was answered by choosing a word that 
best described how the participants felt about the question; ‘strongly disagree’ = 
1, ‘disagree’ = 2, ‘agree’ = 3 and ‘strongly agree’ = 4’.  Each answer had a score 
ranging from 1 – 4.  The negatively worded items were reversed such as (4=1, 
1=4).  This self-report scale had a possible minimum score of 10 and a maximum 
score of 40.  The higher the score indicated that the more supported the participant 
felt.  Social provisions theory considers the functions of social relationships across 
specific social roles including “romantic partner, spouse, family members, friends, 
colleagues etc., especially when individuals face critical life-changing events” 
(Chiu et al., 2016, p. 298).  There are five subscales which include, Guidance, 
Reassurance of Worth, Social Integration, Attachment and Reliable Alliance.   
Guidance refers to having people available who can provide suggestions, 
solutions, and advice when needed; reassurance of worth refers to having 
others validate one’s competence and value; social integration denotes 
sense of belonging to a group with whom one shares common interests and 
social activities; attachment refers to feelings of intimacy, peace, and 
security (similar to emotional support); reliable alliance has to do with 
perceived access to assistance in times of need from others (Chiu et al., 
2016, p. 298). 
It is suggested that people need all five types of social provisions as listed in the 
subscales.  If one is deficient an individual is at risk of experiencing social and or 
emotional loneliness.  Each subscale had two questions the total minimum score 
for each subscale is two and the maximum is eight. 
The SPS is a self-report scale used “to examine the degree to which participants’ 
social relationship provide various dimensions of social support” (Cutrona & 
Russell, 1987, p. 472).  The validity of the SPS is recognised by Caron (2013) 
who states that  
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the SPS items are highly correlated with total scores and its internal 
consistency is excellent.  The alpha for the global scale is 0.880 and the 
alphas for the five subscales ranged from 0.528 to 0.690.  The analyses 
suggest that the SPS is a reliable and valid instrument for measuring the 
availability of social support” (p. 297).    
Further studies concur with these findings and state that the SPS scale is one of 
the most widely used measures of perceived social support in psychological 
literature (Chiu, Motl, & Ditchman, 2016; Perera, 2016).     
The Beck Depression Inventory 
The BDI is an indicator of the presence and degree of depressive symptoms.    
The 21 item self-report scale was analysed using overall results, as well as looking 
at cognitive affective symptom scores and somatic symptom scores (Beck, Steer, 
& Brown, 1996).  The cognitive affective symptoms include sadness, pessimism, 
past failure, loss of pleasure, guilty feelings, punishment feelings, self-dislike, 
self-criticalness, suicidal thoughts or wishes, crying, loss of interest, 
indecisiveness and worthlessness.  The somatic symptoms include agitation, loss 
of energy, changes in sleeping pattern, irritability, changes in appetite, 
concentration difficulty, tiredness or fatigue and loss of interest in sex (Delisle et 
al., 2012). 
The minimum score achievable in this test is 0 and the maximum is 63, a higher 
score indicating increasing symptom severity (Delisle et al., 2012).  The scores 
have four categories which ranged from 0-13 being minimal, 14-19 being mild, 
20-28 being moderate and 29-63 being severe depressive symptoms.  Kimmel 
(2001) recommends a BDI score of >15 for a diagnosis of depressive disorder in 
patients with end stage kidney disease, while Hedayati, Bosworth, Kuchibhatla, 
Kimmel, and Szczech (2006) suggested a score of >14 for a diagnosis.  Nineteen 
of the items are rated from 0 to 3, two items 0 to 6. 
The BDI was used to assess each participant's level of depression.  The BDI on 
average has a “Cronbach’s alpha coefficient of approximately 0.85, and reliability 
of the BDI among medical samples was satisfactory, with an alpha of 
approximately 0.90, ranging between 0.84 and 0.94” (Wang & Gorenstein, 2013b, 
p. 1279).  Wang and Gorenstein (2013a) investigated self-assessment measures to 
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evaluate depression, and found the BDI outnumbers the other measures in the 
amount of published research, and that the BDI is increasingly used in the 
medically ill to evaluate depressive symptoms.  Adult renal haemodialysis 
patients were represented in this finding. 
The Beck Anxiety Inventory 
The BAI is a twenty-one item self-report scale.  The minimum score achievable is 
0 and the maximum is 63, with a higher score indicating increased symptom 
severity.  The participants choose from four options; not at all, mildly (it did not 
bother me much), moderately, (it was very unpleasant, but I could stand it) and 
severely (I could barely stand it).  The score ranges for interpreting the intensity 
of self-reported anxiety were total score 0-7 points indicating minimal anxiety, 8-
15 indicating mild anxiety, 16-25 indicating moderate anxiety and 26-63 
indicating severe anxiety (Beck & Steer, 1993). 
The four subscales included neurophysiological, subjective, panic and autonomic 
symptoms.  The neurophysiological symptoms of anxiety include seven items: 
wobbliness in legs, unsteady, dizzy or lightheaded, numbness or tingling, shaky, 
hands trembling and feeling faint.  The subjective aspects of anxiety include six 
items: unable to relax, fear of the worst happening, nervousness, fear of losing 
control, feeling scared and feeling terrified.  The panic symptoms of anxiety 
include four items: heart pounding or racing, difficulty breathing, fear of dying 
and a feeling of choking.  The autonomic aspects of anxiety include four items: 
indigestion or discomfort in the abdomen, feeling hot, sweating (not due to heat) 
and flushed face (Beck & Steer, 1993). 
The BAI was used to measure the severity of anxiety each participant was 
experiencing.  The BAI “was constructed to measure the symptoms of anxiety, 
and the BAI showed high internal consistency α = .92 (Beck, Epstein, Brown, & 
Steer, 1988).   
Ethical Approval 
Ethical approval for this research was granted from the University of Waikato’s 
School of Psychology Ethics Committee, approval number 16:18.  The DHB 
research committee, and the Te Puna Oranga Māori Consultation Research 
Review Committee, approval number: RD016048.  Furthermore, I based my 
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research approach using the Code of Ethics for Psychologists working in Aotearoa 
/ New Zealand.  The Code of Ethics has four key principles; respect for the 
dignity of persons and people; responsible caring; integrity in relationships; social 
justice and responsibility to society (The New Zealand Psychological Society, 
2012).   
Obtaining ethics from three different agencies was a challenge and very time 
consuming.  It took one month to get ethics approval from the University of 
Waikato and the feedback offered was very helpful and the recommendations 
were implemented.  The Waikato DHB took four months to complete my ethics 
approval which was unexpected, and required a lot of follow-up on my behalf.  
However, communications were very helpful and pleasant whilst working on the 
approval.  Te Puna Oranga Māori Consultation Research Review Committee took 
one month to approve my research.   
Research procedures 
Semi structured interviews 
One-on-one interviews were a part of this research, and there were no time 
restrictions.  It was at the participant’s discretion to advise me when and where 
would be suitable for them to participate.  Interviews were carried out in the 
dialysis patients’ private homes and at the in-care centre in Hamilton.  The health 
professional interviews were all conducted within a workplace environment.   
At the start of every interview I thanked the participant for their time and 
participation, and I introduced myself and discussed with them my background 
and my connection to the research.  I then asked if they had any questions 
regarding the research that I could answer and clarify.  I explained how a semi- 
structured interview was implemented whilst encouraging free discussion.  I asked 
them to read the information sheet and read and sign a consent form.  A copy of 
the information sheet and consent form were left with each participant, and I 
retained a signed consent form for my records.  Once this paperwork was 
completed I asked permission to record the interview and I turned on two 
recording devices to ensure no loss of data.  The interviews then commenced. 
However, after completing a couple of patient interviews I realised that one of my 
questions was too complex:  Do you feel factors such as depression, anxiety, 
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stress, family, financial issues are taken into consideration within your treatment 
programme?  Which ones have you been affected by?  I decided to remove stress, 
family, financial issues and only ask about depression and anxiety.  Another 
patient question that was recorded differently than expected was:  How would you 
rate your health in general now?  This became a Likert Scale answer with 1 being 
poor and 10 being excellent, which was proposed by a participant at an interview.  
At every interview, I tried to use open and probing questions because it “helps 
create a climate of attentiveness and listening where people feel able to respond in 
any way they like.  Probing questions like ‘tell me more about that’ encouraged 
the participant to respond with a deeper level of understanding” (Breakwell, 
Hammond, Fife-Schaw, & Smith, 2006, p. 331).  
In total twenty-five interviews were completed which consisted of eleven dialysis 
patients and fourteen health professionals.  The demographics for the dialysis 
patient participants included five females and six males.  There were four 
participants who identified as Māori and seven as European.  The ages ranged 
from 30-50 years old for five of the participants and 51-75 years old for six 
participants.  The health professionals included 12 females and 2 males.  All 
participants were given a pseudonym to protect their identity and keep their 
participation confidential.  
The average time for the dialysis patients’ interviews was fifty-three minutes, and 
the average time for health professionals was sixty-one minutes, this does not 
include pre-and post-interview discussions or travel.  In total seven of the 
participants lived out of Hamilton and four participants required the travel time of 
over two hundred kilometres to conduct the interviews.  At the end of each 
interview I thanked them for their participation and presented each participant 
with a box of chocolates as a thank you gift.  All the interviews were recorded and 
then transcribed verbatim, because total transcription is regarded as good practice 
(Breakwell et al., 2006).  If requested on the consent form by the participant the 
transcript was sent to them for verification.  I posted out eight transcripts to 
dialysis patients, and nine to the health professionals.  No participants have 
contacted me with any issues or problems.  The transcribed interviews were then 
analysed using thematic analysis.  
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Thematic analysis 
Thematic analysis “involves analysing and interpreting texts and interviews in 
order to discover meaningful patterns descriptive of a particular phenomenon” 
(Auerbach, 2003, p. 13).  A thematic analysis is an “empirically driven approach 
for detecting the most salient of content in interviews” (Harper & Thompson, 
2012, p. 220).  The patient and health professional interviews were analysed using 
thematic analysis to “emphasize both the commonalities and differences between 
participants concerning the dominant themes” (Breakwell et al., 2006, p. 270).  
An appropriate method of analysis is important when completing qualitative 
research, and a thematic analysis is a widely used qualitative analytic method 
within psychology research.  It is similar to grounded theory which allows for 
theories to evolve or be grounded in the data (Braun & Clarke, 2006).  In this 
research, an inductive analysis was chosen to analyse the data, because this 
approach means “the themes identified are strongly linked to the data themselves” 
(Braun & Clarke, 2006, p. 83).  Inductive analysis “is therefore a process of 
coding the data without trying to fit it into a pre-existing coding frame, or the 
researcher’s analytic preconceptions.  In this sense, this form of thematic analysis 
is data driven” (Braun & Clarke, 2006, p. 83).  The semi-structured interview 
format encouraged free discussion from the participants producing rich narrative 
data, and each participant expressed very personal views about their journey.  
Thus, a collection of narrative data rich in depth of knowledge and experience was 
presented to analyse and interpret.  An analysis of the interview data was 
completed using guidelines by (Braun & Clarke, 2006) (Table 10). 
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Table 10: Phases of thematic analysis 
Phase  Description of the process 
1. Familiarizing yourself with 
the data: 
Transcribing data (if necessary), reading and re-
reading the data, noting down initial ideas. 
2. Generating initial codes: Coding interesting features of the data in a systematic 
fashion across the entire data set, collating data 
relevant to each code. 
3. Searching for themes: Collating codes into potential themes, gathering all 
data relevant to each potential theme. 
4. Reviewing themes: Checking if the themes work in relation to the coded 
extracts (Level 1) and the entire data set (Level 2), 
generating a thematic ‘map’ of the analysis. 
5. Defining and naming 
themes: 
Ongoing analysis to refine the specifics of each theme, 
and overall story the analysis tells, generating clear 
definitions and names for each theme. 
6. Producing the report: The final opportunity for analysis.  Selection of vivid, 
compelling extract examples, final analysis of selected 
extracts, relating back to the analysis to the research 
question and literature, producing a scholarly report of 
the analysis.  
 
 
Source: (Braun & Clarke, 2006, p. 87) 
Three main themes were created and fifteen subthemes which have been defined 
as;  
Impacts on psychological well-being 
Need for psychological support for patients 
Need for improved communication 
These themes will be the structure for the findings in the next chapter.  The next 
chapter provides a detailed presentation of the findings from the completed 
questionnaires and interviews with dialysis patients, and health professionals 
working in renal care.   
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Chapter three: Questionnaire Findings  
The questionnaire I administered comprised of five sections the first of which 
contained items that gathered demographic information about the respondents.  
This information has already been presented in chapter two.  The second section 
asked about the type of treatment respondents were on and the length of time they 
had been in treatment.  It also asked about aspects of renal services being 
provided and the individual coping mechanisms respondents used during 
treatment.   The third, fourth and fifth sections contained the three self-report 
scales the SPS, the BDI and the BAI. 
In this chapter, I report the results of the questionnaire survey.  While mostly 
quantitative, there were also items in the questionnaire that sought an explanatory 
or expanded comment from the participant.  I present these comments 
progressively and as appropriate to the quantitative results found and conclude 
with a summary of the results from the completed analysis.   
One hundred and ninety-seven dialysis patients completed the questionnaire.  The 
sample is comprised of 113 (57.7%) respondents on HD and 83 (42.3%) using 
PD.  The four types of treatments the respondents are currently using are 
presented in Table 11.  
Table 11: Types of dialysis treatment 
Treatment option 
           N Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid In care Haemodialysis 82 41.6 44.8 44.8 
Home Haemodialysis 31 15.7 16.9 61.7 
Continuous Ambulatory 
Peritoneal Dialysis 
25 12.7 13.7 75.4 
Automated Peritoneal 
Dialysis 
45 22.8 24.6 100.0 
Total 183 92.9 100.0  
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Missing  14 7.1   
Total 197 100.0   
 
When asked if they had used both haemodialysis and peritoneal dialysis treatment 
options 101 respondents (52.1%) stated ‘yes’ and 93 (47.9%) stated ‘no.’  The 
amount of time respondents had been a dialysis patient ranged from 1 month to 
360 months or 30 years.  The mean was 56.92 months or 4 years 9 months.  The 
majority (N=130, 68.4%) of the respondents have been dialyzing for up to 5 years.  
Forty-two (22.1%) respondents have been dialysing from 5 to 10 years, 9 (4.8%) 
from 10 to 15 years, 7 (3.6%) from 15 to 20 years, one (0.6%) from 20 to 25 years 
and one (0.5%) from 25 to 30 years.    
Transplant list 
Most of the questionnaire respondents 135 (73%) reported that they were not on 
the transplant list.  Several added extra information, “not sure,” “no I am a 
Jehovah’s Witness,” “I have a live donor,” and “suspended until I have had an 
operation.”  Of the 11 patients I interviewed, 9 reported they were not on the 
transplant list.  Amy expressed that for her “the biggest problem is the transplant 
list, I had two donors over three years ago and no one followed them up.”  Zoe 
noted “I have been on the list for a year now,” and Ned commented that he is 
“15kg overweight, if I lose it then I can go onto the transplant list.” 
Coping mechanisms 
The questionnaire respondents were asked ‘do you have any coping mechanisms 
you use whilst in treatment?’  Fifty respondents (26.9%) answered ‘yes’ and 136 
(73.1%) answered ‘no’.  Out of the 50 who answered ‘yes’, many gave qualitative 
responses about their coping mechanisms such as; “squidgy ball to strengthen and 
open up the fistula.”  “I stand up while draining out; this makes me feel I am 
helping to get all the extra fluid out.”  “I make sure I have everything I need, 
phone, drink, emergency numbers.”  “Humor.”  “Relaxation.”  “I think a lot about 
the past.”  “Private sessions, only immediate family come in, I’m on home 
haemodialysis.”  “Prayers, worship, singing.” 
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Requests during treatment 
The respondents were also asked ‘do you feel your requests are being considered 
whilst in treatment, if no why?’  One hundred and seventy-one participants 
(92.4%) answered ‘yes’ and 14 (7.6%) answered ‘no’.  Some of the responses 
were, “not all the time.”  “Specialists don't listen.” 
Feeling secure 
The respondents were asked ‘do you feel secure whilst participating in treatment?’  
Most of the respondents answered ‘yes’ (N=186, 96.4%) and seven (3.6%) 
answered ‘no.’  Four respondents expanded upon their answers, “yes, but it 
depends on procedures being done (e.g. graft issues).”  “Yes, because I have a 
phone close at hand.”  “Yes, providing there are no problems.”  
Nurses responses 
The respondents were then asked, ‘how important is the nurse’s response to your 
requests?’  There was a seven-point scale provided for the respondents to choose 
from (Table 12).  The majority selected ‘very important’ (N=78, 40.8%).  Two 
respondents added extra information, “I can't remember the last time I rang the 
nurse or seen one” and “I would not contact a nurse unless it was an extreme 
emergency.” 
Table 12: Patient requests 
How important is the nurse's response to your requests 
 N Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Not at all important 4 2.0 2.1 2.1 
Very unimportant 20 10.2 10.5 12.6 
Somewhat unimportant 5 2.5 2.6 15.2 
Neither important nor 
unimportant 
5 2.5 2.6 17.8 
Somewhat important 39 19.8 20.4 38.2 
Very important 78 39.6 40.8 79.1 
Extremely important 40 20.3 20.9 100.0 
Total 191 97.0 100.0  
Missing  6 3.0   
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Total 197 100.0   
 
Level of care 
The respondents were also asked ‘do you feel your care level is adequate, if no 
why?  The majority of the respondents reported that ‘yes’ their care level was 
adequate (N=184, 96.3%) and seven (3.7%) answered no to this question.   Some 
respondents expanded on this answer, “no, you’re just left there and expected to 
know how to set up your machine, and not shown how to set up properly.”  “No, 
you feel no one really cares, it’s just a job.”  “No, the nurse is very busy with 
other patients.”  “Yes, fantastic support from all concerned.”  “Yes, but I have 
noticed a few document errors along the way.”  “Yes, although better on call 
support at home would be a great improvement.”  
Health Rating 
The respondents were asked ‘how would you rate your health in general now?  In 
total 192 respondents completed this question.  There was a scale of answers 
provided from ‘much better’ to ‘much worse’ (Table 13).  The majority answered 
‘better’ (N=42, 21.9%) and ‘somewhat better’ (N=41, 21.4%).  Some respondents 
added, “It will never be like before dialysis but the proof is in the monthly blood 
test.”  “Much better than before dialysis.”  “Ten years ago, I was given a 2% 
chance of reaching fifty now I have one year to sixty.”  
Table 13: Health rating   
How would you rate your health in general now 
 N Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Much better 34 17.3 17.7 17.7 
Better 42 21.3 21.9 39.6 
Somewhat better 41 20.8 21.4 60.9 
About the same 36 18.3 18.8 79.7 
Somewhat worse 25 12.7 13.0 92.7 
Worse 9 4.6 4.7 97.4 
Much worse 5 2.5 2.6 100.0 
Total 192 97.5 100.0  
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Missing  5 2.5   
Total 197 100.0   
 
Activities 
The patients who completed the questionnaire were asked about activities they 
prefer to do whilst in treatment.  The most popular activity for the respondents 
was to watch TV (N=118, 60.8%).   
Table 14: Treatment activities  
What activity do you prefer to do whilst in treatment 
 N Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Watch TV 118 59.9 60.8 60.8 
Listen to music 17 8.6 8.8 69.6 
Talk to staff 1 .5 .5 70.1 
Read 22 11.2 11.3 81.4 
Use a computer 14 7.1 7.2 88.7 
Phone family / 
friends 
1 .5 .5 89.2 
Other 21 10.7 10.8 100.0 
Total 194 98.5 100.0  
Missing  3 1.5   
Total 197 100.0   
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Section Three: Social Provisions Scale-Short Version 
In total 188 respondents completed the Social Provision Scale (SPS).  The 
minimum score was 17 and the maximum was 40 (M=31.66, SD=4.39).  
Cronbach’s alpha was used to measure the internal consistency reliability of the 
SPS.  In psychology, a good measure should have a Cronbach’s alpha of at least 
.60 and preferably closer to .90 (Aron, Aron, & Coups, 2009).  Cronbach’s alpha 
of the overall SPS subscale was α.84 indicating good reliability.  
A t test was conducted between the total SPS scores and the age of the 
respondents to determine if age was an indicator for social support.  There was a 
statistically significant difference between the SPS scores and age.  SPS scores 
(N=188, M=31.66, SD=4.40) and age (N=193, M=60.73, SD=12.68), t (379) = -
29.74, p=<.001, are predictors of social support.  The 95% confidence interval 
was -30.99 to -27.14, and Cohens d = 3.0, a large effect size.   
A further t test was conducted between the total SPS scores and the amount of 
time a patient had been on dialysis.  There was a statistically significant difference 
between the SPS scores and the amount of time a patient had been on dialysis.  
SPS scores (N=188, M=31.66, SD=4.40) and time on dialysis (N=190, M=56.92, 
SD=57.14), t (376) = -6.04, p<.001, are predictors of social support.  The 95% 
confidence interval was -33.45 to -17.03 and Cohens d = .60, a medium effect 
size.  Therefore, age and the amount of time a patient has been on dialysis affect 
the perception of social relationships and social support.  An explanation of 
“cohens effect size conventions for mean differences are: small = 0.20; medium = 
0.50; and large = 0.80” (Aron et al., 2009, p. 183).  
An analysis of the five SPS subscales and the role family have in their care was 
completed, this was to determine what subscales were important to the 
respondents to feel they were being supported (Table 15). 
Table 15: SPS subscales and family care 
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Mann-Whitney U Test 
  Do your 
whanau/family/significan
t other have an active role 
in your care N 
Mean 
Rank 
Sum of 
Ranks 
Guidance Yes 132 98.62 13018.00 
No 50 72.70 3635.00 
Total 182   
Reassurance of worth Yes 132 95.04 12545.00 
No 50 82.16 4108.00 
Total 182   
Social interaction Yes 132 95.91 12659.50 
No 50 79.87 3993.50 
Total 182   
Attachment Yes 132 96.32 12714.50 
No 50 78.77 3938.50 
Total 182   
Reliable alliance Yes 132 94.18 12432.00 
No 50 84.42 4221.00 
Total 182   
Test Statisticsa 
 Guidance 
Reassurance 
of worth 
Social 
interaction Attachment 
Reliable 
alliance 
Mann-Whitney U 2360.000 2833.000 2718.500 2663.500 2946.000 
Wilcoxon W 3635.000 4108.000 3993.500 3938.500 4221.000 
Z -3.086 -1.576 -1.929 -2.081 -1.171 
Asymp. Sig. (2-tailed) .002 .115 .054 .037 .242 
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The results of this test indicate that the subscale guidance (p=.002), which 
includes having people who can provide suggestions, solutions and advice, and 
the subscale attachment (p=.037) which is emotional support, were important 
factors contributing to the respondents feeling that the family have an active role 
in their care. 
An analysis of the five SPS subscales and the respondent’s perception of the 
families understanding of their illness was completed, this was to determine what 
subscales were important to the respondents to feel understood (Table 16). 
Table 16: SPS subscales and family understanding of ESKD 
Mann Whitney U Test 
 Do your 
whanau/family/significant 
other understand the nature 
of your illness N Mean Rank Sum of Ranks 
Guidance Yes 172 93.53 16088.00 
No 10 56.50 565.00 
Total 182   
Reassurance of worth Yes 172 91.95 15816.00 
No 10 83.70 837.00 
Total 182   
Social interaction Yes 172 93.73 16122.00 
No 10 53.10 531.00 
Total 182   
Attachment Yes 172 94.71 16290.50 
No 10 36.25 362.50 
Total 182   
Reliable alliance Yes 172 93.30 16047.00 
No 10 60.60 606.00 
Total 182   
Test Statisticsa 
 Guidance 
Reassurance 
of worth 
Social 
interaction 
Attachmen
t 
Reliable 
alliance 
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Mann-Whitney U 510.000 782.000 476.000 307.500 551.000 
Wilcoxon W 565.000 837.000 531.000 362.500 606.000 
Z -2.250 -.515 -2.491 -3.535 -2.003 
Asymp. Sig. (2-
tailed) 
.024 .607 .013 .000 .045 
 
The results of this test indicate that the subscales, guidance (p=.024), social 
interaction (p=.013) which denotes a sense of belonging to a group, attachment 
(p=<.001) and reliable alliance (p=.045) which is a perceived access to assistance 
when needed are important factors for the respondents to feel that their family 
understand the nature of their illness. 
Therefore, the SPS subscales guidance, attachment, social interaction and reliable 
alliance are important factors for a person on dialysis to feel they received social 
support and were connected to social relationships. 
Further tests were completed with the factors gender, ethnicity and treatment 
options but the analysis did not return any significant results, thus they are not 
reported in this study.  
Section Four: Beck Depression Inventory (BDI) – Second Edition 
The BDI is an indicator of the presence and degree of depressive symptoms.  One 
hundred and ninety-seven questionnaire respondents completed the BDI.  The 
overall score results from this research consisted of a minimum score of 1 and a 
maximum score of 44, (M=13.97, SD = 9.33).  A total of 111 respondents (56.3%) 
scored between 1-13 indicating minimal symptoms, 38 respondents (19.3%) 
scored between 14-19 indicating mild symptoms, 28 respondents (14.2%) scored 
between 20-28 indicating moderate symptoms and 20 respondents (10.2%) scored 
between 29-63 indicating severe depressive symptoms. 
The moderate and severe results combined totalled 24.4% which indicates these 
participants have levels of depression in line with the 20-30% reported in the 
literature (Kimmel, 2001).  The mean score for the respondents was 13.97 which 
is lower than the reported mean score for ESKD patients which is >15 for HD or 
PD patients (Kimmel, 2001).     
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Cronbach’s alpha was used to measure the internal consistency reliability of the 
21 BDI test items.  The Cronbach’s alpha coefficient of the overall test items was 
α .87 indicating good reliability.  The BDI tests were also analysed by test items 
to gauge which items patients were reporting as areas of concern (Table 17).  
These items were all somatic symptoms, which included items ‘changes in sleep 
patterns’ and ‘changes in appetite’.  Also, the items loss of interest in sex, loss of 
energy and tiredness or fatigue.  All these symptoms are listed in the DSM-V as 
diagnosis criteria for a major depressive disorder or persistent depressive disorder.  
This indicates that the respondents are showing a high number of diagnosable 
depressive symptoms.   
Table 17: BDI test items 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
Changes in Sleeping Pattern 197 0 6 2.65 2.054 
Changes in Appetite 197 0 6 1.45 1.251 
Loss of Interest in Sex 197 0 3 1.32 1.099 
Loss of Energy 197 0 3 1.24 .638 
Tiredness or Fatigue 197 0 3 1.16 .804 
Loss of Pleasure 197 0 3 .82 .829 
Concentration Difficulty 197 0 3 .69 .708 
Loss of Interest 197 0 3 .61 .905 
Self-Criticalness 197 0 3 .58 .953 
Self-Dislike 197 0 3 .55 .798 
Agitation 197 0 3 .52 .773 
Pessimism 197 0 3 .50 .806 
Irritability 197 0 3 .49 .682 
Indecisiveness 197 0 3 .44 .687 
Punishment Feelings 197 0 3 .44 .922 
Crying 197 0 3 .44 .834 
Guilty Feelings 197 0 3 .39 .601 
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Past Failure 197 0 3 .39 .724 
Worthlessness 197 0 3 .38 .624 
Sadness 197 0 3 .28 .515 
Suicidal Thoughts or Wishes 197 0 2 .15 .396 
Valid N (listwise) 197     
 
A t test was completed between the BDI scores and the age of respondents.  The 
BDI scores (N=197, M=13.97, SD=9.33) and age of respondents (N=193, 
M=60.73, SD=12.68), t (388) = -41.55, p<.001, is a significant factor for 
increased risk of depression.  The 95% confidence interval was -48.97 – -44.55, 
with a Cohens d = 4.0. 
A t test was completed between the BDI scores and the amount of time 
respondents have been on dialysis.  The BDI scores (N=197, M=13.97, SD=9.33) 
and time on dialysis (N=190, M=56.92, SD=57.14), t (385) = -10.41, p<.001, is a 
significant factor for increased risk of depression.  The 95% confidence interval 
was -51.06 – -34.83, with a Cohens d = 1.0.  There was a statistically significant 
difference between the BDI scores and age and the amount of time a patient has 
been on dialysis, indicating that these are risk factors for depression. 
Further tests were analysed with the factors, gender, ethnicity, income, treatment 
options and type of treatment, the perceptions of how much the respondent’s 
family understand of their illness and how much of an active role they have in 
their care.  These analyses did not return any significant results therefore, they are 
not reported in this study.  
Section Five: Beck Anxiety Inventory (BAI) 
The BAI was completed by 197 questionnaire respondents who scored between a 
minimum of 0 and a maximum score of 49, (M= 12.26, SD = 10.42).  A total of 
85 respondents (43.1%) scored between 0-7 for minimal anxiety, 54 respondents 
(27.5%) scored between 8-15 for mild anxiety, 30 respondents (15.2%) scored 
between 16-25 for moderate anxiety and 28 respondents (14.2%) scored between 
26-63 for severe anxiety. 
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Cronbach’s alpha was used to measure the internal consistency reliability of the 
four subscales which examined neurophysiological, subjective, panic and 
autonomic symptoms.  Cronbach’s alpha coefficient of the subscales was α .84 
indicating good reliability.  A t test analysing the four subscales (N=197) was 
completed.  Overall the subscale for ‘neurophysiological’ symptoms had the more 
statistically significant results of the four subscales, which indicated that the 
respondents who completed this test were more concerned with the physical 
symptoms of anxiety they experienced. 
Cronbach’s alpha was also used to measure the internal consistency reliability of 
the 21 items used in the BAI test.  The Cronbach’s alpha coefficient of the 21 
items was α .92 indicating good reliability.  The test items were analysed to 
determine which items respondents reported as areas of concern (Table 18).  The 
four most reported areas of concern were all neurophysiological symptoms and 
included wobbliness in legs, being unsteady, dizzy or lightheaded, experiencing 
numbness or tingling. 
Table 18: BAI test items 
Descriptive Statistics 
 N 
Minimu
m 
Maximu
m Mean Std. Deviation 
Wobbliness in legs 197 0 3 1.05 .949 
Unsteady 197 0 3 .98 .895 
Dizzy or lightheaded 197 0 3 .96 .820 
Numbness or tingling 197 0 3 .93 .904 
Heart pounding or racing 197 0 3 .72 .880 
Unable to relax 197 0 3 .72 .839 
indigestion or discomfort in 
abdomen 
197 0 3 .67 .807 
Fear of the worst 
happening 
197 0 3 .64 .879 
Difficulty breathing 197 0 3 .60 .866 
Feeling hot 197 0 3 .60 .800 
Shaky 197 0 3 .49 .697 
56 
 
Nervous 197 0 3 .47 .760 
Hands trembling 197 0 3 .45 .665 
Fear of losing control 197 0 3 .43 .743 
Fear of dying 197 0 3 .42 .808 
Scared 197 0 3 .41 .800 
Faint 197 0 3 .40 .627 
Terrified 197 0 3 .35 .758 
Sweating (not due to heat) 197 0 3 .35 .617 
Feelings of choking 197 0 3 .31 .687 
Face flushed 197 0 3 .31 .591 
Valid N (listwise) 197     
 
A t test was completed between the BAI scores and the age of respondents.  The 
BAI scores (N=197, M=12.26, SD=10.42) and age of respondents (N=193, 
M=60.73, SD=12.68), t (388) = -41.28, p<.001, is a significant factor for 
increased risk of anxiety.  The 95% confidence interval was -50.78 – -46.16, with 
a Cohens d = 4.0.  
A t test was completed between the BAI scores and the amount of time 
respondents had been on dialysis.  The BAI scores (N=197, M=12.26, SD=10.42) 
and time on dialysis (N=190, M=56.92, SD=57.14), t (385) = -10.78, p<.001, was 
a significant factor for increased risk of anxiety.  The 95% confidence interval 
was -52.80 – -36.51, with a Cohens d = 1.0.  There was a statistically significant 
difference between the BAI scores and age and the amount of time a patient had 
been on dialysis, indicating that these are risk factors for anxiety. 
A Kruskal-Wallis Test was conducted between the BAI scores and household 
income over twelve months (Table 19).  There was a statistically significant 
difference between the BAI scores and income.  Respondents with low income of 
up to $30,000 were at higher risk for anxiety. 
Table 19: BAI and income test 
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Kruskal Wallis Test 
 Household Income over 
12 months N 
Mean 
Rank 
Beck Anxiety 
Inventory 
20,000 or less 71 105.72 
20,001 - 30,000 45 103.32 
30,001 - 50,000 28 77.86 
50,001 - 70,000 19 76.13 
70,001 - 100,000 12 63.50 
100,001 or more 9 52.89 
Total 184  
Test Statisticsa,b 
 
Beck Anxiety 
Inventory 
Chi-
Square 
18.721 
df 5 
Asymp. 
Sig. 
.002 
 
 
A Kruskal-Wallis Test was conducted between the BAI scores and the dialysis 
treatment options currently used by the respondents (Table 20).  There was a 
statistically significant difference between the BAI scores and treatment options 
in-care haemodialysis and continuous ambulatory peritoneal dialysis patients were 
at higher risk of anxiety. 
Table 20: BAI and dialysis treatment option 
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Kruskal Wallis Test 
 
Treatment option N 
Mean 
Rank 
Beck Anxiety 
Inventory 
In care Haemodialysis 82 106.32 
Home Haemodialysis 31 70.50 
Continuous Ambulatory 
Peritoneal Dialysis 
25 100.20 
Automated Peritoneal 
Dialysis 
45 76.17 
Total 183  
Test Statisticsa,b 
 
Beck Anxiety 
Inventory 
Chi-Square 15.752 
df 3 
Asymp. 
Sig. 
.001 
 
 
The completed analysis of the BAI would suggest that age, the amount of time on 
dialysis, low income and the treatment options in-care haemodialysis and 
continuous ambulatory peritoneal dialysis are significant factors for anxiety. 
Further tests were analysed with the factors gender, ethnicity, type of treatment, 
the perceptions of how much the respondents’ family understand their illness and 
how much of an active role they have in their care.  These analyses did not return 
any significant results thus they are not reported in this study.  
Summary 
The majority of the questionnaire respondents were using in-care HD, the next 
highest number were using APD, followed by home HD users and the least 
amount who were using CAPD.  This is consistent with Wilkie (2011) who found 
that in-care HD is continuing its dominance over home based treatments.  The 
amount of time the respondents have been dialyzing ranged from one month to 30 
years, with most respondents being in the up to five years range.  Only a few of 
the respondents reported that they were on the transplant list.  These participants 
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will on average have to wait two to three years for a cadaveric kidney in NZ (New 
Zealand Kidney Foundation, 2007).  The coping mechanisms respondents 
described using whilst in treatment included watching TV, listening to music and 
reading, however a surprisingly large number of respondents indicated that they 
had no coping mechanisms. 
There was a mainly positive response from the respondents about the level of care 
they received.  They reported that whilst in treatment they felt their requests were 
being acknowledged, whether they were using in-care dialysis or home dialysis.  
Furthermore, they reported feeling secure during treatment providing no problems 
arose.  It was very important to the respondents that the nurses responded when 
needed, however some pointed out that they very rarely request to see a nurse.  
Some respondents noted that the health professionals were always very busy, 
however they reported that overall the level of care they received was satisfactory. 
The results of the SPS indicated that relationships and social support were very 
important to the respondents.  Significant factors for determining this support 
were age and the amount of time a patient had been on dialysis.  Out of the five 
subscales, guidance and attachment were considered statistically significant as to 
whether they felt their families were having an active role in their care.  The 
subscales guidance, social interaction, attachment and reliable alliance were 
important with regard to the families understanding of the nature of the illness. 
Kimmel (2005) found that social support can be a source of strength and 
consolation promoting well-being.  The support of friends and family is especially 
important for ESKD patients because of the huge adjustments they must make in 
their lives.   
The BDI tests indicated a range of depressive symptoms with most of the 
respondents in the mild range, however there were respondents who reported 
severe depressive symptoms.  The highest-ranking symptoms reported from the 
respondents all correlated with a clinical diagnosis for depression.  The significant 
factors affecting the risk of depression included age and the amount of time on 
dialysis.  Depression is common in ESKD patients and this was confirmed in this 
study (Keskin & Engin, 2011; Kimmel, 2001). 
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The results of the BAI indicated that the anxiety symptom rates in respondents 
were higher than the depressive symptoms.  It was found that severe anxiety was 
being experienced by some of the respondents, and the neurophysiological 
symptoms were the most reported area of distress.  The significant factors found 
to impact on levels of anxiety included, age, the amount of time on dialysis, low 
income and treatment option, with those using in-care haemodialysis experiencing 
the highest levels of anxiety.  These findings are consistent with the literature 
reporting that ESKD patients have high levels of anxiety which is often under 
diagnosed because of confusion with the physical symptoms displayed by the 
patient due to the illness (Alavi et al., 2009).  
In the next chapter I analyse the completed interviews, and discuss these findings 
and the implications of these for patients and the health professionals working 
with them.   
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Chapter Four: Qualitative Findings 
In this chapter, I present the results of my analysis of the qualitative data.  Three 
broad interconnected themes emerged from my analysis of interview data with 
patients (N=11) and health professionals (N=14) and I have woven their voices 
together in the presentation of their information.  Unless otherwise stated, the 
quotes presented are from patients.  For each of the three major themes, a number 
of sub-themes were identified.  The main themes identified are as follows and 
form the structure for this chapter:  
Impacts affecting renal patients’ psychological well-being 
Need for psychological support for renal patients 
Need for enhanced communication and education 
 
Section one: Impacts on psychological well-being 
This section details a range of factors that impact on the psychological well-being 
of the participants.  The data analysis revealed five aspects pertinent to this which 
were experienced by the participants, and consistent with the literature on ESKD 
for renal patients in general.  These aspects are explored below as sub-themes and 
include; screening for renal disease, pre-dialysis care, reactions to diagnosis and 
treatment, depression, anxiety and compliance.  
Screening for renal disease 
A study by Nikolajenko (2013) analysed five years of results for abnormal GFR in 
8798 participants, looking at levels of CKD.  Although they all had results 
consistent with different stages of CKD and eight with stage 5 ESKD, the vast 
majority of participants were not aware that they had CKD.  Unsurprisingly, 
Nikolajenko (2013) recommended screening for early detection and the 
establishment of a register to more robustly monitor the stages of CKD in patients 
with decreased GFR.  Early detection of renal failure is important because pre-
dialysis education and care can then be implemented.  Pre-dialysis education helps 
patients accept their diagnosis and treatment and can decrease the need for 
commencing urgent dialysis (Walker et al., 2010).  In my interview with Amy, she 
told me that if she had had better pre-dialysis care she could have delayed starting 
62 
 
dialysis.  The implementation of pre-dialysis has been shown to facilitate better 
overall clinical outcomes for renal patients (Walker et al., 2010).   
Reactions to diagnosis and treatment  
Being given the diagnosis of CKD, particularly if dialysis is required, is an 
overwhelming experience.  It is compounded by the subsequent necessity for 
patients to learn an extreme amount of new information regarding their disease, 
which is often difficult for them to comprehend.  Shock and fear dominated 
participants narratives when they described being diagnosed with renal failure.  
Bob told me he cried, and that he was very scared and found the dialysis 
procedure “disturbing.”  Ned reported being “in shock.”  He said that “they made 
it sound like it was a holiday park to go to; they weren’t really upfront about what 
you have to go through before you go on dialysis.”  Eva described her experience 
as “inconvenient.”  Rob commented that he “had never heard of kidney failure, 
but to actually go through it and do it is quite a challenge.”  Joy a health 
professional told me how “a new dialysis patient is usually stunned and numb 
when they come in for treatment.  In the first week, we simply dialyse them 
because they can’t absorb information.” 
The information about kidney disease that dialysis patients must acquire is 
complex and vast.  They must learn to balance their nutrition regarding their 
levels of sodium, potassium and phosphate and strictly regulate their fluid intake.  
Fluid is derived from any foods containing liquid content such as soups, yoghurt 
and gravy not just from drinks such as milk, tea, coffee, water and juice (New 
Zealand Kidney Foundation, 2007).  Different treatments also influence fluid 
retention with PD patients having fewer problems than HD patients (Fouque et al., 
2011).  Bob suggested that “a support group would be beneficial to help the new 
ones learn how to cut down on fluids.”  The monitoring of food intake and 
limiting of fluid intake is challenging.  As Meg, one of the health professionals 
told me, 
new patients struggle with the acceptance of all the limitations and 
constrictions we give them once they are on dialysis.  One day they are 
eating normally, drinking normally, the next day they come in to dialysis 
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and we tell them you’re not allowed to drink this much, you’re not allowed 
to eat this, you’re not allowed to do this.   
A question pertaining to changes in appetite was included in the questionnaire.  
The participants who reported their appetite was ‘less than normal’ was 39.1%, 
and ‘much less than before’ was 22.3%.  This would seem to indicate that appetite 
changes are common for these patients, which is consistent with the literature.  
Learning about medications is also important for a renal patient.  They must be 
aware that a large proportion of all medications are metabolized or filtered by the 
kidneys, and due to reduced GFR medications, must be strictly monitored (Weir 
& Fink, 2014).  Joy, a health professional, said that “not only are they starting 
dialysis, but they have changes in medications which can change how they 
physically feel.”  Val, who is on twenty-five tablets a day told me that they make 
her feel “sick and bloated.” 
Amy discussed how she felt that there was 
discrimination regarding treatment options.  I’m not sure if it is 
discrimination or a lack of allowing things like holistic treatment to be 
considered.  It’s just a Western approach and not enough consideration or 
information is available for staff regarding traditional knowledge.  I have 
had traditional treatment and access to traditional medications and a 
holistic way of care and treatment. 
Patel (1987) recommends that holistic medicine for renal patients be 
complementary to standard treatment options and could include treatments such as 
acupuncture, ayurvedic medicine, massage or homeopathy.  In the questionnaire 
for this study three examples of alternative techniques were suggested for 
participants.  They were asked if they would be interested in learning about 
meditation and 50.8% answered ‘no’.  When asked if they would like access to 
massage 50.3% answered ‘yes’.  The question regarding whether learning about 
visualization techniques would be of interest was asked and 51.9% answered ‘no.’  
This indicates that massage was the form of relaxation more favoured by the 
participants.  However, according to Stanley, Leither, and Sindelir (2011) the 
benefits of using holistic breathing techniques whilst on HD have reportedly 
shown reductions in anxiety, fatigue, insomnia and pain.   
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Depression 
Depression is common in renal patients and it is reported that 20-30% of patients 
with renal failure experience depression (Keskin & Engin, 2011).  I asked patients 
about depression in their interviews.  Two participants stated that they had never 
suffered from depression or anxiety, three hoped the staff would pick it up if they 
showed any signs of depression or anxiety, and six participants said that no help 
was offered when they were suffering with depression and or anxiety.  Zoe said 
that staff “are more interested in the numbers and figures and getting the dialysis 
right, so no, I don’t think depression is taken into consideration.”  Ned shared, 
you do get stressed, it wasn’t easy leaving work. I went through a stage of 
depression, I won’t lie. Leaving work and being home not having the 
strength to be able to mow the lawns, let alone walk is hard.  I’m not a 
depressive person so experiencing it was a bit of a shock. 
Meg a health professional told me “we don’t know what’s running through their 
minds but I think, most commonly, they do get depression.” 
ESKD patients are confronted with so many major changes to their lives.  They 
must deal with ongoing lifestyle adjustments to accommodate invasive treatments 
and cope with the physical and emotional stress of their illness and all the while 
facing the fear of the unknown (Shih & Honey, 2011).  In the questionnaire 79.2% 
of the participants answered that they had not been offered psychological services, 
and 19.2% had themselves sought psychological services.  Psychological services 
were never offered to Ned, who witnessed another patient on dialysis who he says, 
“gave up hope and nearly died.”  Rob recalled that when he went on dialysis he 
was “very depressed, not to the point of suicide, but thinking, what the hell, some 
help would be appreciated.”  Amy stated that “no psychological services have been 
offered and there have been times when I’m very low and have had ideations 
about suicide, with all the poking, prodding and cutting of my body.”  According 
to Keskin and Engin (2011), suicidal ideation increases as the severity of 
depression increases in patients with CKD.  Patients with renal failure are 100-
400 times more inclined to suicide compared with the general population.  
Fortunately, most of the questionnaire participants (86.8%) answered that they did 
not have any thoughts of killing themselves, however 13.2% said that they have 
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these thoughts or would like to die.  As reported by De Sousa (2008) ESKD 
patients have higher suicide rates than the normal population and can cause their 
own death by withdrawing from treatment and monitoring.  Zalai et al. (2012) 
proposes that “suicide and withdrawal from dialysis are complex, socially and 
legally separate, multicausal phenomena, but both are expressions of the desire for 
hastened death” (p. 433). 
Anxiety 
Anxiety in patients with ESKD has not received as much attention as depression 
even though there are many studies that support a correlation between depression 
and anxiety in such patients (Alavi et al., 2009; Hmwe et al., 2015; House, 1987; 
Kohli et al., 2011; Öyekçin et al., 2012; Rajan & Subramanian, 2016).  These 
studies all rate anxiety levels as being lower than depression.  As part of the 
questionnaire, participants completed the BAI, the mean score was 12.26, which 
indicated a level of mild anxiety, however severe anxiety results were also 
reported.   
The four subscales in the anxiety screen administered to the questionnaire 
participants are; neurophysiological, subjective, panic and autonomic symptoms.  
According to the results of the BAI completed by the renal patients the top four 
symptoms they experienced were neurophysiological symptoms.  This included 
wobbliness in the legs, feeling unsteady, dizzy or light-headedness and numbness 
or tingling.  This indicates that these patients are more troubled by the physical 
symptoms that they are experiencing.  These symptoms do not match well with 
the DSM-5 diagnosis of Generalized Anxiety Disorder (GAD), which refers to 
more psychological symptoms, suggesting that the anxiety the participants are 
experiencing could be related to the physical effects of ESKD not GAD.  Physical 
symptoms were experienced by Bob a renal patient who talked about how he used 
to get anxiety, “especially if I was overloaded with fluid.”  Many participants 
mentioned needles.  An example was Amy who spoke of experiencing high 
anxiety “before needling which I hate, and it has taken a long time to get through 
to the nurses and doctors that anxiety and stress affects blood pressure and 
dialysis session outcomes.” 
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Compliance  
Renal patients are expected to ‘comply’ or be ‘compliant’ with all the aspects of 
the management of their disease.  “Compliance is a behaviour resulting from a 
specific set of cues and consequences.  It is self-care behaviour which entails 
obedience to a directive” (Bakshi Anjani, 2014, p. 997).  The term compliance 
which was talked about in the interviews was not embraced by many of the 
participants or health professionals.  This term was used because it is the medical 
term to describe renal patients’ participation in treatment.  Pam, a health 
professional, pointed out that “the million things the hospital sees as non-
compliant, we see as part of a daily struggle and they are doing their best.”  
“Non-compliance is a self-care deficit which calls for rejection of particular 
behaviour which may result in dissonance and may lead to the development of 
metabolic abnormalities in renal patients” (Bakshi Anjani, 2014, p. 997).  Non-
compliance is correlated with higher morbidity and mortality rates.  Godbold 
(2013) and Christensen and Ehlers (2002) report that the non-compliance rate 
among renal dialysis patients is between 30% and 60%.  Calia et al. (2015) report 
that the inability to recognise and express emotions, as well as the inability to 
manage negative emotions may influence compliance.  Amy, an in-care HD 
patient pointed out that “treatment is frustrating, constantly being tied to treatment 
can bring you down.”  Val a PD patient who uses CAPD thinks that dialysis is a 
“real hassle because I can’t go out for long.  Everything has been put on hold, 
because I want to get better not worse.”  Bob, who is on home HD stated that he 
has more control because he “decides when to go on and for how long.”  Amy 
thought that “more flexibility around treatment times would improve 
compliance.”  Eva talked about dialysis being a “jolly nuisance, but you can’t let 
it ruin your life.” 
The perceptions of the health professionals regarding compliance issues were 
varied.  Rae discussed the differences in patient groups, 
we’ve got young people, males, they cope differently than females, 
sometimes males struggle quite a bit with coping.  Older people are a little 
more resourceful sometimes.  Often the young ones I guess are the people 
not turning up to clinics, people not coming to dialysis.  Getting into their 
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headspace about why they drink too much fluid, why they don’t follow the 
diet and why they don’t turn up for dialysis is important.  I just try to 
understand that they must have low mood often, it must be like being in a 
black hole. 
Jan suggested that “sometimes non-compliance can come down to finances, you 
know, lack of support in their wider community and their families.”  Eve revealed 
that “there is not a lot of give and take.  More flexibility is needed to make it 
(dialysis) accessible to patients’ lifestyles.”  Mia also stated, “I think something 
that would help is more flexibility when they can dialyse and more psychological 
support, someone to talk to.”  Eve reported that, 
a lot of patients would prefer their clinic to be when they are on dialysis, 
the doctor could come and see them then. They can’t understand why we 
keep it separate, they think it’s enough that they are already coming in 
here three times a week. 
Mia said “I think dealing with it is huge and some people just don’t deal with it 
very well.  People who have come to the acceptance that this is it maybe comply a 
little bit better.”  An example of this was the patient Jim who stated that “I guess I 
accepted it pretty well, because there are no options.  If you want to live you have 
to do it.”  Mia reported that “the ones who are compliant and do everything 
they’re supposed to do definitely enjoy better health.” 
Leo also said that patients need “choice if we can give it but we cannot always.”  
Kim indicated that what patients need is  
education, because people need to understand why they are being asked to 
do something.  It is also important to have consistency in training.  I think 
we do really badly with compliance.  It’s a huge impact on their lives and I 
don’t think we can minimise this.  I get frustrated sometimes with our 
consultants when they talk to patients about doing another hour of dialysis.  
Asking them to do one more thing can break them. 
Pat expressed her way of helping patients “from my experience, I’ve been here a 
few years now with my patients and I’m always reassuring them.”  Leo concurred 
“listening to them, so that we know what they like, don’t like, want and don’t 
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want.  Compassion I think would help with compliance, empathy, warmth and 
genuineness.”  And Joy also endorsed this, “it’s about looking at people as 
individuals and what’s going on for them, and if there is something you can help 
them with.”  Other health professionals adopted a different viewpoint.  Deb 
pointed out that patients need to “get through the denial, because those that aren’t 
able to get through don’t grow and flourish.”  Meg also spoke of the need for “an 
acceptance on the part of the patient that they need help, acceptance of all the 
limitations and all the restrictions we give them once they are on dialysis.”  Fay 
admitted that “I don’t know, sometimes you just cannot understand why the 
compliance isn’t there or why they go off the rails, that would be a fantastic thing 
to know.  Their lifestyle changes every step along the way, and they just have to 
learn to cope.”   
According to Chan, Zalilah, and Hii (2012) non-compliance is linked to a lack of 
adequate knowledge, inadequate self-efficacy skills, forgetfulness and financial 
constraints.  Whereas Kimmel (2001) reports that “patients increased satisfaction 
with physicians, but not nursing or technical personnel, correlated with improved 
attendance and greater total time compliance with the dialysis prescription” (p. 
1608).  Emma summed up the situation by saying, 
we need to address the reasons they’re not compliant.  I think that 
compliance is not because people are simply choosing not to do it; I think 
non-compliance is a symptom of something else going wrong and I think 
if they had someone to talk to they would do a lot better.  I think it’s about 
looking after people holistically, your physical health and your mental 
health are just as important.  
Implications 
In the section above, I presented the voices of the interview participants, that is, 
those who were renal patients and health professionals, and discussed their 
comments in relation to the literature and psychological well-being.  In their 
narratives, I identified five significant themes: screening for renal disease; pre-
dialysis care; reactions to diagnosis and treatment; depression and anxiety; and 
compliance.  In this section below, I consider the implications of these findings 
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before moving on to present those findings related to the need for psychological 
support for renal patients. 
In New Zealand, screening for kidney disease only occurs among diabetes patients 
but previous research on screening found that other medically unwell cohorts 
would benefit from screening to secure early diagnosis (Nikolajenko, 2013).  
Molitoris (2013) suggests screening will help with the early detection and early 
intervention of kidney disease and reduce the likelihood of kidney failure.  Kirby 
(2010) states that screening will help the people with CKD who present with 
ESKD and their only option is RRT.  If pre-dialysis care and education is put into 
place immediately on diagnosis, renal patients will better manage their disease 
and possibly delay the need to begin dialysis (New Zealand Kidney Foundation, 
2007; Walker et al., 2010).  The findings are clear on the need for effective early 
education for renal patients on how to manage their diet and fluid restrictions, 
medications and lifestyle changes.  These findings also underline the advantage of 
psychological support at the pre-dialysis phase to give patients the resources to 
begin to accept their diagnosis and adjust to the very difficult changes they must 
make to cope with their illness.  The fact that pre-dialysis care also facilitates 
better overall patient and clinical outcomes suggests that pre-dialysis care and 
education should be a priority for individuals in the early stages of CKD (Walker 
et al., 2010).   
Many participants spoke of experiencing high anxiety regarding the needling 
required for HD treatment, and their rates of anxiety in general were much higher 
than in other studies.  In view of the fact that the BAI revealed that 30 participants 
had moderate anxiety and 28 participants were suffering from severe anxiety, this 
strongly suggests the need for intervention.  Approximately half the patients, 
when asked about three alternative relaxation techniques, said they would be 
interested in learning about either meditation or visualization and just over half 
would like access to massage.  This indicates a willingness by a sufficient number 
of patients to justify pursuing ways to make relaxation options available at the 
renal unit.  Holistic breathing techniques have been shown to reduce anxiety, 
fatigue, insomnia and pain in patients on HD, and it would seem apparent that 
implementing these would benefit those patients that want to use them (Stanley et 
al., 2011).   
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The BDI completed by the participants indicated that almost one quarter (24.4%), 
of this group of participants have moderate to severe levels of depression 
potentially contributing to non-compliance.  Many participants in this research 
agreed that incidences of non-compliance impacted negatively on their health with 
greatly increased hospitalisation rates.  Lack of autonomy is a feature of non-
compliance for renal patients and the participants made some suggestions which 
could help.  Participants said compliance would be easier if they had the ability to 
have more choice and flexibility regarding dialysis times and lengths.  Another 
proposal was for clinic appointments to be scheduled on the same day that in-care 
patients have their dialysis, to avoid an additional trip to the hospital to see the 
doctor.  
The impacts pertaining to the psychological well-being of the participants have 
been discussed and areas of concern raised for consideration.  ESKD patients are 
high risk for depression, anxiety and non-compliance all of which require 
continued support. 
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Section two: Need for psychological support for patients  
This section explores why psychological support is particularly important for 
renal patients.  The data analysis revealed five different aspects pertinent to this, 
which is consistent with the literature on ESKD for improving outcomes for renal 
patients.  These aspects are explored below as sub-themes and include; health 
professional training, psychological screening, family support, psychological 
support and spiritual support.  
Psychological training 
Acknowledging the widely reported view in the literature that depression and 
suicide are prevalent in renal patients, the health professionals interviewed were 
asked what training they had in mental health.  According to the health 
professionals their training in mental health was minimal.  Eleven said they had 
no training apart from a small component in their nursing degrees.  The two social 
workers said that they had mental health training.  Pam is a registered 
psychopaedic nurse and Leo is trained as a health social worker.    
The health professionals’ interest in training in relaxation techniques was gauged.  
Two were disinterested, their reason being that they work alongside a wellness 
person who specialises in relaxation for renal patients.  Seven of the participants 
answered in short form ranging from ‘probably not at this point’ to ‘most 
definitely’.  The remaining health professionals gave more descriptive answers 
which were positive towards learning about relaxation techniques.  Mia stated that 
“it would be really useful for us with people who are really needle phobic.  
Breathing techniques, visualisation... I don’t know, just something because we get 
a lot of people where that’s the biggest barrier is the needling.”  Eve conveyed that 
relaxation techniques “would be good, but I just know I wouldn’t have the time in 
this job to fulfil anything that I had learnt.”  Joy a home HD nurse stated that “it 
would be quite good; I think it would be very beneficial for some people 
particularly in our area where we’re training people.”  Leo a social worker thought 
that it is a “very good idea. I have downloaded a few resources myself, abdominal 
breathing, building resilience.”  Kim has done “a biofeedback course that can help 
with needling, so they can cope better.”  Emma thought “staff might get some 
benefit as well.” 
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When queried on how they assess their patients’ mental health status most of the 
health professionals remarked that this was gauged in the course of the 
relationship formed working with the patients.  Joy said that she measures their 
well-being through developing “a therapeutic relationship...We get to know our 
patients very well, it’s an ongoing relationship.”  If they witnessed a change of 
behaviour they would then ask how the patient was feeling and take steps to help 
this person.  Joy said, “we would use our powers of observation and if they need 
assistance we will contact a doctor or social worker for help.”  However, Mia 
recollected one young man who refused any help and she expressed that “it can be 
very tricky.”  Kim stated that “I’ve referred people to mental health services for a 
consult liaison sometimes successfully, sometimes unsuccessfully.  I’ve also 
sought for assistance in the community and find a huge lacking in this area.”  The 
health professionals who I interviewed, confirmed that there is overwhelming 
support for the implementation of psychological support for renal patients, and the 
acknowledgement that it had been lacking for a long time.  As identified by Mia 
“depression is a huge issue here and psychological services would benefit the 
patients.”  It was stated the services that are available are very hard to access.  
Deb shared that  
we don’t have much in the way of psychological support, we can access 
psychological help but it’s always in the extreme.  What we neglect is all 
the other levels of psychological need, especially with those young people.  
Our rates of survival are not good with our young people.  
Kim told me that getting psychological assessments for patients in smaller towns 
is “near on impossible.”  Rae discussed how she doesn’t like the label of 
psychologist and counsellor. “Oncology, hospice and palliative care have people 
that really understand illness, and they engage at a human level which I think 
would be great if we had the right person for this illness.”  Pam felt that “every 
renal unit should have access to a health psychologist.”  The consensus was that 
improved access to psychological services would be hugely beneficial and should 
be made available to the patients. 
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Psychological Screening 
When the health professionals were asked if they measure or test patients for 
depression or anxiety, only one health professional was found to use a variety of 
screening tests.  Leo a social worker said that he uses “standardised screening 
such as the Hospital Anxiety and Depression Scale.”  Eight health professionals 
thought that screening would be a good idea, and six remarked that they did not 
think it would be a good idea.  Emma answered that screening should take place 
“because they have problems with compliance, not turning up to clinics, not 
taking their medications and I’m sure a lot of that is involved in their mental 
health.”  Mia’s response was “absolutely, especially men of a certain age just 
seem to really struggle.”  Whereas, Joe did not think screening was necessary 
“because they’ve got a long term medical condition they’re going to have some 
form of reactive depression so why check for it.”  Leo agrees saying “the benefits 
wouldn’t outweigh the risks” as screening may overly focus patients on the 
subject of depression therefore causing it to manifest.  Zalai et al. (2012) 
recommend that psychological screening should be routine in renal care.  White 
and McDonnell (2014) suggest the BDI as a screening tool because patients can 
complete it in less than five minutes.  However, Hedayati et al. (2008) point out 
that a distinction must be made between depressive affect as assessed by self-
report questionnaires and a diagnosis based on the DSM-5. 
Family support 
Family members need to understand the effects of ESKD to remain supportive 
and active in the health-care equation along with health professionals and family 
members who are patients.  When asked if their family members understood the 
nature of their illness the questionnaire participants’ results were positively 
skewed with 94.1% (N=177) indicating ‘yes’, and 5.9% (N=11) stating ‘no’.  This 
indicated that they felt their families did have sufficient understanding about 
ESKD.  Of those who wrote comments, one participant Ned indicated that his 
family had “no clue.”  He stated that his family did not understand “no they think 
I’m sick and dying.”  Ten of the patients who were interviewed felt there was a 
good understanding of the illness by their family members.  Bob stated that “they 
all know I must charge my battery up every second day.”  While from the 
participants perspective there seems to be a high level of understanding by their 
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family members about ESKD, some of the health professionals doubted the 
degree of families’ understanding.  Eve expressed that “I don’t think they do 
understand, I can tell that from the phone calls that I get from the family members 
and the questions we get asked.”  Meg discussed how “some are really scared to 
be too involved with what is going on with their family member, and they shut off 
once the situation gets out of hand.”  Massey et al. (2011) support home based 
education programmes that involve family and friends, however, they stress that 
the patient needs to be the priority.  Shih and Honey (2011) also posit that 
ongoing education for the family is a necessity so they are aware of the many 
ways they can assist an individual on dialysis. 
In their interviews, many of the health professionals concurred.  Joy commented 
“educating support people and family is huge. They need to learn about fluid and 
diet restrictions.”  Another health professional Pam said that “the cook of the 
house should be at the dietitian’s meetings.  It’s pointless if the person going to 
see the dietitian has never cooked a meal in their life.”  Emma believes that 
“bringing whanau or friends to education sessions and to clinics is beneficial, so 
people can start to grasp what’s happening.”  Some patients noted the need for 
family to learn “more about understanding symptoms, to be more understanding 
when I am emotionally worn out or tired.”  Zoe conveyed that she would like her 
partner to see a psychologist, so that he has a better understanding of what’s going 
on or how he can help.  “Often that’s a hard one for him because he doesn’t quite 
know what to do.”  Statements from the health professionals reiterated that it takes 
time for families to understand such a complex illness.  They acknowledged the 
many changes that the patient and family must make.  These findings suggest that 
as a significant amount of information is required to really understand the 
complexities of ESKD, being open to learning seems to be a first prerequisite for 
family members.  Knowledge about ESKD would seem to be an advantage for 
both the patient and family members, to enable the right kind of support for the 
patient.  
The questionnaire participants were asked about the level of support offered by 
their family members.  Detailed responses were offered by 144 participants.  Their 
answers ranged from ‘nothing’ to ‘full care.’  Some examples of the wide range of 
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support requirements also mentioned in these entries by respondents to the 
questionnaire included “supportive financially, emotionally and spiritually.  They 
keep me happy by visiting and allowing me to see my mokopuna.  They support 
the decisions I make concerning my treatment or my life.”  Some were more 
specific; “provides transport, is my support person when dealing with health 
professionals.”  “Massage, miri miri.”  “Watches my medication, weight, liaises 
with the nurse, checks blood results and now puts me on dialysis using a 
permacath.”  Many of the entries were centred around practical help in the home 
setting which illustrates the extra day to day responsibilities placed on the family; 
“cleaning and cooking,” “helps carry heavy boxes,” and “helps to set up and sort 
out any problems.”  
In the patient interview, participants were also asked about their perceptions on 
levels of family support.  The majority discussed how both practical and 
emotional help is required from their family.  Kay’s comment demonstrates this, 
“they help by supporting me and encouraging me to keep up my treatments, and 
take my medication and check that I’m alright.”  Zoe described how her partner 
does so much extra around the house, that I sometimes don’t have the 
energy to do.  Even now my energy goes in ups and downs, I can be really 
motivated one day and the next day blah.  So, he’s brilliant with doing the 
actual practical stuff.  Mum is there for the psychological stuff.  
Amy states that “they take care of more of my holistic health and well-being which 
is not done here in clinic or renal treatment.  It’s very much westernised, it’s more 
the medical model whereas my family come from traditional healers.”  Ian stated 
that he has a “very supportive wife and she always comes in with me every clinic, 
which I think is important.”  However, some participants stated that no help was 
required.  Ned pronounced that he needs “nothing, apart from my partner.”  
The overall impression from the health professionals’ answers about families was 
the recognition of the burden the extra responsibilities placed on them and that 
what families do is often undervalued.  Leo acknowledged that “sometimes we 
only focus on the patient, yet we should also focus on their family.”  Jan advised 
that a “greater number of support networks are better otherwise the carer burns 
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out, and you do see that.”  Pomaki, DeLongis, Anagnostopoulou, and Heininger 
(2011) discussed the problems families and patients can have in the home 
environment.  Despite the best intentions family members can behave in an 
overprotective manner, which can unnecessarily limit activities for the patient.  
Fay a health professional confirmed this “if their supportive role is a little bit over 
the top and they’re answering for them, telling us everything, it’s difficult.”  
Sometimes feelings of tension, frustration and anger resulting from the experience 
of living with a family member with ESKD can affect the carer and patient.  
Health professional Joe talked about how he tries “to put their tension levels down 
low, make the person on dialysis realise family members are actually living and 
doing this as well.”  However, Jan expressed concern for carers “it’s such a 
burden isn’t it to suddenly find that you’re it, you’re going to have to look after 
him as well.”  Emma described how 
sometimes I look at those wives and husbands and think you’re amazing.  
They travel and they come in and out of hospital and their whole lives are 
turned upside down for a long time.  Some of them have to watch their 
partners fade away and it must be really hard.  Being away from the home 
with frequent or prolonged hospitalisations can also impose stress on 
families.   
Coping with renal failure is difficult and demanding but there are tasks that family 
members can do to support the patient.  In the questionnaire participants were 
asked what tasks or activities their family members could be involved in to make 
coping with renal failure easier for them.  The majority (N=139, 70.6%) answered 
that no extra tasks were required to be done.  Most of the participants expressed 
that help with practical jobs was what helped them to cope, and that emotional 
support was also important to them, “yes there is a lot of minor things I can't do 
on my own,” “they keep me sane,” “everything they do for me is awesome.”  In 
general, the interview participants responded that their families were already 
doing enough to help them.   
Another perspective was sought from the health professionals regarding tasks 
family can undertake.  They told me that the most important aspect was to keep 
the family engaged so they continue to provide their loved one with practical help 
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and support.  Leo was positive saying “there is always a possibility at the in-centre 
for whanau input.”  Jan pointed out that “a lot of it is transport and some of them 
sit through the whole dialysis.  They are probably the exception rather than the 
rule.”  Pat suggested that “there are lots that the family can do to come and help 
them.  Like the family members they will come there and they will set up the 
chair and bring the blanket, bring water, get everything set up.”  However, Eve 
considered that “there probably isn’t a huge amount of tasks as we wouldn’t want 
them to touch any dressings or anything on their bodies.  It’s probably just 
perhaps having more skills to understand what it is like to live with a person that 
has a chronic illness.” 
Deb, a PD nurse, discussed how she does not recommend carers help with 
medical tasks 
because we don’t know if we can rely on them and we can’t give them a 
task, it might be to the detriment of the patient.  Although sometimes like 
for instance if you’re training somebody onto a ‘cycler’ and they are in a 
wheelchair, you have to ask the partner to bring the bags in.  They are six 
litre bags, they are quite hard to lift from a wheelchair.  Sometimes the 
tube that comes out of the tummy, if they’ve got a big tummy and the 
position of the catheter is out of sight, we ask and rely and encourage the 
wife to do the dressing.  But some will say I’m not doing anything, but 
that’s part of their grief. 
Meg conveyed that  
on the self-care side, we do encourage a support person to be there with 
the patient.  Here in PD we just try to get a family member to be with them 
during the training because of the information overload we are giving 
them during their training week.  Somebody who can help them 
understand so they can focus on training and how to do their dialysis 
alone.   
Patients who use home dialysis, either HD and PD or self-care HD can require 
more active assistance from family.  In NZ 23% of renal patients use self-care HD 
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and 27% use home HD (Sinclair, 2009).  PD is the most common form of home 
dialysis, and overall in NZ PD usage is 35%, home HD 18%, and in-care hospital 
dialysis 47%  (Walker & Marshall, 2014).   Walker, Blagg, and Mendelssohn 
(2015) list a key attribute for the home HD patient is family or caregiver support.  
de Maar, de Groot, Luik, Mui, and Hagen (2016) also recommend that optimal 
home HD training will involve a family member who is willing or able to support 
the patient.  Joy who works in the HD home training unit points out that  
it is not a requirement for people to have a support person or family 
member, but we do suggest that it’s more helpful to have somebody there.  
Even for those coming from outside Hamilton we provide accommodation 
for two people when they are training, so a support person is included.  I 
would say 60-70% would have a support person.  
The positive factors when using home either HD or PD, include a higher quality 
of life and longer survival rates (Kutner et al., 2005).  However, Wilkie (2011) 
points out that the international trend for home dialysis continues to decline, with 
full in-care HD continuing its dominance.  Holman (2011) states that home 
dialysis carers provide unpaid care to ill, frail or disabled friends or family 
members.  It is important for health professionals to give carers of home dialysis 
patients time, space and permission to talk about how caring impacts on their 
lives.   
Psychological support 
Different forms of psychological therapy were included in the questionnaire to 
measure the interest of the participants.  When they were asked if they would be 
interested in group therapy, 13.8% (N= 26) answered ‘yes’, 31.7% (N=60) 
answered ‘maybe’ and 54.5% (N=103) answered ‘no.’   Two participants 
expanded their responses, “more for support for my dialysis friends” and “all 
depends where it is and cost.”  The participants were also asked if they would be 
interested in individual therapy, 20.3% (N=38) answered ‘yes’, 30.5% (N=57) 
answered ‘maybe’ and 46.7% (N= 92) answered ‘no’.  Three expanded on their 
answers, “but it is the cost,” “always hard to get extra time off work,” and “if they 
are on dialysis so they know what we are talking about, not reading out of a 
book.”  Duarte, Miyazaki, Blay, and Sesso (2009) conclude from their research 
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that cognitive behavioural group therapy is an effective treatment for major 
depression in HD patients.  Improvements were reported in the areas of sleep, 
quality of social interactions, overall health and the burden of renal disease.  
Kimmel (2005) states that social support can be a source of strength and 
consolation promoting well-being.  Bob states that “I would do group so I could 
share my feelings and experiences.’  Dan expressed an interest in therapy with 
this proviso “later, not right now, closer to my death.”  Ned thought that “any 
session would be great, in a group you could share information with each other.”  
Kay would prefer individual therapy, “I’m more of a one on one person.”  
Eva conveyed that she “tried to organise a morning tea for people on dialysis or 
coming up to go on dialysis.  No one came, no one seemed to be very interested.”  
Bob also “tried to start up a support group for new dialysis patients, to give them 
practical advice about the machine and what to expect.”  Zoe has already done 
individual therapy and told me that it was “very good, the group one sounded 
really cool because often it’s good to know that somebody else is feeling like you 
do, just being around other people so you don’t feel so isolated.”  Williams, 
Manias, Liew, Gock, and Gorelik (2012) found that culturally and linguistically 
diverse people with kidney disease can feel isolated and are often excluded from 
intervention studies.  Their participants were appreciative of the one-on-one home 
visits and were open to learning and taking advice.  Chiou and Chung (2012) 
proposed that multimedia interactive DVDs might be used to educate ESKD 
patients.  In their research, the participants who only had written information were 
more unsure about treatment options and information pertaining to ESKD.  Ned 
agreed that “a DVD to learn from would be simpler and easier, the book was 
confusing with too many pages.”   
Most of the health professionals thought that either individual and / or group 
therapy could assist the renal patients.  Meg’s opinion was that the patients would 
prefer group therapy, “some of them really enjoy spending time with other 
patients, being able to relate to someone.  Some patients tend to push everyone out 
of their life but if they spend time with another patient it makes it more normal.”  
Eve mentioned “they are trying to get a support group for the young people, so 
that could be good for them.”  Joy also thought that “individual and group would 
be really beneficial for some people.”  Fay discussed transplant patients “we can 
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see that when they come to transplant clinics they see patients who are in the same 
boat. I would imagine group therapy would be fabulous.”  But Rae raised the 
concern that some patients may not participate, “if they were a bit depressed or 
whatever they are less likely to want to do therapy, so in actual fact the people 
who need it most, probably aren’t going to get the benefit of a group.  Getting 
someone to engage with help initially is actually quite difficult.”  Leo a social 
worker suggests that “individual sessions ‘yes’, group therapy sessions ‘no’, that’s 
from my personal experience.  We’ve tried different ones and not had great 
uptake”.  Emma a renal transplant nurse discussed her patients,  
would probably like more individual therapy, once they’re transplanted it’s 
about other stuff.  They have like a survivor guilt.  Their mate is still in in-
centre and they’ve got the transplant.  For young people that are struggling 
with fluid balance might prefer a group where you can have a chat about 
what’s a barrier to them and how that works and strategies they have 
developed that might help other people.  So, I suppose it just depends on 
what population.  
However, Joe had a different perspective to the other health professionals.  He 
was adamant that therapy sessions were not a good idea, telling me that “they 
want to be getting on with life, they want normality.”   
Spiritual support 
Spiritual support was inquired about in the questionnaire and whether this form of 
support was important to the participants, and 52.8% (N=102) answered ‘yes’, 
5.7% (N=11) answered ‘maybe’ and 41.5% (N=80) answered ‘no’.  Some 
expanded on their answers, “that’s why I go to mirimiri,” “I am a Jehovah’s 
Witness,” and “committed Christian.”  Leo a social worker remarked that  
I believe that more emphasis on psychological services in renal would give 
better credence to Dr Mason Durie, Te Whare Tapa Wha, it’s not just 
about physical it’s about the mind as well, the spiritual side, people don’t 
often talk about that, but the ones who do, my God it’s important to them.  
The interesting things I’ve seen, the variances of some Pacifika people 
believing in God’s intervention, that’s the faith part, the wairua.   
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Shih and Honey (2011) reported that Te Whare Tapa Whā, would be appropriate 
for ESKD patients.  Egan et al. (2014) indicate that people with ESKD have a 
shortened life expectancy and carry a high symptom burden, and that attending to 
the renal patients’ spiritual needs may contribute to an improvement in their 
quality of life.  Spiritual support was important for over half of the participants, 
however according to Egan et al. (2014) renal specialists may lack an awareness 
of patients’ spiritual and palliative care needs.  Palliative care is offered to renal 
patients whose condition is deteriorating when they are in stage four or five.  They 
will present with at least two of the following indicators: 
Patient for whom the surprise question is applicable, which means for 
patients with advanced disease or progressive life limiting conditions, 
would you be surprised if the patient were to die in the next few months, 
weeks, days. 
Patients choosing the no dialysis option, discounting dialysis or not opting 
for dialysis if their transplant has failed.  
Patients with difficult physical symptoms or psychological symptoms 
despite optimal tolerated renal replacement therapy.   
Symptomatic Renal Failure, nausea and vomiting, anorexia, pruritus (itchy 
skin), reduced functional status, intractable fluid overload (Pallitive Care 
Council of New Zealand, 2014, p. 4). 
Palliative care is available wherever the patient is, be that home, hospital, 
residential care or hospice (Ministry of Health, 2007).  The health professionals in 
this study deal with death on a regular basis.  Emma states that “we feel really sad 
when people we have had a long relationship with die.”  Deb conveyed that she 
would like to “try to teach them about the grieving process, but time is of the 
essence around here and there’s no time for it.”  Leo pointed out that “Te Puni 
Oranga, the Māori unit here at Waikato is really great.  They come in, do a karakia 
after a death and engage whanau support.” 
Implications from this research 
At the renal unit, apart from the social workers, I was unable to identify (via my 
interviews) any health professionals who had training in mental health.  It was not 
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a pre-requisite to working in this unit and there was no training provided at the 
unit to develop this component of health care.  It is puzzling that this important 
area of training and care is overlooked for the health professionals working with 
this vulnerable population.  In view of the increased risk of undiagnosed 
depression and suicidal ideation in renal patients, it would appear that more 
mental health training is required for the staff that work with them.  In the words 
of one health professional “we don’t know what’s running through their minds but 
I think most commonly they do get depression.”  
This study revealed that there are patients at the clinic experiencing depression, 
some severe and others less so.  No help was offered to six of the interview 
participants when they were suffering with depression and or anxiety, while other 
patients in this study said that they hoped the staff would pick it up if they showed 
any signs of depression or anxiety.  So, the expectation of help is there but the 
delivery of this type of help is not possible at present at the unit.  Considering that 
patients with renal failure are more inclined to suicide than the general population, 
it is surprising the lack of psychological support available at the unit for these 
patients.  As reported 13.2% of patients in this study admitted having suicidal 
thoughts. 
In the questionnaire 156 participants reported that they had not been offered 
psychological services.  As part of the BDI results participants also reported that 
they were sleeping less, eating less, less interested in sex, they had less energy, 
were more fatigued and do not enjoy things as much as they used to.  The 
necessity of access to appropriate strategies to increase psychological well-being 
is very apparent for renal patients at the Waikato Renal Centre that I engaged 
with.  Both health professionals and patient participants clearly identified the need 
for increased psychological services with varying recommendations for the form 
this could take.  The majority proposed that a psychologist would be a valuable 
addition to the treatment team for dialysis patients. 
The findings showed areas where this would be advantageous.  A health 
psychologist working with renal patients could implement routine screening for 
depression and it is suggested the BDI be implemented as a screening tool 
because it can be completed by patients in less than five minutes (White & 
McDonnell, 2014).  Once a diagnosis of the level of a patient’s depression has 
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been made a psychologist could then facilitate CBT or other appropriate 
treatments.  There are many patients who are needle phobic or have fearful 
reactions to needling that are a barrier to their treatment.  A specialist in mental 
health would be useful to give patients strategies to deal with the anxiety that they 
feel.  They could instigate the use of relaxation techniques when patients become 
overwhelmed with the many different procedures they must undergo or are just 
not coping with the burden of their disease. 
Pre-dialysis care is important because it has been shown that it can slow down the 
rate of progression on to dialysis.  A person experienced in mental health could 
instigate an effective pre-dialysis programme.  This would be beneficial for 
patients regarding acceptance of their diagnosis and treatment and provide for 
better management earlier in the disease process.  Non-compliance is clearly 
linked to poor outcomes, and as psychological support to promote self-efficacy 
has been shown to facilitate increasing compliance, the implication is that for 
renal patients access to a mental health professional would be highly beneficial if 
not essential (Wu et al., 2016).  Moreover, as this study found outside 
psychological services were very hard to access for patients when needed, a 
psychologist on staff at the renal unit would negate the need to rely on this less 
immediate and inconsistent option. 
Psychological support at the unit could facilitate communication with patients’ 
families.  This study seems to reinforce the literature emphasising how important 
social support is for the psychological well-being of renal patients.  Ongoing 
education for the families who provide this support was suggested by both health 
professionals and patients, including psychological support (Massey et al., 2011; 
Shih & Honey, 2011).  The findings also appear to support the idea that shared 
decision-making helps patients with their treatment choices, and also encourages 
family involvement (Jayanti et al., 2015; Walker, Marshall, & Polaschek, 2013).  
This model could be introduced to promote the increased family engagement 
proposed in the study if there was a psychologist at the unit.  Te Whare Tapa 
Whā, would be an excellent overarching framework to facilitate the instigation of 
any changes or additional services. 
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The next section examines the challenges renal patients and health professionals 
experience, and the impact of challenges on outcomes.  The need for improved 
communication between patients, health professionals and family is raised for 
discussion as well as what actions can be implemented for change. 
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Section Three: Need for improved communication 
Lack of effective communication is a strong recurring theme in the findings of 
this study.  In this section, the patients identify areas with a need for improved 
communication.  The participants discuss frustrations they have had with the 
healthcare system and services provided.  Resources that could conceivably 
improve the services provided by health professionals are mooted.  Also, the 
health professionals discuss the difficulties they encounter working with renal 
patients.  There are five sub-themes in this section which are; negative 
experiences with the healthcare system, resources, pain, challenges for health 
professionals and the coping mechanisms they utilise. 
Negative experiences with the healthcare system 
In the patient interviews, they were asked whether they had any concerns and if 
they felt they were being listened to by the health professionals.  Amy described 
how she has been “very frustrated for the last four years because no one has really 
listened, I felt very bullied like many other patients who have voiced concerns.”  
Rob pronounced that the renal department of course have got to say, “if anything 
goes wrong ring us, but that’s a load of bull-shit too.”  Zoe discussed that “we had 
to be really proactive about wanting to go onto dialysis, it’s so important to have a 
support person.  I had to push the whole way and that’s even to get on the 
transplant list.”  Rob concurred,  
they let me go too long without dialysis. My kidneys were working at 40% 
when they first picked it up but by the time they decided to do anything 
about it my kidneys were working at 4%.  I didn’t know what to expect.  
There was not a great deal of information about how it all works.  They 
first said that I would be up and running within six weeks.  It’s now two 
and a half years later.  For the past 8-9 months, I’ve had no help from the 
renal department; I think I told you I had a go at them.  The only ones that 
have contacted me is the Kidney Society.  
Zalai et al. (2012) purport that negative experiences with the health care system 
can trigger depression in CKD patients.  Eva talked about having a doctor who  
at a clinic appointment informed me that I was taken off the transplant list.  
The doctor said we have been talking about you and we have decided to 
86 
 
take you off the transplant list.  That’s how I found out and then she threw 
me a box of tissues.  It had something to do with the mortality calculator.  
To be told like that was really horrible.  
Rob was also concerned about his chances of a transplant dwindling, 
I was on the transplant list and I got a letter from them at Waikato to say 
that within three months we will be looking at you, it’s now coming nine 
months, no phone call, no letter, no nothing.  I keep telling renal can you 
check it up for me please, to get me back on to this bloody list, heard 
nothing not a thing.   
The interpersonal relationship between patients and healthcare professionals was 
found to be the cause behind the majority of patient complaints in a study by 
Schaad et al. (2015) which analysed the reasons behind hospital patients’ 
grievances.  Several of the participants in my study reported making formal 
complaints to the DHB.  Jim stated that he  
complained about one of the doctors. The first question he asked me was 
how long have you been on dialysis? which said to me you haven’t even 
opened my bloody folder mate.  And he went on with several other things 
that annoyed me as well, so I came home and wrote a letter of complaint.  
Another doctor was talking about statistics and all the rest of it and he said 
to me, you only have five years to live. I don’t think that was the right 
thing to be telling me.  
Val explains that she wrote to the DHB about her renal doctor.  The DHB came 
back and said “no he didn’t say that about the transplant.  I know he told me from 
day one that I would get a transplant and he now says no.”  Ian described being 
prepared for PD surgery,  
the clinic has a system where they mark above the belt line where the tube 
should go.  Unfortunately, the surgeon took the belt line as the mark, so I 
can’t wear a belt any more, I have to wear braces.  I can’t wear anything 
tight around my waist.  We wrote a letter to the hospital board about that, 
that there seemed to be something wrong with their systems.  They said 
they would do something about it, but I don’t think they have because 
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nurses have told me that they are still doing this.  So, I have a problem 
with that aspect of it.  
Ned expressed anger about going to see “a renal doctor about something and he 
referred it back to my GP, he could have just signed it off.  They are too busy, I 
get given the run-around.”  Ned told of his experience with training.  “Self-care 
dialysis was frustrating, you are expected to set up the machine, and the nurses 
were not showing me anything.”  However, he also stated that “I’m gaining a bit 
of control with knowledge and how to set up everything, I’m feeling a little bit 
better.”  Kay had a positive response to and conveyed that she has “had good 
support from the nurses and doctors.” 
Some of the health professionals also had concerns regarding hospital processes.  
Eve pointed out that “I guess a lot of them might be frustrated with the hospital 
system.  They have to wait forever for any kind of procedure, their life is based 
around a machine.”  Jan worried about a “lack of discretion sometimes among 
staff, a lack of respect and sensitivity to the patients who are listening in.  
Generalisations are going on and I think the staff can get a bit cynical, not overall 
but there is an element there being judgemental.”  White and McDonnell (2014) 
stated that the role of the nephrology nurse and other health professionals working 
with ESKD patients is to help them cope and adjust to the significant psychosocial 
challenges they are confronted with every day.  For quite a few of the participants 
in this study this has not always been their experience which can be detrimental to 
their potential for well-being.  Kimmel (2001) gave an example of physical 
changes that occur in patients when they found that “patients increased 
satisfaction with staff and their perception that staff cared about them correlated 
with higher serum albumin levels” (p. 1608).  Serum albumin is the most 
abundant protein in human blood plasma.  Zalai et al. (2012) suggest that CKD 
healthcare teams can learn from treatment models already implemented in other 
medically ill populations, such as those with cancer.   
Resources 
During their interviews, the patient participants were asked if there were any 
additional resources that they felt would, if provided, improve their outcomes.  
Amy discussed this, 
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I think there needs to be more education for medical staff regarding 
holistic care and individualised treatment planning, more preventative care 
in the early stages of renal failure, and better education around diet and 
nutrition.  I think they leave it until you are acutely unwell before you can 
access all these things. 
Stanley et al. (2011) presented a similar view inferring that using holistic 
physiological techniques such as controlled breathing, may offer a unique and 
alternative tool for nurses to help increase health related quality of life in patients 
on HD.  In this respect, Singhania and Mandalika (2012) have developed the 
Holistic Health Assessment Tool for use with people with kidney dysfunction.  
Eva raised the point that “I think one of the problems is that basically when you 
go to the hospital you see a different doctor, you hardly ever see the same one two 
times running.”  Jim compared this situation with his experience at another 
hospital.  “In Whangarei where I started dialysis you have a primary nurse and 
primary doctor, so you are seeing the same doctor all the time,” which he felt was 
a much better system.  Jim also pointed out that  
less waiting at the hospital would be helpful.  The problem in my belief is 
they have all sorts of sundry people bringing people in for dialysis.  In 
Whangarei, they had one contractor who used to bring everyone in for 
dialysis, so in other words the unit knew exactly when they were getting 
their patients.   
Ned also identified the need for “better access to travel when you live out of town, 
and financial help.”  Rob stated that the “smaller towns need two or three 
haemodialysis machines, because travelling to Hamilton three times a week is too 
gruelling.”  Ned indicated the need for more “support with Work and Income, I 
would love to go to work but I can’t.  They keep sticking me on benefits I 
shouldn’t be on.”  Rob said, 
I reckon more communication, even to this day I would have preferred to 
talk to somebody who has been through it, who is doing it, who has lived 
it.  So, I could get their point of view on what to expect, how it all works, 
one on one.  
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Kimmel (2001) report that how staff interact with patients is important for 
mediating improved outcomes for renal patients.  Val talked about this, “I would 
like to know more from the hospital.  Why can’t my nurse ring me and say 
everything’s good or my blood pressure is too high, or I have to drop some of my 
foods to bring something down low?”  Zoe proposed access throughout treatment 
“to a psychologist that you could ring, and maybe a little bit more regular contact 
from the PD nurse.  Because I find with me not being bedridden or really sick 
they forget that I need help.”  White and McDonnell (2014) state that 
psychological stressors were more troublesome than physiological ones, thus easy 
access to a psychologist or other mental health providers would be beneficial.  
Nearly all the health professionals in this study felt that the key additional 
resource required for patients, was psychological services.  However, they added 
the proviso that any such service must recognise the specific needs of renal 
patients and that any psychological resource must not be a standalone specialty 
area.  Kim said, “It should be seen as an integral part of the service because I think 
there is still a stigma attached to mental health support.”  Rae stated that 
I think that would be helpful.  I use our social worker as much as possible 
because that’s all we have really.  It would be great to have somebody who 
could be regular and they could develop the relationships, because I do 
feel that’s key.  Someone who actually understood everything there is to 
know about what they have to go through and what’s coming.  
Emma expressed that “having a psychologist that we can refer to would be 
fabulous, someone who has an interest in renal and understands the journey that 
people go through.”  Eve talked about having 
a psychiatrist of some description.  In the old days, we used to have more 
access to psyc liaison and they would come and see the marginal patients 
that we felt were struggling.  Perhaps we need someone who’s a little bit 
more qualified that can pick up on things, rather than just the lay 
chaplains. 
Deb shared that she has been 
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working in renal for 30 years and way back over 20 years ago we had a 
psychologist as part of our renal team, which was fantastic.  Wouldn’t it be 
just wonderful if we had a psychologist and we could walk into his or her 
office, it would be a natural thing to include a psychologist. 
Meg stated that  
sometimes they feel like everyone is against them, like the nurses, doctors, 
dietitians we are ganging up on them if they’re not doing the right thing.  
They cannot speak freely to a nurse or doctor so a different person who 
they feel is there for them would actually be helpful.   
Joy believes that “having some psychology input would be a big benefit, 
particularly when people are not turning up for dialysis and become more unwell 
and turn up acutely to ED.”  Leo agrees that having a psychologist attached to the 
staff would be beneficial.   
I would have made referrals.  In the past, we’ve made referrals to consult 
psych liaison that have had some input but not always when we want it 
and for the length we wanted.  I don’t think mental health is strongly 
resourced here at Waikato, so it would be great to have more resources 
here. 
Emma discussed transplant patients, “all the recipients and donors have to see a 
psychological person and they have to see the people separately and together and 
we have never been able to provide that service here.  People have always had to 
go to Auckland to get that done.”  Pat suggested “more input from our social 
workers, and more input from our kaitiaki.  We used to but I haven’t seen them 
here for a long while.”  Joe proposes that “a lot of people don’t even know they 
have a social worker, what they actually need is a list of who’s in the team, what 
their role is and a contact number.”  Jan agreed with renal patient Jim that “the 
waiting time for patients before treatment and the shuttle service need to be 
improved.”  
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Pain 
Pain is acknowledged as the most common yet unrecognised symptom 
experienced by patients with ESKD.  In their study, White and McDonnell (2014) 
report that 50% of patients with ESKD experience pain.  In my study, inadequate 
opportunities to discuss pain and the reluctance to prescribe adequate pain relief 
were considered a problem.  Pain resulting from dialysis procedures can be due to 
the cannulation or needling of the fistulae for HD patients, while PD patients can 
suffer from abdominal cramps, distension and back pain (White & McDonnell, 
2014).  Kay described the pain she experienced when she started PD “how awful 
it was getting all of that fluid pushed into you. I thought I was going to explode, it 
was very painful.”  Ian said that when he started PD “they had to peel me off the 
roof; it was just so damned painful. I was allergic to the dialysate.”  The 
undertreatment of pain has a significant impact on the physical and mental well-
being of renal patients with poor pain management being linked to depression and 
anxiety (Salisbury et al., 2009).  Barakzoy and Moss (2006) state that pain 
symptoms for renal patients should be more constantly monitored.  Although 
some medications need to be avoided.  The World Health organisation (WHO) 
scale of analgesic medications adjusted for renal patients allows for the use of 
more medications to adequately manage pain relief (Brown, 2015).   
Challenges to renal health professionals  
Working in renal care requires not only medical training and in most cases direct 
contact with the families of the patient.  The health professionals discussed how 
they felt about family interactions.  Leo “although it can be a two-edged sword 
regarding family.  I have had to politely say to one patient with school age 
children not to bring them into treatment.”  Pat also pointed this out, “sometimes 
it can be hard when whanau bring their little ones.  It’s hard for them to 
understand when we tell them you need to limit the numbers, especially with kids 
because some kids go and touch everything and you don’t want that.”  Families 
can impact on the patient's’ treatment and can make the health professionals’ job 
more difficult.  Leo mentioned an example of this, “when transport is something 
the family have said they will do but they aren’t able to follow through with it, the 
person either misses their dialysis or is late and that can be quite disruptive for 
other patients and staff.”  Rae spoke of this also, 
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I can never understand if they have family, why aren’t they bringing them 
in if patients aren’t turning up to in-centre.  Then obviously if we get 
families that are coming in and they’re being difficult, disruptive, abusive 
that can be difficult as well.  
Kim points out “it’s when they don’t understand and they whisk the patient off, 
miss appointments that sort of thing.”  Pam suggested that “it’s always the loudest 
voice rules the house and the loudest voice is quite often the least informed, and 
that there are a lot of choices made by misinformed or well-meaning but very 
bossy or bullying family members.”  Joe referred to a problem when family 
“make the patient dependent on them, not allowing the person to keep their 
independence.”  The main point raised by these health professionals was that 
communication with the family was very important and working out how to 
bridge the gap so that everyone is well informed is the desired goal.  Leo stated 
that “communication will help because if family perpetuate a lack of knowledge 
or a fear of something that doesn’t help the patient.”  These different perspectives 
demonstrate some of the difficulties with families that health professionals 
encounter in their work environment. 
Coping mechanisms 
Working in a stressful environment requires coping mechanisms to be applied by 
the health professionals.  When asked about the ways they cope with stress they 
mainly agreed that the best strategy was communication with other colleagues 
who understood the challenges of the job.  Some preferred formal meetings with 
colleagues while others preferred a more casual debrief over coffee.  Stanley, 
Worrall-Carter, Rahman, McEvedy, and Langham (2015) call attention to the 
value of mentorship and collaboration in their model of care for dialysis nurse 
practitioners to help them manage work stress.  However, the two overarching 
strategies used by the health professionals to alleviate pressure were to share with 
colleagues and to not take work home.  Meg discussed this, 
I try as much as I can to leave work at work, but sometimes you can’t help 
it.  You get too attached to your patient because you get to see them almost 
every day of your life, and then suddenly you see them get sick and you 
lose them.  I think PD is even harder because we go into their home.  You 
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enter their safe zone, and then just one day you’ll find out they had a heart 
attack and the patient has died.  Us nurses would usually, if we lose a 
patient, we would gather around and spend some time talking about that 
patient.  Sometimes we would have a minister come in and if a patient sits 
on one particular chair the minister would bless the chair and say a prayer. 
Emma talked about what she finds hard.  “When a patient dies, I always, a week 
or so later, ring the spouse.  Those phone calls are really hard, I try not to take it 
home but it is quite consuming.”  Josland, Brennan, Anastasiou, and Brown 
(2012) recommend that being well informed and well versed in renal knowledge 
assists the renal carers as well as the ESKD patients.  Knowing the details about 
what to expect from the time of diagnosis through to death and about bereavement 
enables renal health professionals to better manage the stress involved in their job.  
Implications for improved communication from this research 
The health care equation for renal patients relies significantly on communication 
that is clearly understood and therapeutic.  There is a significant amount of 
information that is communicated.  Sometimes this is done effectively, but often, 
especially in the context of un-wellness, complexity and stress, communication is 
sometimes compromised, misunderstood, or simply not received.  Communication 
impacts all aspects of renal care and negative healthcare experiences cannot be 
underestimated, particularly for renal patients (Christensen & Ehlers, 2002).  In 
my study, a large number of the participants have had negative experiences which 
demonstrates the need for communication to be addressed.  Some of the situations 
described by the renal patients make it easy to understand how these could trigger 
depression and or anxiety which in turn negatively affects health and well-being.  
Interpersonal interactions between patients and providers are the leading cause of 
hospital complaints (Schaad et al., 2015).  As the examples given in this study in 
the main referred to poor communication between patients and health 
professionals, this reflects the need for re-evaluating best practice for 
communicating with patients.  Health professionals need to be able to deliver the 
practical medical advice and information to patients with sensitivity and empathy.  
They need to be mindful of the precarious psychological and physical situation of 
their patients as they negotiate the complexity that is kidney disease.  As much as 
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possible, health professionals need to make every effort to assist and facilitate an 
easy passage for these patients. 
Other changes that may well improve the services provided by the renal unit were 
proposed by participants.  They indicated a lack of continuity with the doctors 
they saw.  The implication of that being that there was no ongoing communication 
with a specifically assigned physician.  Many studies deem the therapeutic 
relationship to be vital for patient well-being and positive outcomes and this is not 
possible with ever changing doctors.  A solution was proposed that each patient be 
assigned one primary doctor that they could have continuity with and build a 
stable therapeutic relationship.  A further suggestion was that a contact list where 
patients could easily access information and support at any time be made available 
to them.  Several participants raised the need for better access of travel to and 
from the unit, and the long waiting times for patients before treatment at the unit. 
White and McDonnell (2014) found that pain is the most common symptom 
experienced by renal patients, which was confirmed in this research by the 
participants.  Inadequate opportunities to discuss pain and the reluctance to 
prescribe adequate pain relief were considered a problem.  The under-treatment of 
pain has a significant impact on the physical and mental well-being of renal 
patients and may induce many arguably avoidable negative ramifications.  As 
poor management of pain is linked to depression and anxiety it is essential that 
health professionals facilitate the improved communication necessary with renal 
patients to better ascertain their levels of pain (Barakzoy & Moss, 2006).   
Communication between fellow health professionals was found to be the main 
way to cope with stress.  They found the best strategy for stress relief was talking 
to other colleagues who understood the challenges of the job.  Because of the 
nature of renal disease, the key stressor the health professionals must deal with is 
losing a patient which occurs frequently at the unit.  Many said what helps the 
most is to gather together and spend some time talking about that patient with 
fellow colleagues.   
Continuing communication with the family to keep everyone well informed 
regarding the patient's requirements is vital to bridge the gap between the hospital 
and the home.  Misinformed family members though well-meaning may 
95 
 
unwittingly cause problems to arise for renal patients through a lack of 
knowledge.  The challenges identified for the health professionals in the study 
could also perhaps be resolved with enhanced communication channels and 
ongoing education for families.  If the patient and family members have clear 
explanations of what is expected of them, some of the problems would be 
reduced.   
Non-compliance is also linked to a lack of adequate knowledge and as it has been 
found that patients’ increased satisfaction with their physicians correlated with 
improved attendance and greater total compliance (Kimmel, 2001).  The inference 
is that quality communication between patients and their doctor giving 
comprehensive explanations on all aspects of their treatment programme would go 
a long way to facilitating increased compliance.  This improved communication 
was suggested by nurses in the study when they talked about the need to find out 
the reasons why patients are not compliant and that non-compliance is a symptom 
of something going wrong.  Communicating with patients about any concerns that 
they may have and giving them the reasons why they are being asked to do 
something would make it easier for them to comply.  
Although from the patient’s perspective the level of understanding about ESKD 
amongst their family members was high, the health professionals gave reasons to 
doubt the degree of families understanding.  Greater communication between the 
hospital and the families and ongoing education will assist their level of 
understanding and show them the many ways they can support their family 
member.  If family members are kept well informed the implementation of the 
shared decision-making model found to be effective for renal patients by Jayanti 
et al. (2015) would be conceivable at the unit. 
In view of the fact that the positive outcomes for patients on home dialysis 
outweigh in-care dialysis and as reported by Wilkie (2011) that the international 
trend for home dialysis is continuing to decline, another benefit of effective 
communication with family may be the potential for increased numbers of 
patients being able to undergo home dialysis.  If health professionals were to give 
carers of home dialysis patients the recommended time, space and permission to 
talk about how caring impacts on their lives more may be able to support their 
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family member to dialyse at home.  This would have a positive effect on patients’ 
psychological well-being due to the increased control, freedom and autonomy that 
comes with home dialysis. 
The impacts of poor communication between patients, health professional and 
families have been discussed and areas of concern raised for consideration.  The 
support required for ESKD patients is complex, thus more transparent 
communication is imperitve to obtain positive oputcomes for the participants in 
this study.   
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Chapter Five: Discussion and Conclusion 
The primary aim of this research was to examine the psychological well-being of 
renal patients who are using dialysis under the care of the Waikato Regional 
Renal Centre.  This involved interviews with dialysis patients and renal health 
professionals and a more widely distributed questionnaire survey of patients.  
In this chapter, the findings that affect dialysis patients’ psychological well-being 
will be identified and discussed.  Of particular note are two recurring themes 
pertaining to both patients and health professionals: the need for ongoing 
education; and the need for effective communication.  The discussion begins with 
the reactions of patients when given their diagnosis and treatment options.  This is 
followed by examining the issue of pre-dialysis.  The implications of diet, fluid 
restriction, medication, depression, anxiety and pain for renal patients are 
discussed.  The health professionals’ training in mental health and their methods 
of assessment of patients’ psychological well- being are reflected upon.  I then 
consider the participants’ perspectives on changes and resources that could 
improve issues of compliance and outcomes.  The importance of support networks 
for patients which include family, psychological and spiritual support will be 
explored.  And finally, challenges for renal health professionals and patient 
experiences with the healthcare system will also be discussed.  I conclude this 
chapter by considering areas for future research. 
Impacts on psychological well-being 
Factors affecting psychological well-being in renal patients begin immediately 
upon diagnosis.  When diagnosed with renal failure most of the patients who were 
interviewed expressed that their initial reaction was that of shock and fear.  This 
was confirmed by the health professionals who see newly diagnosed patients 
presenting as stunned and apprehensive.  These reactions arise for a variety of 
reasons explained in the literature.  Firstly, renal patients’ very reality is altered as 
their identity immediately changes from being ‘healthy’ to ‘sick’.  Secondly many 
of the lifestyle changes attendant with renal disease are very difficult to manage 
for new patients.  They must follow strict dietary and fluid constraints and 
experience disruptions to their freedom. The removal of choice from renal 
patients’ lives eliminates their ability to exercise free-will which depletes their 
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sense of autonomy.  Additionally, they must cope with the effect of chronic 
kidney disease on their financial and social circumstances (Zalai et al., 2012).   
A diagnosis of renal failure with the need for dialysis is usually unexpected, 
which may be in part due to an absence of early screening.  An interesting finding 
in this research is the lack of screening for renal disease in NZ.  Pre-dialysis 
education is reported by Walker et al. (2010) to be necessary so that patients have 
time to accept their diagnosis and understand treatment options.  According to 
New Zealand Kidney Foundation (2007) the need for dialysis can be delayed by 
careful monitoring of diet and fluid intake in pre-dialysis care.  However, the 
patients in this study reported a lack of early access to this type of information or 
assistance.  Many participants described a loss of appetite and the difficulties 
associated with having to be selective about various foods.  Steiber (2014) 
reported that renal patients under the care of a dietician have lower mortality rates. 
The notion of compliance is raised frequently in the findings.  Compliance 
regarding fluid and diet restrictions, the taking of medication, accepting treatment 
and attending clinic appointments were significant issues discussed by the 
participants.  It was suggested that more flexibility and choice regarding dialysis 
treatment times for patients might improve compliance.  One suggestion raised 
was to have the option of clinic appointments on the day of dialysis for the in-care 
participants.  This was proposed to avoid the need for an additional trip to the 
hospital for these already stretched patients.  The results from both patients and 
health professionals found that education is considered to be important for 
patients in order for them to understand why they need to comply.  This was 
consistent with other research which found that non-compliance is linked to a lack 
of adequate knowledge (Chan et al., 2012).  Christensen and Ehlers (2002) 
established that the issue of non-compliance is due to the various psychological 
aspects and lack of autonomy that challenge renal patients.  Similarly, Calia et al. 
(2015) found that when renal patients are provided with specific psychological 
support their compliance increases.  This suggests that psychological assistance 
with the complex problems that renal patients experience could decrease rates of 
non-compliance.  The findings in this research were consistent with those of Calia 
et al. (2015) and the widely held view of the participants emphasised that 
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psychological support should be an integral part of treatment for patients with 
renal disease. 
Participants in this study highlighted a lack of access to the pre-dialysis care 
needed to educate patients and their families on aspects of the disease, including 
how to prepare meals suitable for a renal patient.  The difficulty of having to 
stringently control fluid intake was raised throughout the findings by a vast 
majority of the participants.  The overarching theme conveyed by the renal 
patients was the constant worry of becoming ‘overloaded’ with fluid in-between 
dialysis treatments.  The negative effect of fluid overload is widely researched as 
it contributes to shortened patient survival (Christensen & Ehlers, 2002; White & 
McDonnell, 2014).  The patients reiterated that the management of this aspect of 
the disease was very challenging for them.  
Because ESKD patients are reported to experience high rates of depression 
associated with adverse dialysis outcomes, mental health screening in this 
population would be advantageous (Zalai et al., 2012).  This would identify 
depression earlier and enable the necessary psychological support to be put in 
place.  The argument that diagnosis for depression in ESKD patients is 
problematic should not negate the provision of support.  Even though there are 
similarities between the somatic symptoms of depression and the physical 
symptoms associated with the side effects of ESKD these still need to be 
addressed.  A key finding of this research was the lack of psychological services 
provided at the Waikato Regional Renal Centre.  A majority of participants stated 
that they had never been offered any psychological support.  It appeared that 
while most of the participants were coping quite well with depression, there were 
at risk participants who indicated they were suffering with severe depression.  
Furthermore, a small proportion of the participants expressed that they would like 
to die, and have experienced suicidal ideation at varying times since being 
diagnosed with ESKD.  This is confirmed elsewhere as De Sousa (2008) found 
that ESKD patients have higher suicide rates than the normal population.  These 
findings are not surprising and indicate that the patients in this study need to have 
access to considerably more psychological services than are available at present. 
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This research also found that age of the patient and the amount of time a patient 
had been on dialysis were significant factors affecting the BDI results.  The results 
of the BAI performed by the questionnaire participants suggest a proportion of the 
participants were suffering from severe anxiety.  These results are not surprising 
given that depression and anxiety are highly correlated (Alavi et al., 2009).  
Causes of anxiety for dialysis patients include the dialysis treatment routine, and 
the alarm sounding on the dialysis machines.  For HD patients having their fistula 
cannulated by new dialysis staff caused anxiety (Hmwe et al., 2015).  It was found 
that the neurophysiological aspects, such as wobbliness in legs and feeling 
unsteady were the most problematic for the participants to tolerate.  The BAI 
results found that the age of the participant, their income and treatment option 
were all significant factors affecting anxiety.  These findings could assist health 
professionals working with renal patients to recognise those at risk of depressive 
and or anxiety symptoms.  In this research screening for depression was raised as 
a possible solution for monitoring the mental health of the patients. It is widely 
recommended in the literature that all ESKD patients should be carefully screened 
for depression (Cukor, Rosenthal, Jindal, Brown, & Kimmel, 2009).  Wuerth, 
Finkelstein, and Finkelstein (2005) suggest that regular screening using the BDI 
gives the patient an opportunity to talk to a mental health professional, which may 
relieve situational stress.  Although research has clearly identified that screening 
could benefit renal patients, the surprising view of social workers interviewed for 
this research was that it was not necessary.  
Need for psychological support for patients 
This research sought to determine what training renal health professionals had in 
the area of mental health and well-being.  It was found that apart from the social 
workers other health professionals had minimal or no training in mental health 
and none was undertaken in the unit.  Fairly rudimentary observational methods to 
probe a patient about depression and or anxiety were put into effect by the health 
professionals to assess the mental health status of a patient.  This was often only 
when the patient already had obvious indications that they were struggling.  The 
staff were not able to provide a diagnosis or treatment for what was wrong.  This 
would appear to indicate that the mental health symptoms in these renal patients 
are in danger of being underdiagnosed.  Furthermore, the hospital and community 
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health professionals expressed that even when requested psychological services 
were inconsistent and very hard to access.  They articulated the desire for 
convenient and regular access to psychological services as part of the treatment 
team.  Several conveyed that this had been sadly lacking for a long time.  As Deb 
stated, “I’ve been here 30 years and way back over 20 years ago we had a 
psychologist as part of our renal team, which was fantastic.”  As would be 
expected the overwhelming sentiment of the renal patient participants was that 
psychological support was for them an urgent priority.  These findings 
demonstrate the need for either additional training in mental health for the health 
professionals, and or better access to permanent psychological services at the 
renal unit.  Furthermore, the social workers believed that individual therapy would 
be more beneficial than group therapy.  An interesting finding in this research was 
that most of the renal patients were either ambivalent or not interested in either 
form of therapy when asked about it in the questionnaire which probably suggests 
a lack of knowledge. 
Egan et al. (2014) found that attending to the renal patients’ spiritual needs 
contributes to their improved psychological well-being which leads to a better 
quality of life.  The results in this study indicated that approximately half of the 
participants considered spiritual support to be important.  However, the health 
professionals stated that although they might want to discuss topics like the 
grieving process and spiritual support, they do not have the time to do so.  
Furthermore, it was proposed by one health professional that better availability of 
psychological support for renal patients would give credence to the Te Whare 
Tapa Wha health model.  In view of the research findings that renal specialists 
may lack an awareness of patient’s spiritual needs and also palliative care needs, 
using this model as a framework could address this (Egan et al., 2014).  The 
findings repeatedly stressed the need for improved psychological services and this 
was expressed by both patients and health professionals.  As depression is a 
prevalent under- treated comorbidity in patients with ESKD and is associated with 
increased mortality the need for psychological services is very apparent for these 
patients (Hedayati, Yalamanchili, & Finkelstein, 2012).  Time and time again it 
was suggested in this study that access to psychological services would greatly 
complement the treatment delivered to ESKD patients.   
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The results of this research were consistent with others regarding social support in 
that it was found that a key component for psychological well-being for renal 
patients was that their requirements for help and support be met.  Schick Makaroff 
(2012) found that social support can be received from family, friends and medical 
personnel.  The participants discussed how important family support was and the 
findings confirm that most families had a representative who accompanied the 
renal patient to the education sessions for dialysis.  Being open to learning is a 
prerequisite for family members of renal patients.  The health professionals agreed 
that educating family is huge, and encouraged bringing a support person to 
education sessions and to clinics as they felt this was beneficial.  This fits with the 
literature which postulates that ongoing education for the family is a necessity so 
that they are aware of the many ways to assist an individual on dialysis, and 
support home based education programmes that involve the family (Massey et al., 
2011; Shih & Honey, 2011).   
Pomaki et al. (2011) suggest that some family members are overprotective and 
unnecessarily limit the patient’s activities.  The health professionals confirmed 
this, citing the example of family members speaking for the patient.  An 
interesting finding in this research was that according to most of the renal patients 
they felt that their family members had a good understanding of renal disease.  
They reported that their families understood the implications of dialysis and why 
they required extra help with practical tasks.  However, the perception of some of 
the health professionals was contradictory as they expressed doubt at the degree of 
many families understanding about the renal patients’ illness.  They concluded 
this because of their observations and personal exchanges with family members.  
They also communicated that there were a lot of things a family could learn to do 
to help their member with renal disease.  Conversely, the patient participants 
conveyed that their family were already doing enough to help them.  Overall, the 
patients stated that they were satisfied with the levels of support they were 
receiving from family.  This may be explained by previous findings across the 
literature that indicate that renal patients often feel as though they are a burden on 
their family members (Karamanidou, Weinman, & Horne, 2014; Schick 
Makaroff, 2012).  Many of the patients themselves talked about feeling this way 
in this study.  This may be why they overestimate their family’s understanding of 
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their disease and do not expect them to give any more support than at present.  
They are reluctant to make any more demands on their family members for fear of 
adding to the ‘burden’ on the household of their disease.  As stated by McQuoid, 
Jowsey, and Talaulikar (2017) ESKD is a complex juggling act between illness 
management and other everyday activities.  It was found in this study that the 
level of practical support offered by the family members was considered helpful 
to the renal patients. 
Other support received from family discussed by the participants included 
financial, emotional and spiritual support.  Walker et al. (2013) point out that 
renal patients have many ongoing decisions to make and that a shared decision-
making model helped make this easier for them, whereby the treatment options 
were discussed with the patient and family and decisions were made according to 
what would be most appropriate within that particular family.  Likewise, Jayanti 
et al. (2015) suggest that end stage renal patients are faced with incrementally 
complex decision making throughout their treatment journey and to be supported 
in this process is key.  Crail et al. (2013) recommend that all decisions regarding 
end of life care need to involve the patient and family as a decision in palliative 
care to decline treatment will lead to death within a short period of time (New 
Zealand Kidney Foundation, 2007).   
Patients who use home dialysis can require more active assistance from the 
family.  Walker et al. (2015) suggest a key attribute for home dialysis patients is 
family or caregiver support.  de Maar et al. (2016) indicated that optimal home 
dialysis training involves a family member.  In this research, the literature 
suggests that the positive outcomes for home dialysis such as quality of life and 
longer survival rates outweigh the in-care dialysis outcomes (Kutner et al., 2005). 
Despite this Wilkie (2011) states the international trend for home dialysis 
continues to decline perhaps due to a lack of suitable support.  Holman (2011) 
points out that health professionals need to give carers of home dialysis patients 
time, space and permission to talk about how caring impacts on their lives.  It was 
established in this research that it was important to keep the family engaged so 
they can continue to provide practical help and support.  The health professionals 
acknowledged that it takes time for families to understand such a complex illness.  
In this study, some health professionals also acknowledged that families are often 
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undervalued.  In this study family support was found to be very important to the 
renal patients.  They appreciated the practical help within the home as well as 
emotional support from family.  This research highlighted how renal disease 
affects the whole family not just the patient, and how complex these relationships 
can become when a person has a chronic illness. 
Patients need for improved communication  
When asked whether their concerns about treatment were listened to and acted 
upon, a surprising nine out of eleven patients interviewed had one or more 
negative experiences with health professionals that they wished to recount.  While 
it was reported by some that they have experienced continued provision of good 
care from doctors and nurses, most participants expressed frustration with staff 
over problems they felt were preventable.  Many complained about being unable 
to comprehend poor explanations causing an information overload.  Others felt 
that though they had an understanding of their medical requirements they had to 
bring constant pressure to bear to obtain services.  Whilst patients said they were 
dissatisfied with aspects of the hospital system, more significantly many patients 
criticised the interpersonal communications between health professionals and 
themselves.  This was not just about the information they were being told, but also 
the way in which it was delivered.  It has been found that how staff interact with 
patients is important for mediating improved outcomes for renal patients 
(Kimmel, 2001).   
White and McDonnell (2014) also state that health professionals working with 
renal patients should help them with the significant psychological challenges they 
are confronted with every day.  Schick Makaroff (2012) note that patients want 
closer connections with the health professionals who provide their care, therefore 
a more collaborative relationship with patients would contribute to patients’ 
emotional well-being.  Contrary to this, these patients said they were not listened 
to and sometimes even felt bullied.  Several participants reported that when their 
concerns were serious they followed up by writing official letters of complaint to 
the DHB.  These formal complaints were mainly with regard to communication 
problems and sometimes also medical issues.  Schaad et al. (2015) stated that 
most complaints in hospitals are due to unhappiness with interpersonal 
interactions between patients and their providers. 
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This research explored what other resources the participants thought might 
improve the outcomes for renal patients.  The findings reflect that they have 
frustrations regarding some hospital protocols.  The lack of continuity regarding 
doctors seen at hospital appointments was raised as an issue.  The renal patients 
desired a more personal doctor and patient relationship with a primary doctor they 
can rely on.  Also discussed was improving communication with health 
professionals so that the patient felt more informed and secure.  More open 
communication was made with the suggestion that patients have a list of contact 
numbers for their health team.  A reengagement with kaitiaki services who offer 
cultural support for Māori and their whanau in hospital was also recommended as 
an extra resource for the patients.  The in-care patients proposed that there be less 
waiting time before starting dialysis by having a more effective shuttle system.  
Some patients preferring to travel less requested that HD machines be available in 
smaller communities.  
In their interviews, some of the health professionals also voiced concerns about 
other staff members, stating examples of lack of discretion, respect and sensitivity 
towards patients on the part of some health professionals.  They acknowledged 
also the long waiting lists and delays for necessary procedures and how 
unsatisfactory this situation was for the patients.  Research has clearly identified 
that patients suffer from higher anxiety the longer the waiting time is for surgery, 
and this correlates with decreased health for the patient and the risk of 
complications during the wait (Oudhoff, Timmermans, Knol, Bijnen, & van der 
Wal, 2007).  Zalai et al. (2012) recommended that renal healthcare teams learn 
from treatment models already implemented to promote psychological wellbeing 
in other medically ill populations and that these can be used to support renal 
patients.  The psychological impacts on patients who encounter negative 
healthcare experiences cannot be underestimated.  Renal patients are at higher risk 
for emotional distress leading to depression, which can culminate in earlier 
mortality (Christensen & Ehlers, 2002).  This is preventable with better 
communication and training about standards of care that are conducive to 
patients’ psychological well-being.  
The finding that pain was an ongoing problem experienced by the participants was 
also indicated in the literature which concludes that pain is the most common 
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symptom experienced by ESKD patients (White & McDonnell, 2014).  Both HD 
and PD patients described experiencing pain.  The HD patients complained about 
the pain when their fistula were needled for access, and PD patients about the 
painful abdominal distension they experience.  Furthermore, the participants 
discussed regular cramping, nausea, skin dryness and the excessive time HD 
patients must sit for treatment and how hard this is on their body.  The patients 
expressed that there was a lack of communication with the health professionals 
regarding any pain and also a reluctance to prescribe them with analgesic 
medication.  As Barakzoy and Moss (2006) found the undertreatment of pain has 
negative effects on both the physical and mental well-being of renal patients, it is 
recommended that they be closely monitored for pain and that pain relief should 
be prescribed to adequately manage pain.  The implementation of this should 
perhaps be considered for the participants in this study.  There are eight 
commonly prescribed medications for renal patients and these have been found to 
cause depression or have side effects that mimic its symptomatology (Kimmel, 
2002).  The perception of being over medicated was also raised by patient 
participants as impacting on their psychological wellness.  Many felt concerned 
about the side effects from the drugs.  It is therefore likely that this is a valid 
concern for these particpants which needs further investigation.  
The health professionals interviewed for this study reported that they have also at 
times experienced difficulties in their interactions with patients and family 
members.  They suggested that this could occur due to misconceptions in families 
who lack the appropriate knowledge or have a fear of something because they do 
not understand it.  The health professionals stressed that keeping a family 
cognisant of their member’s situation through regular communication was 
essential, because misinformed families can make their job more difficult, but also 
because these misunderstandings do not help the patient.  The health professionals 
discussed how some families wittingly and unwittingly can limit the patient's’ 
independence.  Sometimes this is done from ignorance but other times family 
members can be domineering and might even bully the patient.  They themselves 
had also encountered family members who have been disruptive and abusive.  The 
health professionals also spoke of occasions where families were unable to follow 
through with arrangements they have made and the difficulties that this can cause 
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for other patients and staff.  These challenges described by the health 
professionals would further suggest the necessity of more effective 
communication channels and education, so expectations of what is appropriate for 
the patient and family to follow are made clear.  
Another challenge talked about by the health professionals was the stress 
incumbent with their jobs.  This arises as a consequence of their everyday 
dealings with the grim nature and progression of renal disease in their patients.  
The coping mechanisms they used to alleviate the pressures of their work were 
discussed in this study.  The most common strategy the health professionals 
reported was the sharing of thoughts and feelings by talking with another 
colleague.  This is in line with literature which states that mentorship and 
collaboration between colleagues helps them to manage stress (Stanley et al., 
2015).  Josland et al. (2012) point out that if health professionals have 
comprehensive knowledge about what to expect through all the stages of renal 
disease from pre-dialysis to death, they may be able to partially pre-empt their 
emotional reactions.  The health professionals spoke of the emotional toll of 
losing a patient.  They said they cope by talking about the patient with other 
colleagues at work and emphasised that it was imperative to not take work 
pressures home.  
This research sought to explore the psychological wellness of renal patients using 
dialysis who were under the care of the Waikato Regional Renal Unit.  The renal 
patients were asked to share, via face to face interviews and responding to a 
questionnaire, their experiences about living with dialysis, and the health 
professionals, again via face to face interviews, about working with patients who 
have renal failure.  This investigation into the lived realities of the participants 
provided insight into the needs of renal patients, their families and health 
professionals and generated ideas about how renal services could be more 
responsive to people with renal failure.  
Future research 
The results of this study present a solid foundation for understanding the nature of 
psychological wellness of renal patients on dialysis under the care of the Waikato 
Regional Renal Centre.  Broad in their scope, the findings suggest that there are a 
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number of areas for improvement to the service that is offered.  To strengthen the 
service and our understanding of dialysis patients, further research information is 
required of specific groups.  Priority needs to be given to a study of young adults 
who are on dialysis.  According to the health professionals in my research “our 
rates of survival are not good with our young people.”  The influence of culture 
and ethnicity is another under researched area and requires attention especially 
given the high number of Māori and Pacific peoples with renal disease.  There is 
also a group of patients likely to have not participated in this study because they 
were too mentally or physically unwell to do so.  While deteriorating health might 
be an expected part of renal disease, it remains incumbent upon us to understand 
the fullness of the disease journey so as to offer timely and appropriate services 
and support.  Because in the main the interviewed participants were coping 
relatively well with treatment this was not a true representation of renal patients 
with end stage kidney disease.   
This research has highlighted a need for more inquiry into pain management and 
the use of appropriate analgesic medication for renal patients.  While this area of 
inquiry is outside the scope of this study and the researchers expertise it is 
important that the issue is raised for further investigation. 
While there is ongoing work in the area of palliative and end of life care it would 
be useful to more specifically understand the caregiver burden of supporting a 
dialysis patient.  While I surveyed with participants the nature of support they 
received from family, friends and other support people, their voices remain absent 
from the conversation. 
Possible research for the Waikato Renal Centre would be to conduct cost benefit 
evaluations on each of the issues raised in this study.  This study clearly found 
that there were areas for improvement that the centre should attend to and 
consider implementing.  It would seem that not only will these implementations 
benefit patient outcomes but they will likely make financial sense also. 
Why this research? 
Over the four years I have been visiting the renal unit as a support person to my 
friend as she undergoes dialysis.  It has been my privilege to observe the strength 
and courage and the acceptance with which the patients cope with their highly 
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debilitating disease and intrusive treatments.  I have witnessed the distress and 
pain and trauma that are a part of the relentless struggle that is end stage kidney 
disease.  It is for these people that I undertook this research in an effort to 
determine the psychological toll this disease has on them and the ways this may 
be remediated for them.  I also came to realise, as had been my own case, that 
very little is known about ESKD and the renal replacement treatments needed to 
survive.  It my hope to raise this awareness and perhaps contribute towards 
positive change in the difficult lives that renal patients are required to endure. 
Through the process of this research I have come to truly value my health and 
autonomy and wish to continue to use these to give support to those who have lost 
theirs. 
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Appendix A: Questionnaire confirmation sheet 
 
Thank you 
 for addressing and posting the questionnaires 
 
Please confirm for statistical purposes the number of envelopes you posted on my 
behalf: 
 
Satellite dialysis patients 
 
This box contains 50 envelopes  
 
If total amount was handed out posted, please tick here  
    
Or amount handed out _________________ 
 
Please hand this form to Helen upon collection and I will collect from her, this is 
so I can accurately analyse the data. 
 
Enjoy the chocolate ☺ 
 
Kind regards 
Cherie Pepperell 
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Appendix B: Dialysis patient questionnaire 
 
Kia ora / Greetings 
 
Exploring the psychological wellbeing of renal patients in New Zealand 
 
My name is Cherie Pepperell and I am a Masters psychology student at the 
University of Waikato.  I am conducting research into the psychological health of 
dialysis patients.  I became interested in this topic because my best friend is living 
with renal failure.  I have witnessed and continue to support her through her 
journey of dialysis and the vast array of emotional difficulties along the way.  My 
goal is to provide more research involving New Zealand dialysis patients because 
there is limited research available. 
 
You are invited to complete this questionnaire, which takes about fifteen 
minutes, if you are currently using peritoneal dialysis or haemodialysis.  The 
questionnaire consists of questions about your health and mental wellbeing.  The 
information collected will be used in a data analysis and will be reported in a 
thesis.  This research is supervised by Professor Linda Nikora and Dr Carrie 
Barber. 
 
A medical issue such as renal failure can be stressful.  You are not obliged to 
complete the questionnaire and can choose to opt out at any time.  You have the 
right not to answer particular questions.  This research has been reviewed and 
approved by the University of Waikato School of Psychology Ethics Committee, 
and the Waikato District Health Board (DHB).  Furthermore, a consultation with 
Te Puna Oranga Maori Consultation Research Committee, Waikato DHB for 
cultural and community approval was completed.  If you have any questions or 
concerns about your rights as a participant in this research, you can contact the 
conveyor of the Psychology Research and Ethics Committee (Dr Rebecca 
Sargisson, phone 07 5578673, email: rebeccas@waikato.ac.nz 
 
Your details will be kept anonymous and confidential.  You will not be able to be 
identified in the data as the completed questionnaire will not be linked to any 
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identifying details.  The completed questionnaire will only be seen by me and my 
supervisor and will remain confidential. 
 
By completing this questionnaire, you are consenting to the data being used in the 
study.  If you would like a brief summary report of the findings, please email me 
and I will send you a summary after the study is finished.   
 
Contact Details 
 
Cherie Pepperell.  Email: csk5@students.waikato.ac.nz or phone: 021 082 
17722              Professor Linda Nikora (supervisor).  Email: 
psyc2046@waikato.ac.nz   
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Background Questions 
 
What is your gender? 
 Male 
 Female 
 
What is your age? 
 please insert ____________________ 
 
What is your marital status? 
 Never married 
 Married or de facto 
 Widowed 
 Separated / Divorced 
 
What is your ethnicity? 
 NZ Maori 
 NZ European 
 Other European 
 Pacific Islander 
 Other ____________________ 
 
Approximate total household income over the last 12 months: 
 20,000 or less 
 20,001 - 30,000 
 30,001 - 50,000 
 50,001 - 70,000 
 70,001 - 100,000 
 100,001 or more 
 
What dialysis treatment are you currently using? 
 Peritoneal Dialysis 
 Haemodialysis 
 
Which treatment option are you currently using? 
 In care Haemodialysis 
 Home Haemodialysis 
 Continuous Ambulatory Peritoneal Dialysis 
 Automated Peritoneal Dialysis 
 
Have you used both treatment options? 
 Yes 
 No 
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How long have you been receiving dialysis treatments? 
 Please advise ____________________ 
 
Are you on the kidney transplant waiting list? 
 Yes 
 No 
 
The following question are about social support using the Social Provisions 
Scale-Short Version. 
 
There are people I can depend on to help me if I really need it. 
 Strongly disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
I feel that I do not have close personal relationships with other people 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
There is no one I can turn to for guidance in times of stress. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
There are people who enjoy the same social activities that I do. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
I do not think other people respect my skills and abilities. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
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If something went wrong, no one would come to my assistance. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
I have close relationships that provide me with a sense of emotional security and 
wellbeing. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
I have relationships where my competence and skills are recognized. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
There is no one who shares my interests and concerns. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
 
There is a trustworthy person I could turn to for advice if I were having problems. 
 Strongly Disagree 
 Disagree 
 Agree 
 Strongly Agree 
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This section is to ascertain levels of depression using the Beck Depression 
Inventory-Second Edition. 
 
Instructions: This questionnaire consists of 21 groups of statements.  Please read 
each group of statements carefully, and then pick out the one statement in each 
group that best describes the way you have been feeling during the past two 
weeks, including today.  Circle or if completing online choose the number beside 
the statement you have picked.  If several statements in the group seem to apply 
equally well, circle the highest number for that group.  Be sure that you do not 
choose more than one statement for any group, including Item 16 (Changes in 
Sleeping Pattern) or Item 18 (Changes in Appetite). 
 
1.  Sadness 
 0.  I do not feel sad. 
 1.   I feel sad much of the time. 
 2. I am sad all the time. 
 3.  I am so sad or unhappy that I can't stand it. 
 
2.  Pessimism 
 0. I am not discouraged about my future. 
 1. I feel more discouraged about my future than I used to be. 
 2. I do not expect things to work out for me. 
 3. I feel my future is hopeless and will only get worse. 
 
3.  Past Failure 
 0. I do not feel like a failure. 
 1. I have failed more than I should have. 
 2. As I look back, I see a lot of failures. 
 3. I feel I am a total failure as a person. 
 
4.  Loss of Pleasure 
 0. I get as much pleasure as I ever did from the things I enjoy. 
 1. I don't enjoy things as much as I used to. 
 2. I get very little pleasure from the things I used to enjoy. 
 3. I can't get any pleasure from the things I used to enjoy. 
 
5.  Guilty Feelings 
 0. I don't feel particularly guilty. 
 1. I feel guilty over many things I have done or should have done. 
 2. I feel guilty most of the time. 
 3. I feel guilty all of the time. 
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6.  Punishment Feelings 
 0. I don't feel I am being punished. 
 1. I feel I may be punished. 
 2. I expect to be punished. 
 3. I feel I am being punished. 
 
7.  Self-Dislike 
 0. I feel the same about myself as ever. 
 1. I have lost confidence in myself. 
 2. I am disappointed in myself. 
 3. I dislike myself. 
 
8.  Self-Criticalness 
 0. I don't criticize or blame myself more than usual. 
 1. I am more critical of myself than I used to be. 
 2. I criticize myself for all of my faults. 
 3. I blame myself for everything bad that happens. 
 
9.  Suicidal Thoughts or Wishes 
 0. I don't have any thoughts of killing myself. 
 1. I have thoughts of killing myself, but I would not carry them out. 
 2. I would like to kill myself. 
 3. I would kill myself if I had the chance. 
 
10.  Crying 
 0. I don't cry any more than I used to. 
 1. I cry more than I used to. 
 2. I cry over every little thing. 
 3. I feel like crying, but I can't. 
 
11.  Agitation 
 0. I am no more restless or wound up than usual. 
 1. I feel more restless or wound up than usual. 
 2. I am so restless or agitated that it's hard to stay still. 
 3. I am so restless or agitated that I have to keep moving or doing something. 
 
12.  Loss of Interest 
 0. I have not lost interest in other people or activities. 
 1. I am less interested in other people or things than before. 
 2. I have lost most of my interest in other people or things. 
 3. It's hard to get interested in anything. 
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13.  Indecisiveness 
 0. I make decisions about as well as ever. 
 1. I find it more difficult to make decisions than usual. 
 2. I have much greater difficulty in making decisions than I used to. 
 3. I have trouble making any decisions. 
 
14.  Worthlessness 
 0. I do not feel I am worthless. 
 1. I don't consider myself as worthwhile and useful as I used to. 
 2. I feel more worthless as compared to other people. 
 3. I feel utterly worthless. 
 
15.  Loss of Energy 
 0. I have as much energy as ever. 
 1. I have less energy than I used to have. 
 2. I don't have enough energy to do very much. 
 3. I don't have enough energy to do anything. 
 
16.  Changes in Sleeping Pattern 
 0. I have not experienced any change in my sleeping pattern. 
 1a. I sleep somewhat more than usual. 
 1b. I sleep somewhat less than usual. 
 2a. I sleep a lot more than usual. 
 2b. I sleep a lot less than usual. 
 3a. I sleep most of the day. 
 3b. I wake up 1-2 hours early and can't get back to sleep. 
 
17.  Irritability 
 0. I am no more irritable than usual. 
 1. I am more irritable than usual. 
 2. I am much more irritable than usual. 
 3. I am irritable all the time. 
 
18.  Changes in Appetite 
 0. I have not experienced any change in my appetite. 
 1a. My appetite is somewhat less than usual. 
 1b. My appetite is somewhat greater than usual. 
 2a. My appetite is much less than before. 
 2b. My appetite is much greater than usual. 
 3a. I have no appetite at all. 
 3b. I crave food all the time. 
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19.  Concentration Difficulty 
 0. I can concentrate as well as ever. 
 1. I can't concentrate as well as usual. 
 2. It's hard to keep my mind on anything for very long. 
 3. I find I can't concentrate on anything. 
 
20.  Tiredness or Fatigue 
 0. I am no more tired or fatigued than usual. 
 1. I get more tired or fatigued more easily than usual. 
 2. I am too tired or fatigued to do a lot of the things I used to do. 
 3. I am too tired or fatigued to do most of the things I used to do. 
 
21.  Loss of Interest in Sex 
 0. I have not noticed any recent change in my interest in sex. 
 1. I am less interested in sex than I sued to be. 
 2. I am much less interested in sex now. 
 3. I have lost interest in sex completely 
 
 
 
 
 
 
 
 
 
 
This section is to ascertain levels of anxiety using the Beck Anxiety Inventory. 
 
Instructions:  Below is a list of common symptoms of anxiety.  Please carefully 
read each item in the list.  Indicate how much you have been bothered by each 
symptom during the PAST WEEK, INCLUDING TODAY, by placing an X in the 
corresponding space in the column next to each symptom.  
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NOT AT 
ALL 
MILDLY (It 
did not 
bother me 
much) 
MODERATELY 
(It was very 
unpleasant, but I 
could stand it). 
SEVERELY 
(I could barely 
stand it). 
1. Numbness or 
tingling. 
        
2. Feeling hot.         
3. Wobbliness 
in legs. 
        
4. Unable to 
relax. 
        
5. Fear of the 
worst 
happening. 
        
6. Dizzy or 
lightheaded. 
        
7. Heart 
pounding or 
racing. 
        
8. Unsteady.         
9. Terrified.         
10. Nervous.         
11. Feelings of 
choking. 
        
12. Hands 
Trembling. 
        
13. Shaky.         
14. Fear of 
losing control. 
        
15. Difficulty 
breathing. 
        
16. Fear of 
dying. 
        
17. Scared.         
18. Indigestion 
or discomfort 
in abdomen. 
        
19. Faint.         
20. Face 
flushed. 
        
21. Sweating 
(not due to 
heat) 
        
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The following questions are about psychological wellbeing 
 
Have you ever been offered any psychological services whilst receiving renal 
treatments? 
 Yes 
 please describe: ____________________ 
 No 
 
What activity do you prefer to do whilst in treatment? 
 watch TV 
 listen to music 
 talk to staff 
 read a book 
 use your computer 
 phone friends / family 
 other ____________________ 
 
Do you have any coping mechanisms you use whilst in treatment? 
 Yes ____________________ 
 No 
 
Do you feel your requests are being considered whilst in treatment, if no why? 
 Yes 
 No ____________________ 
 
Do you feel secure whilst participating in treatment? 
 Yes 
 No 
 
How important is the nurse's response your requests? 
 Not at all Important 
 Very Unimportant 
 Somewhat Unimportant 
 Neither Important nor Unimportant 
 Somewhat Important 
 Very Important 
 Extremely Important 
 
Do you feel your care level is adequate, if no why?  
 Yes 
 No ____________________ 
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Do your whanau/family/significant other have an active role in your care? 
 Yes 
 No 
 
Do your whanau/family/significant other understand the nature of your illness? 
 Yes 
 No 
 
What does your whanau/family/significant other do to help support you in your 
care? 
 Please list ____________________ 
 
Are their tasks/activities you would like your whanau/family/significant other to 
be involved in that would make coping easier for you? 
 Please list ____________________ 
 
Would you be interested in attending group therapy sessions? 
 Yes 
 Maybe 
 No 
 
Would you be interested in attending individual therapy? 
 yes 
 Maybe 
 No 
 
Would you like access to massage therapy? 
 Yes 
 Maybe 
 No 
 
Would you be interested in learning about meditation techniques? 
 Yes 
 Maybe 
 No 
 
Would you be interested in learning visualization techniques?  
 Yes 
 Maybe 
 No 
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Is spiritual support important to you? 
 Yes 
 Maybe 
 No 
 
How would you rate your health in general now? 
 Much better 
 Better 
 Somewhat Better 
 About the Same 
 Somewhat Worse 
 Worse 
 Much Worse 
 
 
 
Thank you for completing this questionnaire.  
 
Please post the completed questionnaire directly to me in the pre-paid envelope, 
or you can take it to the renal unit at the Waikato Hospital in Hamilton and place 
in collection box. 
 
If you have any questions do not hesitate to contact me, 
Cherie Pepperell: email: csk5@students.waikato.ac.nz or phone: 021 082 17722 
 
If you feel completing this questionnaire has been emotionally difficult for you 
and you would like to talk to someone about your feelings and experiences please 
contact your health professional, or there is a free, confidential counseling service 
called Lifeline and you can contact them by calling 0800 543 354.   
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Appendix C: Flyer - Patient 
 
Exploring the level of psychological wellness of renal patients using dialysis in 
Waikato, NZ 
My name is Cherie Pepperell and I am looking for people to interview who are 
using dialysis.  I am researching the level of psychological wellness for peritoneal 
and haemodialysis patients for my master’s thesis. 
I would really appreciate it if you could complete the enclosed questionnaire as 
well as contact me so that I can interview you about your dialysis journey. 
If you would like to talk to me please text, email or phone using the numbers 
below: 
Email: csk5@students.waikato.ac.nz 
Phone / Text: 021 082 17722 
 
Your information is confidential at all times. 
This research has been approved by the Waikato University Ethics Committee, 
Waikato District Health Board and Te Puna Oranga Māori Consultation Research 
Review Committee. 
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Appendix D: Flyer – Health Professional 
 
Exploring the level of psychological wellness of renal patients using dialysis in 
Waikato, NZ 
My name is Cherie Pepperell and I am looking for people to interview who are 
working with patients who are using dialysis.  I am researching the level of 
psychological wellness of dialysis patients for my master’s thesis. 
 
I would really appreciate it if you would contact me so that I can interview you 
about your experiences. 
 
If you would like to talk to me please text, email or phone using the numbers 
below: 
Email: csk5@students.waikato.ac.nz 
Phone / Text: 021 082 17722 
 
 Your information is confidential at all times. 
This research has been approved by the Waikato University Ethics Committee, 
Waikato District Health Board and Te Puna Oranga Māori Consultation Research 
Review Committee. 
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Appendix E: Information sheet - Patients  
 
Information sheet for patients using dialysis 
Exploring the psychological wellbeing of renal patients in NZ 
What is the project about? 
This research project seeks to explore what the level of psychological wellness is 
for renal patients in the Waikato region.  At present there is little information 
pertaining to the levels of social support, depression, anxiety and psychological 
wellness for renal patients on dialysis.   
Who are the researchers? 
I am a Masters student for the School of Psychology at Waikato University.  I am 
working under the supervision of Professor Linda Nikora and Dr Carrie Barber.  
This research project has been given ethical approval by the University of 
Waikato, Waikato District Health Board and Te Puna Oranga Māori Consultation 
Research Review Committee.  If you have any concerns, you can contact my 
supervisor or the Chair of the Ethics Committee (contact detail below). 
Why are you being asked to participate? 
Your lived experiences of renal failure will provide valuable information. 
What will happen to my information?  
All information gathered will be held at the University of Waikato and it will only 
be available to me or my supervisor.  If you would like a summary of the final 
results I can send you a copy. 
Will other people know who I am or what I say? 
No a pseudonym will be used to protect your privacy.  I will be the only person 
who knows where the information has come from. 
What if I agree to participate and then change my mind?   
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If you change your mind and wish to withdraw your interview data, you have up 
to two weeks after the interview to inform me and I will remove this data. 
 
Researcher contacts: 
Cherie Pepperell (Masters Student), Phone: 021 082 17722 
email: csk5@students.waikato.ac.nz    
Professor Linda Nikora (Supervisor) email: psyc2046@waikato.ac.nz   
If you have any questions or concerns about your rights as a participant in this 
research, you can contact the conveyor of the Psychology Research and Ethics 
Committee (Dr Rebecca Sargisson, phone 07 5578673, email: 
rebeccas@waikato.ac.nz). 
 
Address: School of Psychology 
  University of Waikato 
  Private Bag 3105  
  Hamilton 3240  
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Appendix F: Information sheet – Health professional 
 
Information sheet for health professionals 
Exploring the psychological wellbeing of renal patients in NZ 
What is the project about? 
This research project seeks to explore what the level of psychological wellness is 
for renal patients in the Waikato region.  At present there is little information 
pertaining to the levels of social support, depression, anxiety and psychological 
wellness for renal patients on dialysis.   
Who are the researchers? 
I am a Masters student for the School of Psychology at Waikato University.  I am 
working under the supervision of Professor Linda Nikora and Dr Carrie Barber.  
This research project has been given ethical approval by the University of 
Waikato, Waikato District Health Board and Te Puna Oranga Māori Consultation 
Research Review Committee.  If you have any concerns, you can contact my 
supervisor or the Chair of the Ethics Committee (contact detail below). 
Why are you being asked to participate? 
Your experiences working with renal patients will provide valuable information. 
What will happen to my information?  
All information gathered will be held at the University of Waikato and it will only 
be available to me or my supervisor.  If you would like a summary of the final 
results I can send you a copy. 
Will other people know who I am or what I say? 
No a pseudonym will be used to protect your privacy.  I will be the only person 
who knows where the information has come from. 
What if I agree to participate and then change my mind?   
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If you change your mind and wish to withdraw your interview data, you have up 
to two weeks after the interview to inform me and I will remove this data. 
 
Researcher contacts: 
Cherie Pepperell (Masters Student). Phone: 021 082 17722 
email: csk5@students.waikato.ac.nz    
Professor Linda Nikora (Supervisor) email: psyc2046@waikato.ac.nz   
Conveyor of the Psychology Research and Ethics Committee: Dr Rebecca 
Sargisson, phone 07 5578673, email: rebeccas@waikato.ac.nz 
 
Address: School of Psychology 
  University of Waikato 
  Private Bag 3105  
  Hamilton 3240    
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Appendix G: Consent form - Patients  
CONSENT FORM FOR DIALYSIS PATIENTS 
      A completed copy of this form should be retained by both the researcher and the participant. 
Research Project: Exploring the level of psychological wellness of renal patients on dialysis 
in the Waikato, NZ. 
Please complete the following checklist.  Tick () the appropriate box for each point.  YES NO 
1. I have read the Participant Information Sheet (or it has been read to me) and I understand it.     
2. I have been given sufficient time to consider whether or not to participate in this study.   
3. I am satisfied with the answers I have been given regarding the study and I have a copy of 
this consent form and information sheet. 
  
4. I understand that taking part in this study is voluntary (my choice) and that I may withdraw 
from the study up to two weeks after the interview. 
  
5. I have the right to decline to participate in any part of the research activity.   
6. I know who to contact if I have any questions about the study in general.   
7. I understand that my interview is being recorded.   
8. I understand that my participation in this study is confidential and that no material, which 
could identify me personally, will be used in any reports on this study. 
  
9. I wish to receive a copy of the findings.      
10. I wish to view the summary report of my interview.   
Declaration by participant: 
I agree to participate in this 
I agree to participate in this research project.  If I have any concerns about this project, I may contact 
the convenor of the Psychology Research and Ethics Committee (Dr Rebecca Sargisson, phone 07 
557 8673, email: rebeccas@waikato.ac.nz)  
Participant’s name (Please print): 
Signature: Date: 
Declaration by member of research team: 
I have given a verbal explanation of the research project to the participant, and have answered the 
participant’s questions about it. I believe that the participant understands the study and has given 
informed consent to participate. 
Researcher’s name: Cherie Pepperell 
Signature: Date: 
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Appendix H: Consent form – Health professional  
CONSENT FORM FOR RENAL HEALTH PROFESSIONALS 
A completed copy of this form should be retained by both the researcher and the participant.  
Research Project: Exploring the level of psychological wellness of renal patients on dialysis 
in the Waikato, NZ. 
Please complete the following checklist.  Tick () the appropriate box for each point.  YES NO 
11. I have read the Participant Information Sheet (or it has been read to me) and I understand it.     
12. I have been given sufficient time to consider whether or not to participate in this study.   
13. I am satisfied with the answers I have been given regarding the study and I have a copy of 
this consent form and information sheet. 
  
14. I understand that taking part in this study is voluntary (my choice) and that I may withdraw 
from the study up to two weeks after the interview. 
  
15. I have the right to decline to participate in any part of the research activity.   
16. I know who to contact if I have any questions about the study in general.   
17. I understand that my interview is being recorded.   
18. I understand that my participation in this study is confidential and that no material, which 
could identify me personally, will be used in any reports on this study. 
  
19. I wish to receive a copy of the findings.      
20. I wish to view the summary report of my interview.   
Declaration by participant: 
I agree to participate in this research project.  If I have any concerns about this project, I may contact 
the convenor of the Psychology Research and Ethics Committee (Dr Rebecca Sargisson, phone 07 
557 8673, email: rebeccas@waikato.ac.nz)  
Participant’s name (Please print): 
Signature: Date: 
Declaration by member of research team: 
I have given a verbal explanation of the research project to the participant, and have answered the 
participant’s questions about it. I believe that the participant understands the study and has given 
informed consent to participate. 
Researcher’s name: Cherie Pepperell 
Signature: Date: 
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Appendix I: Interview questions - Patients 
 
Questions for renal patients 
General Questions 
How long have you had renal failure? 
When did you start dialysis? What was that like for you? 
Do you use haemodialysis or peritoneal dialysis as a treatment option?  Have you used 
both? 
How would you describe your experience of kidney failure? 
In your opinion what resources do you think would improve your overall wellbeing? 
Have you been offered any psychological help since diagnosed with renal failure? Can 
you tell me about this? 
Do you feel factors such as depression, anxiety, stress, family, financial issues are taken 
into consideration within your treatment programme?  Which ones have you been 
effected by? 
Do you work? Have you encountered discrimination regarding your treatment routine? 
Do you feel when you have a concern that you are listened to by your health professionals 
and action is taken? 
Do you feel you have any control over your treatment? Can you tell me more about that?  
Are you currently on the transplant list? Is this an option you would consider? 
How would you rate your health in general now? 
What do you do to relax? 
Would you be interested in individual or group therapy sessions? Why?  
What role does your whanau/family/significant other play in your care? 
Does your whanau/family/significant other understand the nature of your illness? 
What does your whanau/family/significant other do to help support you in your care? 
Are their tasks/activities you would like your whanau/family/significant other to be 
involved in that would make coping with renal failure easier for you? 
Any further comments? 
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Appendix J: Interview question – Health professional 
 
Questions for health professionals 
General Questions 
What is your role?  
How long have you been working / or worked in renal services? 
Do you have any training in mental health? If so what? 
Do you measure / test patients for depression / anxiety? If so how? 
Do you think that routine screening for depression is a good idea? If so, why? 
What do you think would increase compliance for patients? 
What impact do you think psychological services has/would have for patients? 
How do you gage the psychological wellness of a patient? What do you do if you feel 
they are in need of assistance?   
What resources do you think would improve the overall wellness of renal patients?  
Do you think the patients would be interested in individual or group therapy sessions?  
In your opinion what do you think the patients struggle with the most? 
Would you be interested in learning about relaxation techniques that may benefit 
patients? 
What techniques do you use to cope with work stress? 
What role do you think whanau/family/significant others typically play in the care of 
patients? 
Do whanau/family/significant others typically understand the nature of the illness? 
Are their tasks/activities/knowledge that whanau/family/significant others might be more 
involved with to support the care of patients? 
Are their things that whanau/family/significant others do that make your job more 
difficult? 
Any further comments? 
 
